Research

Items from Faculty of Science > Pharmacy & Pharmacology

Up a level
Export as [feed] RSS 1.0 [feed] Atom [feed] RSS 2.0
Group by: Creators | Date | Item Type | No Grouping
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Number of items at this level: 2713.

A

Abbate, F., Winum, J.-Y., Potter, B. V. L., Casini, A., Montero, J.-L., Scozzafava, A. and Supuran, C. T., 2004. Carbonic anhydrase inhibitors : X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase. Bioorganic & Medicinal Chemistry Letters, 14 (1), pp. 231-234.

Abbate, S., Longhi, G., Castiglioni, E., Lebon, F., Wood, P. M., Woo, L. W. L. and Potter, B. V. L., 2009. Determination of the absolute configuration of aromatase and dual aromatase-sulfatase inhibitors by vibrational and electronic circular dichroism spectra analysis. Chirality, 21 (9), pp. 802-808.

Abbate, V., Hider, R. C., Pourzand, C. and Reelfs, O., 2013. Mitochondia-targeted iron chelators for the monitoring and adjustment of cellular labile iron pools. In: Fifth Congress of the International BioIron Society (IBIS), 2013-04-13 - 2013-04-17, London.

Abdallah, A. M., Renzoni, E. A., Anevlavis, S., Lagan, A. L., Munkonge, F. M., Fonseca, C., Black, C. M., Briggs, D., Wells, A. U., Marshall, S. E., McHugh, N., du Bois, R. M. and Welsh, K. I., 2006. A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis. International journal of immunogenetics, 33 (3), pp. 155-161.

Abla, N., Geiser, L., Mirgaldi, M., Naik, A., Veuthey, J. L., Guy, R. H. and Kalia, Y. N., 2005. Capillary zone electrophoresis for the estimation of transdermal iontophoretic mobility. Journal of Pharmaceutical Sciences, 94 (12), pp. 2667-2675.

Abla, N., Naik, A., Guy, R. H. and Kalia, Y. N., 2005. Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin. Journal of Controlled Release, 108, pp. 319-330.

Abla, N., Naik, A., Guy, R. H. and Kalia, Y. N., 2005. Effect of charge and molecular weight on transdermal peptide delivery by iontophoresis. Pharmaceutical Research, 22 (12), pp. 2069-2078.

Abla, N., Naik, A., Guy, R. H. and Kalia, Y. N., 2006. Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery. Pharmaceutical Research, 23 (8), pp. 1842-1849.

Abla, N., Raik, A., Guy, R. H. and Kalia, Y. N., 2005. Iontophoresis: clinical applications and future challenges. In: Smith, E. W. and Maibach, H. I., eds. Percutaneous Penetration Enhancers, 2nd ed. Vol. 2nd Edition. Boca Raton, Florida: CRC Press, pp. 177-219.

Acharya, K. R. and Lloyd, M. D., 2005. The advantages and limitations of protein crystal structures. Trends in Pharmacological Sciences, 26 (1), pp. 10-14.

Acosta Felquer, M. L., Coates, L. C., Soriano, E. R., Ranza, R., Espinoza, L. R., Helliwell, P. S., FitzGerald, O., McHugh, N., Roussou, E. and Mease, P. J., 2014. Drug therapies for peripheral joint disease in psoriatic arthritis : a systematic review. The Journal of Rheumatology, 41 (11), pp. 2277-2285.

Adjimatera, N., Blagbrough, I. S. and Pourzand, C., 2005. Monitoring formulation and intracellular delivery of plasmids by lipopolyamines. Abstracts of Papers of the American Chemical Society, 229, U211-U211.

Adjimatera, N., Kral, T., Hof, M. and Blagbrough, I. S., 2006. Lipopolyamine-mediated single nanoparticle formation of calf thymus DNA analyzed by fluorescence correlation spectroscopy. Pharmaceutical Research, 23 (7), pp. 1564-1573.

Adjimatera, N., Neal, A. P. and Blagbrough, I. S., 2005. Fluorescence techniques in non-viral gene therapy. In: Hof, M., Hutterer, R. and Fidler, V., eds. Fluorescence Spectroscopy in Biology: Advanced Methods and their Applications to Membranes, Proteins, DNA, and Cells. Vol. 3. Heidelberg: Springer, pp. 201-228. (Springer Series on Fluorescence)

Adjimatera, N., Neal, A. P. and Blagbrough, I. S., 2005. Sensing DNA nanocomplex delivery by fluorescent probes. Abstracts of Papers of the American Chemical Society, 229, U140-U140.

Adjimatera, N., Neal, A. P., Pourzand, C. and Blagbrough, I. S., 2005. Fluorescent lipopolyamines: A new class of molecular probes in non-viral gene therapy. Abstracts of Papers of the American Chemical Society, 229, U117-U117.

Adkins, C. E., Wissing, F., Potter, B. V. L. and Taylor, C. W., 2000. Rapid activation and partial inactivation of inositol trisphosphate receptors by adenophostin A. Biochemical Journal, 352, pp. 929-933.

Agbor, T. A., Demma, Z., Mrsny, R. J., Castillo, A., Boll, E. J. and Mccormick, B. A., 2014. The oxido-reductase enzyme glutathione peroxidase 4 (GPX4) governs Salmonella Typhimurium-induced neutrophil transepithelial migration. Cellular Microbiology, 16 (9), pp. 1339-1353.

Ahmed, O. A. A., Adjimatera, N., Pourzand, C. and Blagbrough, I. S., 2005. N4,N9-dioleoyl spermine is a novel nonviral lipopolyamine vector for plasmid DNA formulation. Pharmaceutical Research, 22 (6), pp. 972-980.

Ahmed, O. A. A. and Blagbrough, I. S., 2006. Formulation and delivery of p-EGFP DNA condensed by a synthetic lipospermine. Journal of Pharmacy and Pharmacology, 58, A63-A63.

Akasaka, T., Balasas, T., Russell, L. J., Sugimoto, K. J., Majid, A., Walewska, R., Karran, E. L., Brown, D. G., Cain, K., Harder, L., Gesk, S., Martin-Subero, J. I., Atherton, M. G., Brüggemann, M., Calasanz, M. J., Davies, T., Haas, O. A., Hagemeijer, A., Kempski, H., Lessard, M., Lillington, D. M., Moore, S., Nguyen-Khac, F., Radford-Weiss, I., Schoch, C., Struski, S., Talley, P., Welham, M. J., Worley, H., Strefford, J. C., Harrison, C. J., Siebert, R. and Dyer, M. J. S., 2007. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood, 109 (8), pp. 3451-3461.

Akkaya, Ö., İşsever Öztürk, S., Bolhuis, A. and Gümüşel, F., 2012. Mutations in the translation initiation region of the pac gene resulting in increased levels of activity of penicillin G acylase. World Journal of Microbiology and Biotechnology, 28 (5), pp. 2159-2164.

Al-Heresh, A. M., Proctor, J., Jones, S. M., Dixey, J., Cox, B., Welsh, K. and McHugh, N., 2002. Tumour necrosis factor‐α polymorphism and the HLA‐Cw*0602 allele in psoriatic arthritis. Rheumatology, 41 (5), pp. 525-530.

Al-Qenaei, A., Yiakouvaki, A., Hall, N. D. and Pourzand, C., 2007. The role of lysosomal labile iron pool in differential sensitivity of Jurkat T cell lines to hydrogen peroxide. American Journal of Hematology, 82 (6), p. 565.

Al-Qenaei, A., 2008. The role of iron in rheumatoid arthritis. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Al-Qenaei, A., Yiakouvaki, A., Reelfs, O., Santambrogio, P., Levi, S., Hall, N. D., Tyrrell, R. M. and Pourzand, C., 2014. Role of intracellular labile iron, ferritin, and antioxidant defence in resistance of chronically adapted Jurkat T cells to hydrogen peroxide. Free Radical Biology and Medicine, 68, pp. 87-100.

Al-Shukaily, A., Lyndon, G. J., Baugh, J. A. and Hall, N. D., 2003. Oxidative stress as a pro-inflammatory modulator of T cell-monocyte interactions. Inflammation Research, 52 (Suppl 2), S148.

Alam, J., Igarashi, K., Immenshuh, S., Shibabara, S. and Tyrrell, R. M., 2004. Regulation of the heme oxygenase 1 gene: recent advances and highlights from the international conference (Uppsala, 2003) on heme oxygenase. Antioxidants & Redox Signaling, 6 (5), pp. 924-933.

Alberti, I., Kalia, Y. N., Naik, A., Bonny, J. D. and Guy, R. H., 2001. Effect of ethanol and isopropyl myristate on the bioavailability of topical terbinafine in human stratum corneum, in vivo. International Journal of Pharmaceutics, 219, pp. 11-19.

Alberti, I., Kalia, Y. N., Naik, A., Bonny, J. D. and Guy, R. H., 2001. In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum. Journal of Controlled Release, 71, pp. 319-327.

Alberti, I., Kalia, Y. N., Naik, A. and Guy, R. H., 2001. Assessment and prediction of the cutaneous bioavailability of topical terbinafine, in vivo , in man. Pharmaceutical Research, 18 (10), pp. 1472-1475.

Ali Khan, M., Wood, P. J., Lamb-Guhren, N. M., Caggiano, L., Kociok-Köhn, G., Tosh, D. and Lewis, S. E., 2014. The enone motif of (+)-grandifloracin is not essential for 'anti-austerity' antiproliferative activity. Bioorganic & Medicinal Chemistry Letters, 24 (13), pp. 2815-2819.

Ali-Hassan, S., 2012. The Development of Biological Therapeutics. Thesis (Master of Philosophy (MPhil)). University of Bath.

Allan, G. M., Bubert, C., Vicker, N., Smith, A., Tutill, H. J., Purohit, A., Reed, M. J. and Potter, B. V. L., 2006. Novel, potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1. Molecular and Cellular Endocrinology, 248 (1), pp. 204-207.

Allan, G. M., Lawrence, H. R., Cornet, J., Bubert, C., Fischer, D. S., Vicker, N., Smith, A., Tutill, H. J., Purohit, A., Day, J. M., Mahon, M. F., Reed, M. J. and Potter, B. V. L., 2006. Modification of estrone at the 6, 16, and 17 positions : novel potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1. Journal of Medicinal Chemistry, 49 (4), pp. 1325-1345.

Allan, G. M., Vicker, N., Lawrence, H. R., Tutill, H. J., Day, J. M., Huchet, M., Ferrandis, E., Reed, M. J., Purohit, A. and Potter, B. V. L., 2008. Novel inhibitors of 17β-hydroxysteroid dehydrogenase type 1 : templates for design. Bioorganic and Medicinal Chemistry, 16 (8), pp. 4438-4456.

Allen, T., Iftinca, M., Cole, W. C. and Plane, F., 2002. Smooth muscle membrane potential modulates endothelium-dependent relaxation of rat basilar artery via myo-endothelial gap junctions. The Journal of Physiology, 545 (3), pp. 975-986.

Allwood, M. B., Cannan, B., van Aalten, D. M. F. and Eggleston, I. M., 2007. Efficient synthesis of 1,3,7-substituted xanthines by a safety-catch protection strategy. Tetrahedron, 63, pp. 12294-12302.

Altroff, H., Van der Walle, C. F., Asselin, J., Fairless, R., Campbell, I. D. and Mardon, H. J., 2001. The eighth FIII domain of human fibronectin promotes integrin α5β1binding via stabilization of the ninth FIII domain. Journal of Biological Chemistry, 276 (42), pp. 38885-38892.

Alvarez-Figueroa, M. J., Delgado-Charro, M. B. and Blanco-Méndez, J., 2001. Passive and iontophoretic transdermal penetration of methotrexate. International Journal of Pharmaceutics, 212, pp. 101-107.

Alvarez-Román, R., Barré, G., Guy, R. H. and Fessi, H., 2001. Biodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection. European Journal of Pharmaceutics and Biopharmaceutics, 52, pp. 191-195.

Alvarez-Román, R., Merino, G., Kalia, Y. N., Naik, A. and Guy, R. H., 2003. Skin permeability enhancement by low frequency sonophoresis: lipid extraction and transport pathways. Journal of Pharmaceutical Sciences, 92 (6), pp. 1138-1146.

Alvarez-Román, R., Naik, A., Kalia, Y. N., Fessi, H. and Guy, R. H., 2004. Visualization of skin penetration using confocal laser scanning microscopy. European Journal of Pharmaceutics and Biopharmaceutics, 58, pp. 301-316.

Alvarez-Román, R., Naik, A., Kalia, Y. N., Guy, R. H. and Fessi, H., 2004. Enhancement of topical delivery from biodegradable nanoparticles. Pharmaceutical Research, 21 (10), pp. 1818-1825.

Alvarez-Román, R., Naik, A., Kalia, Y. N., Guy, R. H. and Fessi, H., 2004. Skin penetration and distribution of polymeric nanoparticles. Journal of Controlled Release, 99, pp. 53-62.

Amadesi, S., Grant, A. D., Cottrell, G. S., Vaksman, N., Poole, D. P., Rozengurt, E. and Bunnett, N. W., 2009. Protein kinase D isoforms are expressed in rat and mouse primary sensory neurons and are activated by agonists of protease-activated receptor 2. The Journal of Comparative Neurology, 516 (2), pp. 141-156.

Amaya, M. F., Watts, A. G., Damager, I., Wehenkel, A., Nguyen, T., Buschiazzo, A., Paris, G., Frasch, A. C., Withers, S. G. and Alzari, P. M., 2004. Structural insights into the catalytic mechanism of trypanosoma cruzi trans-sialidase. Structure, 12 (5), pp. 775-784.

Andersen, O. A., Dixon, M. J., Eggleston, I. M. and van Aalten, D. M. F., 2005. Natural product family 18 chitinase inhibitors. Natural Product Reports, 22, pp. 563-579.

Andersen, O. A., Nathubhai, A., Dixon, M. J., Eggleston, I. M. and van Aalten, D. M. F., 2008. Structure-based dissection of the natural product cyclopentapeptide chitinase inhibitor argifin. Chemistry & Biology, 15 (3), pp. 295-301.

Anderson, H., Bartley, E., Davison, A. M., Haines, S. L. and Rogers, P. J., 2002. Patients' experiences of over-the-counter treatments for irritable bowel syndrome. International Journal of Pharmacy Practice, 10 ((Suppl)), R21.

Anderson, N. J., Robinson, E. S. J., Husbands, S. M., Delagrange, P., Nutt, D. J. and Hudson, A. L., 2003. Characterization of [3H]Harmane Binding to Rat Whole Brain Membranes. Annals of the New York Academy of Sciences, 1009 (1), pp. 175-179.

Anderson, N. J., Tyacke, R. J., Husbands, S. M., Nutt, D. J., Hudson, A. L. and Robinson, E. S. J., 2006. In vitro and ex vivo distribution of [ 3 H]harmane, an endogenous β-carboline, in rat brain. Neuropharmacology, 50, pp. 269-276.

Anto, B., James, K.L., Barlow, D., Brinklow, N., Oborne, C.A. and Whittlesea, C., 2013. Exploratory study to identify the process used by pharmacy staff to verify the accuracy of dispensed medicines. International Journal of Pharmacy Practice, 21 (4), pp. 233-242.

Apel, M., Uebe, S., Bowes, J., Giardina, E., Korendowych, E., Juneblad, K., Pasutto, F., Ekici, A. B., McManus, R., Ho, P., Bruce, I. N., Ryan, A. W., Behrens, F., Böhm, B., Traupe, H., Lohmann, J., Gieger, C., Wichmann, H.-E., Padyukov, L., Fitzgerald, O., Alenius, G.-M., McHugh, N. J., Novelli, G., Burkhardt, H., Barton, A., Reis, A. and Hüffmeier, U., 2013. Variants in RUNX3 contribute to susceptibility to psoriatic arthritis exhibiting further common ground with ankylosing spondylitis. Arthritis & Rheumatism, 65 (5), pp. 1224-1231.

Ariza, A., Vickers, T. J., Greig, N., Armour, K. A., Dixon, M. J., Eggleston, I. M., Fairlamb, A. H. and Bond, C. S., 2006. Specificity of the trypanothione-dependent Leishmania major glyoxalase 1: structure and biochemical comparison with the human enzyme. Molecular Microbiology, 59 (4), pp. 1239-1248.

Armas, J. B., Dantas, J., Mendonça, D., Farto, R., Ribeiro, M., Herrero-Beaumont, G., Gouveia, J. and McHugh, N. J., 2000. Anticardiolipin and antinuclear antibodies in cancer patients--a case control study. Clinical and Experimental Rheumatology, 18 (2), pp. 227-232.

Armas, J. B., Davies, J., Davis, M., Lovell, C. and McHugh, N., 1992. Atypical Behçet's disease with peripheral erosive arthropathy and pyoderma gangrenosum. Clinical and Experimental Rheumatology, 10 (2), pp. 177-180.

Aroun, A., Zhong, J. L., Tyrrell, R. M. and Pourzand, C., 2012. Iron, oxidative stress and the example of solar ultraviolet A radiation. Photochemical & Photobiological Sciences, 11 (1), pp. 118-134.

Arrowsmith, R. L., Waghorn, P. A., Jones, M. W., Bauman, A., Brayshaw, S. K., Hu, Z. Y., Kociok-Kohn, G., Mindt, T. L., Tyrrell, R. M., Botchway, S. W., Dilworth, J. R. and Pascu, S. I., 2011. Fluorescent gallium and indium bis(thiosemicarbazonates) and their radiolabelled analogues: Synthesis, structures and cellular confocal fluorescence imaging investigations. Dalton Transactions, 40 (23), pp. 6238-6252.

Arrowsmith, R. L., Zeglis, B. M., Viola-Villegas, N., Divilov, V., Jones, M., Waghorn, P. A., Phillips, F. L., Mindt, T. L., Eggleston, I. M., Botchway, S. W., Dilworth, J. R., Aigbirhio, F. I., Lewis, J. S. and Pascu, S. I., 2011. Fluorescent copper(II), gallium(III) and indium(III) bis(thiosemicarbazonates) : Radiolabeling, cellular confocal fluorescence and PET imaging studies. Journal of Labelled Compounds & Radiopharmaceuticals, 54 (Supplement 1), S59.

Arumugam, R. and McHugh, N. J., 2012. Mortality and causes of death in psoriatic arthritis. Journal of Rheumatology, Supplement 89, pp. 32-35.

Ashamu, G. A., Galione, A. and Potter, B. V. L., 1995. Chemoenzymatic synthesis of analogues of the second messenger candidate cyclic adenosine 5′-diphosphate ribose. Journal of the Chemical Society, Chemical Communications, 1995 (13), pp. 1359-1360.

Ashamu, G. A., Sethi, J. K., Galione, A. and Potter, B. V. L., 1997. Roles for adenosine ribose hydroxyl groups in cyclic adenosine 5‘-diphosphate ribose-mediated Ca2+ release. Biochemistry, 36 (31), pp. 9509-9517.

Astoul, E., Edmunds, C., Cantrell, D. A. and Ward, S. G., 2001. PI 3-K and T-cell activation: limitations of T-leukemic cell lines as signaling models. Trends in Immunology, 22 (9), pp. 490-496.

Auner, B. G., O'Neill, M. A. A., Valenta, C. and Hadgraft, J., 2005. Interaction of phloretin and 6-ketocholestanol with DPPC-liposomes as phospholipid model membranes. International Journal of Pharmaceutics, 294, pp. 149-155.

B

Babu, K. S., Woodcock, D. A., Smith, S. E., Staniforth, J. N., Holgate, S. T. and Conway, J. H., 2003. Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma. European Respiratory Journal, 21 (6), pp. 1046-1049.

Bailey, C., Henderson, G. and Kelly, E., 2008. Functional selectivity in GPCR desensitization. Fundamental & Clinical Pharmacology, 22, p. 7.

Bailey, C. P., 2007. Morphine tolerance: getting hooked. The Biochemist, 29, pp. 12-15.

Bailey, C. P. and Connor, M., 2005. Opioids: cellular mechanisms of tolerance and physical dependence. Current Opinion in Pharmacology, 5 (1), pp. 60-68.

Bailey, C. P., Couch, D., Johnson, E., Griffiths, K., Kelly, E. and Henderson, G., 2003. μ-Opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine. Journal of Neuroscience, 23 (33), pp. 10515-10520.

Bailey, C. P., O'Callaghan, M. J., Croft, A. P., Manley, S. J. and Little, H. J., 2001. Alterations in mesolimbic dopamine function during the abstinence period following chronic ethanol consumption. Neuropharmacology, 41, pp. 989-999.

Bailey, C. P., Smith, F. L., Kelly, E., Dewey, W. L. and Henderson, G., 2006. How important is protein kinase C in μ-opioid receptor desensitization and morphine tolerance? Trends in Pharmacological Sciences, 27 (11), pp. 558-565.

Bailey, C. P., Llorente, J., Gabra, B. H., Smith, F. L., Dewey, W. L., Kelly, E. and Henderson, G., 2009. Role of protein kinase C and μ-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons. European Journal of Neuroscience, 29 (2), pp. 307-318.

Bailey, C. P., Nicholls, R. E., Zhang, X. L., Zhou, Z. Y., Muller, W., Kandel, E. R. and Stanton, P. K., 2008. Gαi2 inhibition of adenylate cyclase regulates presynaptic activity and unmasks cGMP-dependent long-term depression at Schaffer collateral-CA1 hippocampal synapses. Learning and Memory, 15 (4), pp. 261-270.

Bailey, C. P., Oldfield, S., Llorente, J., Caunt, C. J., Teschemacher, A., Roberts, L., McArdle, C., Smith, F., Dewey, W., Kelly, E. and Henderson, G., 2009. Involvement of PKCα and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of µ-opioid receptors in mature brain neurons. British Journal of Pharmacology, 158 (1), pp. 157-164.

Bailey, H. V., Heaton, W., Vicker, N. and Potter, B. V. L., 2006. Rapid microwave-assisted reductive amination of ketones with anilines. Synlett, 2006 (15), pp. 2444-2448.

Bailey, H. V., 2007. Drug design and novel anti-cancer therapeutics: inhibitors of 17β [beta] hydroxysteroid dehydrogenase type 3. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Bailey, S., Casal-Dominguez, J. and Husbands, S. M., 2012. Antidepressant effects of novel kappa-opioid receptor antagonists in the forced swim test. Journal of Psychopharmacology, 26 (8), A16.

Bailey, S. J., Casal-Dominguez, J. J., Bradbury, F. A., Traynor, J. R. and Husbands, S. M., 2010. In vivo characterisation of 5'-amino and amidino-alkyl,naltrindole derivatives at the kappa-opioid receptor. Journal of Psychopharmacology, 24 (Supplement 3), A42.

Bailey, S. J., Casal-Dominguez, J. J. and Husbands, S. M., 2011. Anxiolytic effects of novel kappa-opioid receptor antagonists in the elevated plus maze. Journal of Psychopharmacology, 25 (8), A76.

Bailey, S. J. and McCaffery, P. J., 2009. Retinoic acid signalling in neuropsychiatric disease: possible markers and treatment agents. In: Ritsner, M. S., ed. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes, and Genes. Volume III: Metabolic and Peripheral Biomarkers. Vol. 3. Netherlands: Springer, pp. 171-189.

Bailey, S. J. and McCaffery, P. J., 2010. Vulnerability of the brain to neuropsychiatric disorders resulting from abnormal thyroid hormone or vitamin D homeostasis. In: Ritsner, M., ed. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Netherlands: Springer, pp. 105-133.

Bailey, V. C., Fortt, S. M., Summerhill, R. J., Galione, A. and Potter, B. V.l., 1996. Cyclic aristeromycin diphosphate ribose : a potent and poorly hydrolysable Ca2+-mobilising mimic of cyclic adenosine diphosphate ribose. FEBS Letters, 379 (3), pp. 227-230.

Ball, A. L., Chambers, K. A., Hewinson, M., Navaratnarajah, S., Samrin, L., Thomas, N., Tyler, A. E. H., Wall, A. J. and Lloyd, M. D., 2008. A microtitre plate assay for measuring glycosidase activity. Journal of Enzyme Inhibition and Medicinal Chemistry, 23 (1), pp. 131-135.

Ballard, K. D., Seaman, H. E., de Vries, C. S. and Wright, J. T., 2008. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study - Part 1. BJOG : An International Journal Of Obstetrics & Gynaecology, 115 (11), pp. 1382-1391.

Banks, J., Shaw, A. and Weiss, M. C., 2007. The community pharmacy and discursive complexity: A qualitative study of interaction between counter assistants and customers. Health and Social Care in the Community, 15 (4), pp. 313-321.

Banks, J., Shaw, A. and Weiss, M. C., 2005. Walking a line between health care and sales: The role of the medicines counter assistant. Pharmaceutical Journal, 274 (7349), pp. 586-589.

Baptist, M., Braksator, E., Bailey, C., Kelly, E. and Henderson, G., 2008. Mu-opioid receptor internalisation : Studies using a pHluorin tag. Fundamental & Clinical Pharmacology, 22, p. 60.

Baraldi, E., Carugo, K. D., Hyvönen, M., Surdo, P. L., Riley, A. M., Potter, B. V. L., O’Brien, R., Ladbury, J. E. and Saraste, M., 1999. Structure of the PH domain from Bruton's tyrosine kinase in complex with inositol 1,3,4,5-tetrakisphosphate. Structure, 7 (4), pp. 449-460.

Barrett, C. M. L., Ray, N., Thomas, J. D., Robinson, C. and Bolhuis, A., 2003. Quantitative export of a reporter protein, GFP, by the twin-arginine translocation pathway in Escherichia coli. Biochemical and Biophysical Research Communications, 304 (2), pp. 279-284.

Barrington, S. L., Carroll, R., Hewitson, M., Munangatire, B., Rogers, P. J. and Wood, S. M., 2003. Use of diphenhydramine as a non-prescription hypnotic: patients' experiences. International Journal of Pharmacy Practice, 11, R25.

Bartlett, T. E., Bannister, N. J., Collett, V. J., Dargan, S. L., Massey, P. V., Bortolotto, Z. A., Fitzjohn, S. M., Bashir, Z. I., Collingridge, G. L. and Lodge, D., 2007. Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus. Neuropharmacology, 52 (1), pp. 60-70.

Bartrum, H. E., Adams, H., Caggiano, L. and Jackson, R. F. W., 2008. Synthesis of β2-homophenylalanine derivatives by Negishi cross-coupling reactions. Tetrahedron, 64 (17), pp. 3701-3712.

Bashir, Z. I. and Massey, P. V., 2006. Long-term potentiation & long-term depression. In: Selzer, M., Clarke, L., Cohen, P., Duncan, P. and Gage, F., eds. Textbook of Neural Repair and Rehabillitation: Neural Repair and Plasticity. Vol. 1. New York: Cambridge University Press, pp. 60-78.

Basu-Modak, S., Ali, D., Gordon, M., Polte, T., Yiakouvaki, A., Pourzand, C., Rice-Evans, C. and Tyrrell, R. M., 2006. Suppression of UVA-mediated release of labile iron by epicatechin - A link to lysosomal protection. Free Radical Biology and Medicine, 41 (8), pp. 1197-1204.

Basu-Modak, S., Gordon, M. J., Dobson, L. H., Spencer, J. P. E., Rice-Evans, C. and Tyrrell, R. M., 2003. Epicatechin and its methylated metabolite attenuate UVA-induced oxidative damage to human skin fibroblasts. Free Radical Biology and Medicine, 35 (8), pp. 910-921.

Basu-Modak, S. and Tyrrell, R. M., 2001. Modulation of gene expression by solar ultraviolet radiation. In: Giacomoni, P. U., ed. Sun Protection in Man. Elsevier Science B.V., pp. 303-320.

Batchelor, H.K., Fotaki, N. and Klein, S., 2014. Paediatric oral biopharmaceutics : Key considerations and current challenges. Advanced Drug Delivery Reviews, 73, pp. 102-126.

Batt, M. E., Jaques, R. and Stone, M., 2004. Preparticipation examination (screening): Practical issues as determined by sport - A United Kingdom perspective. Clinical Journal of Sport Medicine, 14 (3), pp. 178-182.

Baxter, K., Weiss, M. C. and LeGrand, J., 2007. Collaborative commissioning of secondary care services by Primary Care Trusts. Public Money and Management, 27 (3), pp. 207-214.

Baxter, K., Weiss, M. C. and Grand, J. L., 2008. The dynamics of commissioning across organisational and clinical boundaries. Journal of Health, Organisation and Management, 22 (2), pp. 111-128.

Bayoumi, S. A. L. H., 2008. Molecular genetic analysis of secondary metabolite biosynthesis in cassava as an economic and nutritious plant. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Beard, J. D., Burbridge, D. J., Moskalenko, A. V., Dudko, O., Yarova, P. L., Smirnov, S. V. and Gordeev, S. N., 2009. An atomic force microscope nanoscalpel for nanolithography and biological applications. Nanotechnology, 20 (44), 445302.

Beard, J. D., Gordeev, S. N. and Guy, R. H., 2011. AFM nanotools for surgery of biological Cells. Journal of Physics: Conference Series, 286 (1), 012003.

Beard, J. D., Guy, R. H. and Gordeev, S. N., 2013. Mechanical tomography of human corneocytes with a nanoneedle. Journal Of Investigative Dermatology, 133 (6), pp. 1565-1571.

Beauchard, A., Phillips, V. A., Lloyd, M. D. and Threadgill, M. D., 2009. Synthesis of 2-(4-carboxybutenyl)- and 2-(4-carboxybutynyl)-cyclopentene-1-carboxamides. Tetrahedron, 65 (39), pp. 8176-8184.

Beauchard, A., Phillips, V. A., Lloyd, M. D. and Threadgill, M. D., 2008. Synthesis of a mimic of phosphorserylproline as a potential inhibitor of Pin1. In: RSC Bioorganic Group Annual Post-Graduate Symposium P13, 2008, 2008-03-01.

Beecroft, M. D., Marchant, J. S., Riley, A. M., Van Straten, N. C. R., Van Der Marel, G. A., Van Boom, J. H., Potter, B. V. L. and Taylor, C. W., 1999. Acyclophostin : a ribose-modified analog of adenophostin A with high affinity for inositol 1,4,5-trisphosphate receptors and pH-dependent efficacy. Molecular Pharmacology, 55 (1), pp. 109-117.

Beeton, M.L., Aldrich-Wright, J.R. and Bolhuis, A., 2014. The antimicrobial and antibiofilm activities of copper(II) complexes. Journal of Inorganic Biochemistry, 140, pp. 167-172.

Beezer, A. E., Hills, A. K., O'Neill, M. A. A., Morris, A. C., Kierstan, K. T. E., Deal, R. M., Waters, L. J., Hadgraft, J., Mitchell, J. C., Connor, J. A., Orchard, J. E., Willson, R. J., Hofelich, T. C., Beaudin, J., Wolf, G., Baitalow, F., Gaisford, S., Lane, R. A., Buckton, G., Phipps, M. A., Winneke, R. A., Schmitt, E. A., Hansen, L. D., O'Sullivan, D. and Parmar, M. K., 2001. The imidazole catalysed hydrolysis of triacetin: an inter- and intra-laboratory development of a test reaction for isothermal heat conduction microcalorimeters used for determination of both thermodynamic and kinetic parameters. Thermochimica Acta, 380, pp. 13-17.

Beezer, A. E., Morris, A. C., O'Neill, M. A. A., Willson, R. J., Hills, A. K., Mitchell, J. C. and Connor, J. A., 2001. Direct determination of equilibrium thermodynamic and kinetic parameters from isothermal heat conduction microcalorimetry. Journal of Physical Chemistry B, 105, pp. 1212-1215.

Beezer, A. E., O'Neill, M. A. A., Urakami, K., Connor, J. A. and Tetteh, J., 2004. Pharmaceutical microcalorimetry: recent advances in the study of solid state materials. Thermochimica Acta, 420, pp. 19-22.

Begat, P., Morton, D. A. V., Staniforth, J. N. and Price, R., 2004. The cohesive-adhesive balances in dry powder inhaler formulations II: Influence on fine particle delivery characteristics. Pharmaceutical Research, 21 (10), pp. 1826-1833.

Begat, P., Young, P. M., Edge, S., Kaerger, J. S. and Price, R., 2003. The effect of mechanical processing on surface stability of pharmaceutical powders: Visualization by atomic force microscopy. Journal of Pharmaceutical Sciences, 92 (3), pp. 611-620.

Begat, P., Morton, D. A. V., Shur, J., Kippax, P., Staniforth, J. N. and Price, R., 2009. The role of force control agents in high-dose dry powder inhaler formulations. Journal of Pharmaceutical Sciences, 98 (8), pp. 2770-2783.

Begat, P., Morton, D. A. V., Staniforth, J. N. and Price, R., 2004. The cohesive-adhesive balances in dry powder inhaler formulations I: direct quantification by atomic force microscopy. Pharmaceutical Research, 21 (9), pp. 1591-1597.

Behrens, F., Cañete, J. D., Olivieri, I., van Kuijk, A. W., McHugh, N. and Combe, B., 2014. Tumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA : a systematic review of the literature. Rheumatology

Belevych, A. E., Beck, R., Tammaro, P., Poston, L. and Smirnov, S. V., 2002. Developmental changes in the functional characteristics and expression of voltage-gated K + channel currents in rat aortic myocytes. Cardiovascular Research, 54 (1), pp. 152-161.

Beleznai, T., Takano, H., Hamill, C., Yarova, P., Douglas, G., Channon, K. and Dora, K., 2011. Enhanced K+-channel-mediated endothelium-dependent local and conducted dilation of small mesenteric arteries from ApoE -/- mice. Cardiovascular Research, 92 (2), pp. 199-208.

Beleznai, T. Z., Yarova, P. L., Yuill, K. H. and Dora, K. A., 2011. Smooth Muscle Ca(2+)-Activated and Voltage-Gated K(+) Channels Modulate Conducted Dilation in Rat Isolated Small Mesenteric Arteries. Microcirculation, 18 (6), pp. 487-500.

Belsey, N. A., Cordery, S. F., Bunge, A. L. and Guy, R. H., 2011. Assessment of dermal exposure to pesticide residues during re-entry. Environmental Science & Technology, 45 (10), pp. 4609-4615.

Belsey, N. A., Garrett, N. L., Contreras-Rojas, L. R., Pickup-Gerlaugh, A. J., Price, G. J., Moger, J. and Guy, R. H., 2014. Evaluation of drug delivery to intact and porated skin by coherent Raman scattering and fluorescence microscopies. Journal of Controlled Release, 174 (28), pp. 37-42.

Bennett, J. H., Carter, D. H., Alavi, A. L., Beresford, J. N. and Walsh, S., 2001. Patterns of integrin expression in a human mandibular explant model of osteoblast differentiation. Archives of Oral Biology, 46 (3), pp. 229-238.

Berg, I., Potter, B. V. L., Mayr, G. W. and Guse, A. H., 2000. Nicotinic acid adenine dinucleotide phosphate (NAADP+) is an essential regulator of T-lymphocyte Ca2+-signaling. The Journal of Cell Biology (JCB), 150 (3), pp. 581-588.

Betteridge, Z., Chinoy, H., Vencovsky, J., Cooper, R. G. and McHugh, N. J., 2011. Identification of autoantibodies to a novel autoantigen protein complex (EIF3) in polymyositis patients. Rheumatology, 50 (Supplement 3), pp. 105-106.

Betteridge, Z. E., Gunawardena, H. and McHugh, N. J., 2011. Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. Arthritis Research & Therapy, 13 (2), 209.

Betteridge, Z. E., Gunawardena, H. and McHugh, N. J., 2009. Pathogenic mechanisms of disease in myositis: autoantigens as clues. Current Opinion in Rheumatology, 21 (6), pp. 604-9.

Bhalla, N., Di Lorenzo, M., Pula, G. and Estrela, P., 2014. Novel tools for protein phosphorylation analysis based on proton release detection. In: 24th Anniversary World Congress on Biosensors, 2014-05-27 - 2014-05-30, Melbourne.

Bhalla, N., Formisano, N., Miodek, A., Di Lorenzo, M., Pula, G. and Estrela, P., 2015. Integrated nanoplasmonic and field-effect sensing for kinase drug discovery applications. In: 2nd International Conference on Label-Free Technologies, 2015-03-12 - 2015-03-14, Boston.

Bhalla, N., Formisano, N., Miodek, A., Di Lorenzo, M., Pula, G. and Estrela, P., 2015. Integrated nanoplasmonic and field-effect devices for kinase drug discovery. In: 2nd International Conference on Label-Free Technologies, 2015-03-01, Boston.

Bhalla, N., Formisano, N., Miodek, A., Jain, A., Di Lorenzo, M., Pula, G. and Estrela, P., 2015. Plasmonic ruler on field-effect devices for kinase drug discovery applications. Biosensors and Bioelectronics, 71, pp. 121-128. Item availability may be restricted.

Bhalla, N., Pathak, S., Bowen, C., Taylor, J., Di Lorenzo, M., Pula, G. and Estrela, P., 2015. Field-effect devices for kinase drug discovery. In: 4th International Conference on Bio-Sensing Technology, 2015-05-10 - 2015-05-13, Lisbon.

Bittner, B., McIntyre, C., Tian, H., Tang, K., Shah, N., Phuapradit, W., Ahmed, H., Chokshi, H., Infeld, M., Fotaki, N., Ma, H., Portron, A., Jordan, P. and Schmidt, J., 2012. Phase I clinical study to select a novel oral formulation for ibandronate containing the excipient sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC). Die Pharmazie - An International Journal of Pharmaceutical Sciences, 67 (3), pp. 233-241.

Black, S. L., Chauvignac, C., Grundt, P., Miller, C. N., Wood, S., Traynor, J. R., Lewis, J. W. and Husbands, S. M., 2003. Guanidino N-substituted and N,N-disubstituted derivatives of the k -opioid antagonist GNTI. Journal of Medicinal Chemistry, 46, pp. 5505-5511.

Black, S. L., Jales, A. R., Brandt, W., Lewis, J. W. and Husbands, S. M., 2003. The role of the side chain in determining relative δ- and k -affinity in C5'-substituted analogues of naltrindole. Journal of Medicinal Chemistry, 46, pp. 314-317.

Black, S. J., Jones, C. and Junk, P. C., 2004. The molecular structure of [2Me2N(Me)]}2]. Main Group Metal Chemistry, 24 (7), pp. 453-454.

Blagbrough, I. S., Adjimatera, N., Ahmed, O. A. A., Neal, A. P. and Pourzand, C. A., 2004. Spermine and lipopolyamines as gene delivery agents. In: Beadle, D. J., Mellor, I. R. and Usherwood, P. N. R., eds. Neurotox '03: Neurotoxicological targets from Functional Genomics and Proteomics. Society of Chemical Industry, pp. 147-159. (Functional Genomics and Proteomics)

Blagbrough, I. S., Adjimatera, N., Neal, A. P. and Haworth, I. S., 2004. Fluorescence techniques in non-viral gene therapy: Using spermine and lipopolyamines as DNA delivery agents. Abstracts of Papers of the American Chemical Society, 227, U34-U34.

Blagbrough, I. S. and Geall, A. J., 2002. Synthesis and DNA binding of steroid lipopolyamine conjugates: PKA studies of polyammonium ion ligands. Abstracts of Papers of the American Chemical Society, 224, U40-U40.

Blagbrough, I. S., Geall, A. J. and Al-Hadithi, D., 2001. Sar of bile acid polyamine conjugates in binding and condensation of DNA. Abstracts of Papers of the American Chemical Society, 221, U58-U58.

Blagbrough, I. S., Geall, A. J. and Neal, A. P., 2003. Polyamines and novel polyamine conjugates interact with DNA in ways that can be exploited in non-viral gene therapy. Biochemical Society Transactions, 31 (2), pp. 397-406.

Blagbrough, I. S., Geall, A. J., Taylor, R. J., Earll, M. E. and Eaton, M. W., 2001. Synthesis, DNA binding, and pK(a) studies of cholesterol-polyamine carbamates. Abstracts of Papers of the American Chemical Society, 221, U58-U58.

Blagbrough, I. S., Haworth, I. S., Taylor, S. and Carrington, S., 2001. Synthesis and DNA binding studies of 9-anthracenyl and 9-acridinyl-polyamine conjugates: Ligands designed with two discrete binding modes. Abstracts of Papers of the American Chemical Society, 221, U61-U62.

Blagbrough, I. S. and Metwally, A. A., 2013. siRNA and Gene Formulation for Efficient Gene Therapy. In: Molina, F. M., ed. Gene Therapy: Tools and Potential Applications. InTech.

Blagbrough, I. S. and Neal, A. P., 2002. Design and synthesis of fluorescent steroidal lipopolyamine conjugates for monitoring gene delivery. In: Matsoukas, J. and Mavromoustakos, T., eds. Drug Discovery and Design: Medical Aspects. Vol. 55. Amsterdam: IOS Press, pp. 64-75. (Biomedical and Health Research)

Blagbrough, I. S., Elmasry, M. S., Woodman, T. J., Saleh, H. M. and Kheir, A. A., 2009. Quantitative determination of mebeverine HCl by NMR chemical shift migration. Tetrahedron, 65 (25), pp. 4930-4936.

Blagbrough, I. S., Geall, A. J. and David, S. A., 2000. Lipopolyamines incorporating the tetraamine spermine, bound to an alkyl chain, sequester bacterial lipopolysaccharide. Bioorganic & Medicinal Chemistry Letters, 10 (17), pp. 1959-1962.

Blagbrough, I. S., Coates, P. A., Hardick, D. J., Lewis, T., Rowan, M. G., Wonnacott, S. and Potter, B. V. L., 1994. Acylation of lycoctonine : semi-synthesis of inuline, delsemine analogues and methyllycaconitine. Tetrahedron Letters, 35 (46), pp. 8705-8708.

Blagbrough, I. S., Hardick, D. J., Wonnacott, S. and Potter, B. V. L., 1994. Regioselective demethylation of aconitine. Tetrahedron Letters, 35 (20), pp. 3367-3370.

Blake, D. R. and Taylor, G., 2003. An Iconoclastic Approach to Pharmacodynamics in Model Systems : Their Relevance to Humans: Introduction to Part 3. In: Winyard, P. G. and Willoughby, D. A., eds. Inflammation Protocols. Springer, pp. 263-268. (Methods in Molecular Biology; 225)

Blake, K. V., De Vries, C. S., Arlett, P., Kurz, X. and Fitt, H., 2012. Increasing scientific standards, independence and transparency in post-authorisation studies: The role of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. Pharmacoepidemiology and Drug Safety, 21 (7), pp. 690-696.

Blazer, L. L., Roman, D. L., Chung, A., Larsen, M. J., Greedy, B. M., Husbands, S. M. and Neubig, R. R., 2010. Reversible, allosteric small-molecule inhibitors of regulator of G protein signaling proteins. Molecular Pharmacology, 78 (3), pp. 524-533.

Blazer, L. L., Zhang, H. M., Casey, E. M., Husbands, S. M. and Neubig, R. R., 2011. A nanomolar-potency small molecule inhibitor of regulator of G-protein signaling proteins. Biochemistry, 50 (15), pp. 3181-3192.

Bloomfield, K., John, N., McGrogan, A., Jones, R. and De Vries, C., 2010. Co-Prescribing of medications with anticholinergicproperties to those using cholinesterase inhibitors fordementia. Pharmacoepidemiology and Drug Safety, 19 (S1), 112.

Blunt, M. D. and Ward, S. G., 2012. Targeting PI3K isoforms and SHIP in the immune system: new therapeutics for inflammation and leukemia. Current Opinion in Pharmacology, 12 (4), pp. 444-451.

Boardman, A., Schlindwein, F. S., Rocha, A. P. and Leite, A., 2002. A study on the optimum order of autoregressive models for heart rate variability. Physiological Measurement, 23 (2), pp. 325-336.

Boardman, A., Schlindwein, F. S., Thakor, N. V., Kimura, T. and Geocadin, R. G., 2002. Detection of asphyxia using heart rate variability. Medical and Biological Engineering and Computing, 40 (6), pp. 618-624.

Bochmann, M., Lancaster, S. J., Hannant, M. D., Rodriguez, A., Schormann, M., Walker, D. A. and Woodman, T. J., 2003. Role of B(C 6 F 5 ) 3 in catalyst activation, anion formation, and as C 6 F 5 transfer agent. Pure and Applied Chemistry, 75 (9), pp. 1183-1195.

Bojarová, P., Denehy, E., Walker, I., Loft, K., De Souza, D. P., Woo, L. W. L., Potter, B. V. L., McConville, M. J. and Williams, S. J., 2008. Direct evidence for ArO-S bond cleavage upon inactivation of Pseudomonas aeruginosa Arylsulfatase by Aryl Sulfamates. ChemBiochem, 9 (4), pp. 613-623.

Boleij, A., Muytjens, C. M. J., Bukhari, S. I., Cayet, N., Glaser, P., Hermans, P. W. M., Swinkels, D. W., Bolhuis, A. and Tjalsma, H., 2011. Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer. Journal of Infectious Diseases, 203 (8), pp. 1101-1109.

Bolhuis, A., 2004. The archaeal Sec-dependent protein translocation pathway. Philosophical Transactions of the Royal Society B, 359, pp. 919-927.

Bolhuis, A., Mathers, J. E., Thomas, J. D., Barrett, C. L. and Robinson, C., 2001. TatB and TatC form a functional and structural unit of the twin arginine translocase from Escherichia coli. Journal of Biological Chemistry, 276 (23), pp. 20213-20219.

Bolhuis, A., Kwan, D. and Thomas, J.R., 2010. Halophilic adaptations of proteins. In: Ortendhal, V. and Salchow, H., eds. Ribosomal Proteins and Protein Engineering. Nova Science, pp. 143-174. (Protein Science and Engineering)

Bolhuis, A. and Aldrich-Wright, J. R., 2014. DNA as a target for antimicrobials. Bioorganic Chemistry, 55, pp. 51-59.

Bolhuis, A., Bogsch, E. G. and Robinson, C., 2000. Subunit interactions in the twin-arginine translocase complex of Escherichia coli. FEBS Letters, 472 (1), pp. 88-92.

Bolhuis, A., Hand, L., Marshall, J. E., Richards, A. D., Rodger, A. and Aldrich-Wright, J., 2011. Antimicrobial activity of ruthenium-based intercalators. European Journal of Pharmaceutical Sciences, 42 (4), pp. 313-317.

Bolhuis, A., Koetje, E., Dubois, J. Y., Vehmaanpera, J., Venema, G., Bron, S. and van Dijl, J. M., 2000. Did the mitochondrial processing peptidase evolve from a eubacterial regulator of gene expression? Molecular Biology and Evolution, 17 (1), pp. 198-201.

Bolhuis, A., Kwan, D. and Thomas, J. R., 2008. Halophilic adaptation of proteins. In: Siddiqui, K. S. and Thomas, T., eds. Protein Adaptation in Extremophiles. New York: Nova Science, pp. 71-104. (Molecular Anatomy and Physiology of Proteins)

Bolhuis, A. and Richards, A. D., 2011. Development of metal complexes as potential antimicrobials. In: Aldrich-Wright, J., ed. Metallointercalators: Synthesis and Techniques to Probe Their Interactions with Biomolecules. New York: Springer, pp. 373-388.

Bonander, N., Darby, R. A. J., Grgic, L., Bora, N., Wen, J., Brogna, S., Poyner, D. R., O'Neill, M. A. A. and Bill, R. M., 2009. Altering the ribosomal subunit ratio in yeast maximizes recombinant protein yield. Microbial Cell Factories, 8, 10.

Bond, C., Smith, E. and Garland, C., 2004. Survey of P13-kinase RNA expression in the rat. British Journal of Pharmacology, 2 (2), 80P.

Bone, H. K., Damiano, T., Bartlett, S., Perry, A., Letchford, J., Ripoli, Y. S., Nelson, A. S. and Welham, M. J., 2009. Involvement of GSK-3 in regulation of murine embryonic stem cell self-renewal revealed by a series of bisindolylmaleimides. Chemistry & Biology, 16 (1), pp. 15-27.

Bone, H. K., Nelson, A. S., Goldring, C. E., Tosh, D. and Welham, M. J., 2011. A novel chemically directed route for the generation of definitive endoderm from human embryonic stem cells based on inhibition of GSK-3. Journal of Cell Science, 124 (12), pp. 1992-2000.

Bone, H. K. and Welham, M. J., 2007. Phosphoinositide 3-kinase signalling regulates early development and developmental haemopoiesis. Journal of Cell Science, 120 (10), pp. 1752-1762.

Bonser, J., Walker, J., Purohit, A., Reed, M. J., Potter, B. V. L., Willis, D. S., Franks, S. and Mason, H. D., 2000. Human granulosa cells are a site of sulphatase activity and are able to utilize dehydroepiandrosterone sulphate as a precursor for oestradiol production. The Journal of Endocrinology, 167 (3), pp. 465-471.

Borissow, C. N., Black, S. J., Paul, M., Tovey, S. C., Dedos, S. G., Taylor, C. W. and Potter, B. V. L., 2005. Adenophostin A and analogues modified at the adenine moiety: synthesis, conformational analysis and biological activity. Organic and Biomolecular Chemistry, 3, pp. 245-252.

Bouissou, C., Begat, P., van der Walle, C. and Price, R., 2005. Study of the surface mobility of PLGA microspheres using high-resolution topography measurements with the atomic force microscope. Journal of Controlled Release, 101 (1-3), pp. 290-292.

Bouissou, C., Rouse, J. J., Price, R. and van der Walle, C. F., 2006. The influence of surfactant on PLGA microsphere glass transition and water sorption: Remodeling the surface morphology to attenuate the burst release. Pharmaceutical Research, 23 (6), pp. 1295-1305.

Bouissou, C., Potter, U., Altroff, H., Mardon, H. and van der Walle, C., 2004. Controlled release of the fibronectin central cell binding domain from polymeric microspheres. Journal of Controlled Release, 95 (3), pp. 557-566.

Bourre, L., Giuntini, F., Eggleston, I. M., Wilson, M. and MacRobert, A. J., 2008. 5-aminolaevulinic acid peptide prodrugs enhance photosensitization for photodynamic therapy. Molecular Cancer Therapeutics, 7 (6), pp. 1720-1729.

Bourre, L., Giuntini, F., Eggleston, I. M., Wilson, M. and MacRobert, A. J., 2009. Protoporphyrin IX enhancement by 5-aminolaevulinic acid peptide derivatives and the effect of RNA silencing on intracellular metabolism. British Journal of Cancer, 100 (5), pp. 723-731.

Bourre, L., Giuntini, F., Eggleston, I. M., Mosse, C. A., MacRobert, A. J. and Wilson, M., 2010. Effective photoinactivation of Gram-positive and Gram-negative bacterial strains using an HIV-1 Tat peptide-porphyrin conjugate. Photochemical & Photobiological Sciences, 9 (12), pp. 1613-1620.

Bowes, J., Eyre, S., Flynn, E., Ho, P., Salah, S., Warren, R. B., Marzo-Ortega, H., Coates, L., McManus, R., Ryan, A. W., Kane, D., Korendowych, E., McHugh, N. J., FitzGerald, O., Packham, J., Morgan, A. W., Griffiths, C. E. M., Bruce, I. N., Worthington, J. and Barton, A., 2011. Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris. Annals of the Rheumatic Diseases, 70 (6), pp. 1016-1019.

Bowes, J., Flynn, E., Ho, P., Aly, B., Morgan, A. W., Marzo-Ortega, H., Coates, L., McManus, R., Ryan, A. W., Kane, D., Korendowych, E., McHugh, N. J., FitzGerald, O., Packham, J., Bruce, I. N. and Barton, A., 2010. Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis. Annals of the Rheumatic Diseases, 69 (12), pp. 2199-2203.

Bowes, J., Ho, P., Flynn, E., Ali, F., Marzo-Ortega, H., Coates, L. C., Warren, R. B., McManus, R., Ryan, A. W., Kane, D., Korendowych, E., McHugh, N. J., FitzGerald, O., Packham, J., Morgan, A. W., Bruce, I. N. and Barton, A., 2011. Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort. Annals of the Rheumatic Diseases, 71, pp. 1350-1354.

Bowes, J., Orozco, G., Flynn, E., Ho, P., Brier, R., Marzo-Ortega, H., Coates, L., McManus, R., Ryan, A. W., Kane, D., Korendowych, E., McHugh, N. J., FitzGerald, O., Packham, J., Morgan, A. W., Bruce, I. N. and Barton, A., 2011. Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Annals of the Rheumatic Diseases, 70 (9), pp. 1641-1644.

Bowes, J., Budu-Aggrey, A., Huffmeier, U., Uebe, S., Steel, K., Hebert, H. L., Wallace, C., Massey, J., Bruce, I. N., Bluett, J., Feletar, M., Morgan, A. W., Marzo-Ortega, H., Donohoe, G., Morris, D. W., Helliwell, P., Ryan, A. W., Kane, D., Warren, R. B., Korendowych, E., Alenius, G.-M., Giardina, E., Packham, J., McManus, R., FitzGerald, O., McHugh, N., Brown, M. A., Ho, P., Behrens, F., Burkhardt, H., Reis, A. and Barton, A., 2015. Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis. Nature Communications, 6, 6046.

Bowes, J., Ho, P., Flynn, E., Salah, S., McHugh, N. J., Fitzgerald, O., Packham, J., Morgan, A. W., Helliwell, P. S., Bruce, I. N. and Barton, A., 2012. Investigation of IL1, VEGF, PPARG and MEFV genes in psoriatic arthritis susceptibility. Annals of the Rheumatic Diseases, 71, pp. 313-314.

Bowes, J., Loehr, S., Budu-Aggrey, A., Uebe, S., Bruce, I. N., Feletar, M., Marzo-Ortega, H., Helliwell, P., Ryan, A. W., Kane, D., Korendowych, E., Alenius, G.-M., Giardina, E., Packham, J., McManus, R., FitzGerald, O., Brown, M. A., Behrens, F., Burkhardt, H., McHugh, N., Huffmeier, U., Ho, P., Reis, A. and Barton, A., 2015. Forthcoming. PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis : evidence for a further PsA-specific risk locus. Annals of the Rheumatic Diseases

Box, K., Comer, J., Mole, J., Taylor, R., Karki, S., Price, R. and Fotaki, N., 2012. Small scale assays for studying dissolution and precipitation of pharmaceutical cocrystals. AAPS Journal

Boyce, V., Beaton, D., Govinda, R. A., Maetzel, A. M., Inman, R. D., Lapp, V. and Stone, M. A., 2007. The MCID for response to TNF blockers varies widely depending on the method chosen to calculate the MCID. Rheumatology, 46, I57-I57.

Brambilla, G., Ganderton, D., Garzia, R., Lewis, D., Meakin, B. and Ventura, P., 1999. Modulation of aerosol clouds produced by pressurised inhalation aerosols. International Journal of Pharmaceutics, 186 (1), pp. 53-61.

Braun, J., Cook, R., Landewe, R., Gladman, D. D., Inman, R. D., Maksymowych, W., Mease, P., Davis, J., Van der Heijde, D., Brandt, J., Vargas, R. B., Chandran, V., Helliwell, P., Kavanaugh, A., Khan, M., O'Shea, F. D., Pipitone, N., Rahman, P., Reveille, J. D., Stone, M., Taylor, W. and Veale, D., 2006. Inspire lateral flexion: A new method to measure lateral spinal mobility in patients with spondyloarthritis (SpA). Annals of the Rheumatic Diseases, 65, p. 208.

Brayden, D. J. and Mrsny, R. J., 2011. Oral peptide delivery: Prioritizing the leading technologies. Therapeutic Delivery, 2 (12), pp. 1567-1573.

Breuer, E., Karaman, R., Goldblum, A., Gibson, D., Leader, H., Potter, B. V. L. and Cummins, J. H., 1988. α-Oxyiminophosphonates : chemical and physical properties. Reactions, theoretical calculations, and X-ray crystal structures of (E) and (Z)-dimethyl α-hydroxyiminobenzylphosphonates. Journal of the Chemical Society, Perkin Transactions 1, 1988 (11), pp. 3047-3057.

Brimson, J. M., 2010. The Pharmacology of the Sigma-1 Receptor. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Brimson, J. M., Brown, C. A. and Safrany, S. T., 2011. Antagonists show GTP-sensitive high affinity binding to the sigma-1 receptor. British Journal of Pharmacology, 164 (2B), pp. 772-780.

Britten, N. and Weiss, M. C., 2004. What is concordance? In: Bond, C., ed. Concordance: A Partnership in Medicine-taking. London: Pharmaceutical Press, pp. 9-28.

Britton, R. and Scott, J., 2006. Community pharmacy services to drug misusers in the south west of England - results of the 2003-2004 postal survey. International Journal of Pharmacy Practice, 14, pp. 235-241.

Britton, R. and Scott, J., 2005. Pharmacy based needle exchange in the South West of England - cause for concern? In: 16th International Conference in the Reduction of Drug Related Harm, 2005-03-20 - 2005-03-24, Waterfront, Belfast.

Bromley, S. E., de Vries, C. S. and Farmer, R. D. T., 2004. Utilisation of hormone replacement therapy in the United Kingdom. A descriptive study using the general practice research database. BJOG : An International Journal Of Obstetrics & Gynaecology, 111 (4), pp. 369-376.

Bromley, S. E., de Vries, C. S., Thomas, D. and Farmer, R. D. T., 2005. Hormone replacement therapy and risk of acute myocardial infarction: a review of the literature. Drug Safety, 28 (6), pp. 473-493.

Brown, L., Joseph, L., Crosbie, P., Landberg, G., Barber, P., Lindsay, M. and Booton, R., 2012. RNA from FFPE tissue is suitable for exon array analysis if extracted utilizing a robust protocol which incorporates laser capture microdissection. Lung Cancer, 75 (Supplement 1), S4.

Brown, M. R. W., Smith, A. W., O'Flaherty, V., Moran, P., Lens, P. and Stoodley, P., 2003. Resistance of medical biofilms. In: Lens, P., Moran, A. P., Mahony, T., Stoodley, P. and O'Flaherty, V., eds. Biofilms in Medicine, Industry and Environmental Biotechnology. London, U. K.: IWA Publishing.

Brown, M. R. W. and Kornberg, A., 2004. Inorganic polyphosphate in the origin and survival of species. Proceedings of the National Academy of Sciences of the United States of America (PNAS) ISSN 1091-6490, 101 (46), pp. 16085-16087.

Brown, M. R. W. and Smith, A. W., 2003. Antimicrobiol agents and biofilms. In: Wilson, M. and Devine, D., eds. Medical Implications of Biofilms. Cambridge, U. K.: Cambridge University Press, pp. 36-58.

Brown, M. R. W. and Smith, A. W., 2001. Dormancy and persistence in chronic infection : role of the general stress response in resistance to chemotherapy. Journal of Antimicrobial Chemotherapy, 48 (1), pp. 141-142.

Brown, M. R. W., Smith, A. W., Barker, J., Humphrey, T. J. and Dixon, B., 2002. E-coli O157 persistence in the environment. Microbiology, 148 (1), pp. 1-2.

Brown, R. S., Dowden, J., Moreau, C. and Potter, B. V. L., 2002. A concise route to tiazofurin. Tetrahedron Letters, 43 (37), pp. 6561-6562.

Brown, S., James, J., Pauling, J. D., Shipley, J. A., Korenodwych, E. and McHugh, N. J., 2010. Vacuum assisted closure therapy : A novel treatment for refractory digital ulceration in systemic sclerosis. Clinical and Experimental Rheumatology, 28 (2 Supp 58), S162-S163.

Buckley, C., Cavill, C., Taylor, G., Kay, H., Waldron, N., Korendowych, E. and McHugh, N. J., 2010. Mortality in psoriatic arthritis: a single-center study from the UK. Journal of Rheumatology, 37 (10), pp. 2141-2144.

Bukhari, S., 2013. Biofilm in Enterococci and Streptococci. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Bunge, A. L., Touraille, G. D., Marty, J. P. and Guy, R. H., 2005. Modeling dermal absorption from soils and powders using stratum corneum tape-stripping in vivo. In: Riviere, J. E., ed. Dermal Absorption Models in Toxicology and Pharmacology. Boca Raton, Florida: CRC Press, pp. 191-212.

Bunnett, N. W. and Cottrell, G. S., 2010. Trafficking and signaling of G protein-coupled receptors in the nervous system : Implications for disease and therapy. CNS & Neurological Disorders-Drug Targets, 9 (5), pp. 539-556.

Buranaphalin, S., 2009. Pharmaceutical Analysis of Polyamines and Aminoglycosides. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Burgess, S. E., O'Neill, M. A. A., Beezer, A. E., Hadgraft, J. and Gaisford, S., 2005. Thermodynamics of membrane transport and implications for dermal delivery. Journal of Drug Delivery Science and Technology, 15 (4), pp. 325-327.

Burton, E., Harrigan, E., Mok, Y., Scott, J. and Yahie, U., 2003. Results of a 2003 national survey on paraphernalia supply from UK needle exchange agencies. In: Society for the Study of Addiction Annual Symposium,, 2003-01-01, Leeds.

Buscemi, G., Miller, P. W., Kealey, S., Gee, A. D., Long, N. J., Passchier, J. and Vilar, R., 2011. Rapid carbonylative coupling reactions using palladium(I) dimers: applications to (CO)-C-11-radiolabelling for the synthesis of PET tracers. Organic and Biomolecular Chemistry, 9 (9), pp. 3499-3503.

Busteed, S., Bennett, M. W., Molloy, C., Houston, A., Stone, M. A., Shanahan, F., Molloy, M. G. and O'Connell, J., 2006. Bcl-x(L) expression in vivo in rheumatoid synovium. Clinical Rheumatology, 25 (6), pp. 789-793.

Byron, P. R., Peart, J. and Staniforth, J. N., 1997. Aerosol electrostatics I: properties of fine powders before and after aerosolization by dry powder inhalers. Pharmaceutical Research, 14 (6), pp. 698-705.

Byrum, J., Jordan, S., Safrany, S. T. and Rodgers, W., 2004. Visualization of inositol phosphate-dependent mobility of Ku: depletion of the DNA-PK cofactor InsP 6 inhibits Ku mobility. Nucleic Acids Research, 32, pp. 2776-2784.

C

Cabana Montenegro, S., Delgado-Charro, M. B. and Fotaki, N., 2012. Development and evaluation of age appropriate pellet formulations for an antiepileptic drug. In: 4th Conference of the European Paediatric Formulation Initiative (EuPFI) 2012, 2012-09-19 - 2012-09-20, Prague.

Caggiano, L., 2005. Silicon-mediated transformations of functional groups (Book review). Applied Organometallic Chemistry, 19 (5), p. 699.

Caggiano, L., Castoldi, D., Beumer, R., Bayon, P., Telser, J. and Gennari, C., 2003. Effects of allylic and homoallylic substituents on the ring closing metatheses reaction used to synthesise simplified eleuthesides. Tetrahedron Letters, 44, pp. 7913-7919.

Caggiano, L., Davies, J., Fox, D. J., Moody, D. C. and Warren, S., 2003. A novel silica catalysed stereoselective cyclic carbamate and carbonate rearrangement. Chemical Communications, 14, pp. 1650-1651.

Caggiano, L., Davies, J., Fox, D. J., Moody, D. C. and Warren, S., 2003. Stereoselective substituted pyrrolidine and cyclic ether synthesis by PhS migration. Chemical Communications, 14, pp. 1648-1649.

Caggiano, L., Fox, D. J., House, D., Jones, Z. A., Kerr, F. and Warren, S., 2002. Asymmetric synthesis of tetrahydrofurans by competitive [1,2]-phenylsulfanyl (PhS) migrations under thermodynamic control. Journal of the Chemical Society - Perkin Transcriptions 1, 23, pp. 2634-2645.

Caggiano, L., Fox, D. J., House, D., Jones, Z. A., Kerr, F. and Warren, S., 2002. Asymmetric synthesis of tetrahydropyrans with competitive [1,2]-phenylsulfanyl (PhS) migrations. Journal of the Chemical Society - Perkin Transcriptions 1, 23, pp. 2646-2651.

Caggiano, L., Jackson, R. F. W., Meijer, A. J. H. M., Pickup, B. T. and Wilkinson, K. A., 2008. Ionisation of the zinc/iodine bond of alkylzinc iodides in dimethylformamide from theory and experiment. Chemistry - A European Journal, 14 (29), p. 8798.

Cai, L., Threadgill, M. D., Wang, Y. L. and Li, M., 2009. Effect of poly (ADP-ribose) polymerase-1 inhibition on the proliferation of murine colon carcinoma CT26 cells. Pathology & Oncology Research, 15 (3), pp. 323-328.

Cami-Kobeci, G., Neale, A. P., Bradbury, F. A., Purington, L. C., Aceto, M. D., Harris, L. S., Lewis, J. W., Traynor, J. R. and Husbands, S. M., 2009. Mixed κ/μ Opioid Receptor Agonists: The 6β-Naltrexamines. Journal of Medicinal Chemistry, 52 (6), pp. 1546-1552.

Cami-Kobeci, G., Polgar, W. E., Khroyan, T. V., Toll, L. and Husbands, S. M., 2011. Structural determinants of opioid and NOP receptor activity in derivatives of buprenorphine. Journal of Medicinal Chemistry, 54 (19), pp. 6531-6537.

Cami-Kobeci, G., Polgar, W. E., Khroyan, T. V., Toll, L. and Husbands, S. M., 2011. Universal opioid receptor ligands - buprenorphine and related orvinols. Pharmacological Reports, 63 (1), p. 210.

Campbell, C., 2008. Poly(lactide-co-glycolide) devices for drug delivery. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Canobbio, I., Guidetti, G.F., Oliviero, B., Manganaro, D., Vara, D., Torti, M. and Pula, G., 2014. Amyloid β-peptide-dependent activation of human platelets : Essential role for Ca2=+ and ADP in aggregation and thrombus formation. Biochemical Journal, 462 (3), pp. 513-523.

Canobbio, I., Abubaker, A. A., Visconte, C., Torti, M. and Pula, G., 2015. Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer’s disease. Frontiers in Cellular Neuroscience, 9 (65).

Canobbio, I., Alsheikh Abubaker, A., Visconte, C., Torti, M. and Pula, G., 2015. Forthcoming. Role of amyloid peptides in vascular dysfunction and platelets dysregulation in Alzheimer's disease. Frontiers in Cellular Neuroscience

Cantaert, T., Stone, M., ter Borg, M., de Vries, N., Wilson, A., Tak, P. and Baeten, D., 2008. A functional variant of TIR-domain-containing adaptor protein (TIRAP) is not associated with spondyloarthritis. Clinical Immunology, 127, S85-S85.

Cantaert, T., Stone, M. A., ter Borg, M., Mogg, R., De Vries, N., Wilson, A. G., Tak, P. P. and Baeten, D., 2008. A functional polymorphism of TIR-domain-containing adaptor protein is not associated with axial spondyloarthritis. Annals of the Rheumatic Diseases, 67 (5), pp. 720-722.

Cantrill, J., Morris, C. and Weiss, M. C., 2006. How patients perceive minor illness and factors influencing seeing a doctor. Primary Health Care Research and Development, 7 (2), pp. 157-164.

Cao, J., Husbands, S. M., Kopajtic, T., Katz, J. L. and Newman, A. H., 2001. [(3- cis -3,5-dimethyl-1-piperazinyl)alkyl-bis-(4'-fluorophenyl)amine analogs as novel probes for the dopamine transporter. Bioorganic & Medicinal Chemistry Letters, 11, pp. 3169-3173.

Cao, J., Kulkarni, S. S., Husbands, S. M., Bowen, W. D., Williams, W., Kopajtic, T., Katz, J. L., George, C. and Newman, A. H., 2003. Dual probles for the dopamine transporter and σ1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amyl analogues as potential cocaine-abuse therapeutic agents. Journal of Medicinal Chemistry, 46, pp. 2589-2598.

Carmichael, C., Lalani, M., Poon, L. M., Scott, J., Laaksonen, R., Rogers, P. and Scott, J., 2011. What do community pharmacists really think of the electronic prescription service (EPS)? International Journal of Pharmacy Practice, 19 (Suppl 2), p. 86.

Carrillo-Marquez, T., Caggiano, L., Jackson, R. F. W., Graboswka, U., Rae, A. and Tozer, M. J., 2005. New routes to b-cycloalkylalanine derivatives using serine-derived organozinc reagents. Organic and Biomolecular Chemistry, 3, pp. 4117-4123.

Cartwright, J. L., Safrany, S. T., Dixon, L. K., Darzynkiewicz, J., Stepenski, J., Burke, R. and McLennan, A. G., 2002. The g5R (D250) gene of African swine fever virus encodes a Nudix hydrolase that preferentially degrades diphosphoinositol polyphosphates. Journal of Virology, 76, pp. 1415-1421.

Carvajal, M. T. and Staniforth, J. N., 2006. Interactions of water with the surfaces of crystal polymorphs. International Journal of Pharmaceutics, 307 (2), pp. 216-224.

Casal-Dominguez, J. J., Clark, M., Traynor, J. R., Husbands, S. M. and Bailey, S. J., 2013. In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor. Journal of Psychopharmacology, 27 (2), pp. 192-202.

Casal-Dominguez, J. J., Furkert, D., Ostovar, M., Teintang, L., Clarke, M. J., Traynor, J. R., Husbands, S. M. and Bailey, S. J., 2014. Characterization of BU09059 : A novel potent selective κ-receptor antagonist. ACS Chemical Neuroscience, 5 (3), pp. 177-184.

Castoldi, D., Caggiano, L., Bayon, P., Costa, A. M., Cappella, P., Sharon, O. and Gennari, C., 2005. Synthesis of novel, simplified, C-7 substituted eleutheside analogues with potent microtubule-stabilizing activity. Tetrahedron, 61, pp. 2123-2139.

Castoldi, D., Caggiano, L., Panigada, L., Sharon, O., Costa, A. M. and Gennari, C., 2005. A formal total synthesis of eleutherobin through an unprecedented kinetically controlled ring-closing-metathesis reaction of a densely functionalized diene. Angewandte Chemie-International Edition, 44, pp. 588-591.

Cattaruzza, F., Cottrell, G., Vaksman, N. and Bunnett, N. W., 2009. Endothelin-converting enzyme 1 promotes re-sensitization of neurokinin 1 receptor-dependent neurogenic inflammation. British Journal of Pharmacology, 156 (5), pp. 730-739.

Challiss, R. A. J., Willcocks, A. L., Mulloy, B., Potter, B. V. L. and Nahorski, S. R., 1991. Characterization of inositol 1,4,5-trisphosphate- and inositol 1,3,4,5-tetrakisphosphate-binding sites in rat cerebellum. Biochemical Journal, 274 (3), pp. 861-867.

Chamberlain, S., 2009. Functional role of kainate receptors in the rat entorhinal cortex. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Chamberlain, S. E. L., Yang, J. and Jones, R. S. G., 2008. The role of NMDA receptor subtypes in short-term plasticity in the rat entorhinal cortex. Neural Plasticity, 2008, 872456.

Chan, C. C., Inrig, T., Molloy, C. B., Stone, M. A. and Derzko-Dzulynsky, L., 2012. Prevalence of inflammatory back pain in a cohort of patients with anterior uveitis. American Journal of Ophthalmology, 153 (6), pp. 1025-1030.

Chan, M. T., Owen, P., Dunphy, J., Cox, B., Carmichael, C., Korendowych, E. and McHugh, N. J., 2008. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. Journal of Rheumatology, 35 (1), pp. 77-83.

Chander, S. K., Foster, P. A., Leese, M. P., Newman, S. P., Potter, B. V. L., Purohit, A. and Reed, M. J., 2007. In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol. British Journal of Cancer, 96 (9), pp. 1368-1376.

Chander, S. K., Purohit, A., Woo, L. W. L., Potter, B. V. L. and Reed, M. J., 2004. The role of steroid suophatase in regulating the oestrogenicity of oestrogen sulphamates. Biochemical and Biophysical Research Communications, 322 (1), pp. 217-222.

Chandran, V., Gottlieb, A., Cook, R. J., Duffin, K. C., Garg, A., Helliwell, P., Kavanaugh, A., Krueger, G. G., Langley, R. G., Lynde, C., Mchugh, N. J., Mease, P., Olivieri, I., Rahman, P., Rosen, C. F., Salvarani, C., Thaci, D., Toloza, S. M. A., Wong, M. Y. W., Zhou, Q. M. and Gladman, D. D., 2009. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis & Rheumatism, 61 (9), pp. 1235-1242.

Changya, L., Gallacher, D. V., Irvine, R. F., Potter, B. V. L. and Petersen, O. H., 1989. Inositol 1,3,4,5-tetrakisphosphate is essential for sustained activation of the Ca2+-dependent K+ current in single internally perfused mouse lacrimal acinar cells. Journal of Membrane Biology, 109 (1), pp. 85-93.

Chapman, C. A., Jones, R. S. G. and Jung, M., 2008. Neuronal plasticity in the entorhinal cortex. Neural Plasticity, 2008, 314785.

Chapman, C.J. and Frost, C.G., 2003. Synthesis of functionalised phenylalanines using rhodium catalysis in water. Advanced Synthesis & Catalysis, 345 (3), pp. 353-355.

Chapman, C.J. and Frost, C.G., 2007. Tandem and domino catalytic strategies for enantioselective synthesis. Synthesis, 2007 (1), pp. 1-21.

Chapman, C.J., Frost, C.G., Hartley, J.P. and Whittle, A.J., 2001. Efficient aromatic and heteroatom acylations using catalytic indium complexes with lithium perchlorate. Tetrahedron Letters, 42 (5), pp. 773-775.

Chapman, C.J., Frost, C.G., Matsuno, A. and Willis, M. C., 2007. Site-selective modification of peptides using rhodium and palladium catalysis : Complementary electrophilic and nucleophilic arylation. Chemical Communications, 2007 (38), pp. 3903-3905.

Chapman, C.J., Wadsworth, K.J. and Frost, C.G., 2003. Enantioselective rhodium-catalysed addition of boronic acids using C-symmetric aryl diphosphite ligands. Journal of Organometallic Chemistry, 680 (1-2), pp. 206-211.

Chapman, C. J., Frost, C. G., Gill-Carey, M. P., Kociok-Kohn, G., Mahon, M. F., Weller, A. S. and Willis, M. C., 2003. Diphosphine mono-sulfides: readily available chiral monophosphines. Tetrahedron: Asymmetry, 14 (6), pp. 705-710.

Chappell, F., Crampton, R., Miles, R. and Rogers, P., 2009. Exploring the views of community pharmacists and potential patients on the reclassification of azithromycin from POM to P for the treatment of chlamydial infection. International Journal of Pharmacy Practice, 17 (Supplement 2), B6-B7.

Charlton, R., Cunnington, M., Weil, J. and de Vries, C. S., 2009. Regarding the need, or lack thereof, of a comparator group for pregnancy registries. Birth Defects Research Part A: Clinical and Molecular Teratology, 85 (9), p. 808.

Charlton, R., Snowball, J., Bloomfield, K. and De Vries, C., 2012. Colorectal cancer incidence on the General Practice Research Database. Pharmacoepidemiology and Drug Safety, 21 (7), pp. 775-783.

Charlton, R., Weil, J., Curmington, M. and de Vries, C. S., 2008. The general practice research database as a pregnancy registry system : Anticonvulsants as an example. Pharmacoepidemiology and Drug Safety, 17 (Supplement 1), 362.

Charlton, R. A., Hutchison, A., Davis, K. J. and De Vries, C. S., 2013. Asthma management in pregnancy. PLoS ONE, 8 (4), e60247.

Charlton, R. A., Snowball, J. M., Bloomfield, K. and De Vries, C. S., 2011. Macrogol laxatives and colorectal cancer risk. Pharmacoepidemiology and Drug Safety, 20 (Supplement 1), S270-S271.

Charlton, R. A., Weil, J. G., Snowball, J. M., Cunnington, M. C. and de Vries, C. S., 2009. Can the General Practice Research Database identify a known teratogenic association? Pharmacoepidemiology and Drug Safety, 18 (Supplement 1), S12.

Charlton, R. A., Neville, A. J., Jordan, S., Pierini, A., Damase-Michel, C., Klungsøyr, K., Nybo Andersen, A.-M., Hansen, A. V., Gini, R., Bos, J. H. J., Puccini, A., Hurault-Delarue, C., Brooks, C. J., De Jong-Van Den Berg, L. T. W. and De Vries, C. S., 2014. Healthcare databases in europe for studying medicine use and safety during pregnancy. Pharmacoepidemiology and Drug Safety, 23 (6), pp. 586-594.

Chatterjee, P. K., Chatterjee, B. E., Pederson, H., Sivarajah, A., McDonald, M. C., Mota-Filipe, H., Brown, P. A. J., Stewart, K. N., Cuzzocrea, S., Threadgill, M. D. and Thiemermann, C., 2004. 5-Aminoisoquinolinone reduces renal injury and dysfunction caused by experimental ischemia/reperfusion. Kidney International, 65 (2), pp. 499-509.

Chauvignac, C., Miller, C. N., Srivastava, S. K., Lewis, J. W., Husbands, S. M. and Traynor, J. R., 2005. Major effect of pyrrolic N-benzylation in norbinaltorphimine, the selective k -opioid receptor antagonist. Journal of Medicinal Chemistry, 48, pp. 1676-1679.

Chen, M.-H., Cui, S.-X., Cheng, Y.-N., Sun, L.-R., Li, Q.-B., Xu, W.-F., Ward, S. G., Tang, W. and Qu, X.-J., 2008. Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity. Anti-Cancer Drugs, 19 (10), pp. 957-965.

Chilton, L., Smirnov, S. V., Loutzenhiser, K., Wang, X. and Loutzenhiser, R., 2011. Segment-specific differences in the inward rectifier K+ current along the renal interlobular artery. Cardiovascular Research, 92 (1), pp. 169-177.

Chilvers, E. R., Challiss, R. J., Willcocks, A. L., Potter, B. V. L., Barnes, P. J. and Nahorski, S. R., 1990. Characterisation of stereospecific binding sites for inositol 1,4,5-trisphosphate in airway smooth muscle. British Journal of Pharmacology, 99 (2), pp. 297-302.

Chinoy, H., Platt, H., Lamb, J. A., Betteridge, Z., Gunawardena, H., Fertig, N., Varsani, H., Davidson, J., Oddis, C. V., McHugh, N. J., Wedderburn, L. R., Ollier, W. E. R. and Cooper, R. G., 2008. The Protein Tyrosine Phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British caucasian patients. Arthritis & Rheumatism, 58 (10), pp. 3247-3254.

Chinoy, H., Li, C. K.-C., Platt, H., Fertig, N., Varsani, H., Gunawardena, H., Betteridge, Z., Oddis, C. V., McHugh, N. J., Wedderburn, L. R., Ollier, W. E. R., Cooper, R. G. and , U. A. O. M. I. C. a. U. J. D. R. G., 2012. Genetic association study of NF-κB genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopathy. Rheumatology, 51 (5), pp. 794-799.

Chinoy, H., Payne, D., Poulton, K. V., Fertig, N., Betteridge, Z., Gunawardena, H., Davidson, J. E., Oddis, C. V., McHugh, N. J., Wedderburn, L. R., Ollier, W. E. and Cooper, R. G., 2009. HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy. Rheumatology, 48 (10), pp. 1213-7.

Chiu, C. P. C., Watts, A. G., Lairson, L. L., Gilbert, M., Lim, D., Wakarchuk, W. W., Withers, S. G. and Strynadka, N. C. J., 2004. Structural analysis of the sialyltransferase CstII from Campylobacter jejuni in complex with a substrate analog. Nature Structural and Molecular Biology, 11 (2), pp. 163-170.

Ciupa, A., De Bank, P. A. and Caggiano, L., 2013. Multicellular aggregation of maltol-modified cells triggered by Fe3+ ions. Chemical Communications, 49 (86), pp. 10148-10150.

Clarke, J. F., Cordery, S. F., Morgan, N. A., Knowles, P. K. and Guy, R. H., 2015. In vitro method to quantify dermal absorption of pesticide residues. Chemical Research in Toxicology, 28 (2), 150205134307000. Item availability may be restricted.

Clarke, M. J., Tobyn, M. J. and Staniforth, J., 2000. Physicochemical factors governing the performance of nedocromil sodium as a dry powder aerosol. Journal of Pharmaceutical Sciences, 89 (9), pp. 1160-1169.

Clayburgh, D. R., Barrett, T. A., Tang, Y., Meddings, J. B., Van Eldik, L. J., Watterson, D. M., Clarke, L. L., Mrsny, R. J. and Turner, J. R., 2005. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induce diarrhea in vivo. Journal of Clinical Investigation, 115 (10), pp. 2702-2715.

Clayson, J., Jales, A. R., Tyacke, R. J., Hudson, A. L., Nutt, D. J., Lewis, J. W. and Husbands, S. M., 2001. Selective δ-opioid receptor ligands: potential PET ligands based on naltrindole. Bioorganic & Medicinal Chemistry Letters, 11, pp. 939-943.

Cleland, J. L., Daugherty, A. and Mrsny, R., 2001. Emerging protein delivery methods. Current Opinion in Biotechnology, 12, pp. 212-219.

Coates, L., Pauling, J., Pomeroy, E., Richardson, J., Gay, L., Mogg, R. and Stone, M., 2007. Validation study to assess responsiveness of the INSPIRE method for the evaluation of lateral spinal bending. Annals of the Rheumatic Diseases, 66 (Suppl II), p. 615.

Coates, L. C., Aslam, T., Al Balushi, F., Burden, A. D., Burden-The, E., Caperon, A. R., Cerio, R., Chattopadhyay, C., Chinoy, H., Goodfield, M. J. D., Kay, L., Kelly, S., Kirkham, B. W., Lovell, C. R., Marzo-Ortega, H., Murphy, R., Reynolds, N. J., Smith, C. H., Warren, R. B., Waxman, R., Wilson, H. E., Helliwell, P. S. and McHugh, N., 2013. Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). British Journal of Dermatology, 168 (4), pp. 802-807.

Coates, L.C., Tillett, W., Chandler, D., Helliwell, P.S., Korendowych, E., Kyle, S., McInnes, I.B., Oliver, S., Ormerod, A., Smith, C., Symmons, D., Waldron, N. and McHugh, N.J., 2013. The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics. Rheumatology, 52 (10), pp. 1754-1757.

Coates, L. C., Fitzgerald, O., Mease, P. J., Gladman, D. D., Strand, V., Goel, N., Campbell, I., Krueger, G., McHugh, N. J. and Helliwell, P. S., 2014. Development of a Disease Activity and Responder Index for Psoriatic Arthritis -- Report of the Psoriatic Arthritis Module at OMERACT 11. The Journal of Rheumatology, 41 (4), pp. 782-791.

Coates, L. C., Walsh, J., Haroon, M., Fitzgerald, O., Aslam, T., Al Balushi, F., Burden, A. D., Burden-Teh, E., Caperon, A. R., Cerio, R., Chattopadhyay, C., Chinoy, H., Goodfield, M. J. D., Kay, L., Kelly, S., Kirkham, B. W., Lovell, C. R., Marzo-Ortega, H., McHugh, N., Murphy, R., Reynolds, N. J., Smith, C. H., Stewart, E. J. C., Warren, R. B., Waxman, R., Wilson, H. E. and Helliwell, P. S., 2014. Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing tools. Arthritis Care and Research

Coates, L. C., Fitzgerald, O., Gladman, D. D., McHugh, N., Mease, P., Strand, V. and Helliwell, P. S., 2013. Brief report : Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease. Arthritis and Rheumatism, 65 (6), pp. 1504-1509.

Coates, P. A., Blagbrough, I. S., Lewis, T., Potter, B. V. L. and Rowan, M. G., 1995. An HPLC assay for the norditerpenoid alkaloid methyllycaconitine, a potent nicotinic acetylcholine receptor antagonist. Journal of Pharmaceutical and Biomedical Analysis, 13 (12), pp. 1541-1544.

Colleypriest, B. J., Palmer, R. M., Ward, S. G. and Tosh, D., 2009. Cdx genes, inflammation and the pathogenesis of Barrett's metaplasia. Trends in Molecular Medicine, 15 (7), pp. 313-322.

Colleypriest, B. J., Ward, S. G. and Tosh, D., 2009. How does inflammation cause Barrett's metaplasia? Current Opinion in Pharmacology, 9 (6), pp. 721-726.

Collins, A. R., Gedik, C., Wood, S., White, A., Dubois, J., Duez, P., Rees, J. F., Legall, R., Degand, L., Loft, S., Jensen, A., Poulsen, H., Weimann, A., Jensen, B. R., Cadet, J., Douki, T., Ravanat, J. L., Faure, H., Tripier, M., Morel, I., Sergent, O., Cillard, P., Morin, B., Epe, B., Phoa, N., Hartwig, A., Pelzer, A., Dolara, P., Casalini, C., Guglielmi, F., Luceri, C., Kasai, H., Kido, R., Olinski, R., Bialkowski, K., Durackova, Z., Hlincikova, L., Korytar, P., Dusinska, M., Mislanova, C., Vina, J., Lloret, A., Moller, L., Hofer, T., Gremaud, E., Fay, L., Stadler, R., Eakins, J., Pognan, F., O'Brien, J., Elliott, R., Astley, S., Bailley, A., Herbert, K., Chauhan, D., Kelly, F., Dunster, C., Lunec, J., Podmore, I., Patel, P., Johnson, S., Evans, M., Tyrrell, R., Gordon, M., Wild, C., Hardie, L., Smith, E. and Escodd, [N. V.], 2002. Inter-laboratory validation of procedures for measuring 8-oxo-7,8-dihydroguanine/8-oxo-7,8-dihydro-2 '-deoxyguanosine in DNA. Free Radical Research, 36 (3), pp. 239-245.

Collins, C. A., Fry, F. H., Holme, A. L., Yiakouvaki, A., Al-Qenaei, A., Pourzand, C. A. and Jacob, C., 2005. Towards multifunctional antioxidants: synthesis, electrochemistry, in vitro and cell culture evaluation of compounds with ligand/catalytic properties. Organic and Biomolecular Chemistry, 3, pp. 1541-1546.

Collins, G. T., Newman, A. H., Grundt, P., Rice, K. C., Husbands, S. M., Chauvignac, C., Chen, J., Wang, S. and Woods, J. H., 2007. Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists. Psychopharmacology

Collins, G. T., Truccone, A., Haji-Abdi, F., Newman, A. H., Grundt, P., Rice, K. C., Husbands, S. M., Greedy, B. M., Enguehard-Gueiffier, C., Gueiffier, A., Chen, J., Wang, S., Katz, J. L., Grandy, D. K., Sunahara, R. K. and Woods, J. H., 2009. Proerectile Effects of Dopamine D2-Like Agonists Are Mediated by the D3 Receptor in Rats and Mice. Journal of Pharmacology and Experimental Therapeutics, 329 (1), pp. 210-217.

Cooke, A. M., Gigg, R. and Potter, B. V. L., 1987. Synthesis of DL-Myo-inositol 1,4,5-triphosphate. Tetrahedron Letters, 28 (20), pp. 2305-2308.

Cooke, A. M., Gigg, R. and Potter, B. V. L., 1987. myo-Inositol 1,4,5-trisphosphorothioate : a novel analogue of a biological second messenger. Journal of the Chemical Society, Chemical Communications, 1987 (20), pp. 1525-1526.

Cooke, A. M., Noble, N. J., Payne, S., Gigg, R. and Potter, B. V. L., 1989. Synthesis of myo-inositol 1,4-bisphosphate-5-phosphorothioate. Journal of the Chemical Society, Chemical Communications, 1989 (5), pp. 269-271.

Coopman, K., Smith, L. D., Wright, K. L. and Ward, S. G., 2007. Temporal variation in CB2R levels following T lymphocyte activation: Evidence that cannabinoids modulate CXCL12-induced chemotaxis. International Immunopharmacology, 7 (3), pp. 360-371.

Cordiglieri, C., Odoardi, F., Zhang, B., Nebel, M., Kawakami, N., Klinkert, W. E. F., Lodygin, D., Luhder, F., Breunig, E., Schild, D., Ulaganathan, V. K., Dornmair, K., Dammermann, W., Potter, B. V. L., Guse, A. H. and Flugel, A., 2010. Nicotinic acid adenine dinucleotide phosphate-mediated calcium signalling in effector T cells regulates autoimmunity of the central nervous system. Brain, 133 (7), pp. 1930-1943.

Cork, M. J., Varghese, J., Hadcraft, J., Lane, M., Ferguson, A., Moustafa, M., Guy, R. H. and Ward, S., 2007. Differences in the effect of topical corticosteroids and calcineurin inhibitors on the skin barrier - Implications for therapy. Journal Of Investigative Dermatology, 127, S45-S45.

Cork, M. J., Danby, S. G., Vasilopoulos, Y., Hadgraft, J., Lane, M. E., Moustafa, M., Guy, R. H., Macgowan, A. L., Tazi-Ahnini, R. and Ward, S. J., 2009. Epidermal barrier dysfunction in atopic dermatitis. Journal Of Investigative Dermatology, 129 (8), pp. 1892-1908.

Correa, V., Riley, A. M., Shuto, S., Horne, G., Nerou, E. P., Marwood, R. D., Potter, B. V. L. and Taylor, C. W., 2001. Structural determinants of adenophostin A activity at inositol trisphosphate receptors. Molecular Pharmacology, 59 (5), pp. 1206-1215.

Cottrell, G. and Turner, A. J., 2013. Aminopeptidase P1. In: Rawlings, N. D. and Salvesen, G., eds. Handbook of Proteolytic Enzymes. Vol. 2. 3rd ed. London: Academic Press, pp. 1525-1528.

Cottrell, G. S., Padilla, B. E., Amadesi, S., Poole, D. P., Murphy, J. E., Hardt, M., Roosterman, D., Steinhoff, M. and Bunnett, N. W., 2009. Endosomal Endothelin-converting Enzyme-1: A Regulator of β-Arrestin-Dependent ERK Signaling. Journal of Biological Chemistry, 284 (33), pp. 22411-22425.

Crabbe, T., Welham, M. and Ward, S., 2007. The PI3K inhibitor arsenal: choose your weapon! Trends in Biochemical Sciences, 32 (10), pp. 450-456.

Craddock, N., Hurles, M. E., Cardin, N., Pearson, R. D., Plagnol, V., Robson, S., Vukcevic, D., Barnes, C., Conrad, D. F., Giannoulatou, E., Holmes, C., Marchini, J. L., Stirrups, K., Tobin, M. D., Wain, L. V., Yau, C., Aerts, J., Ahmad, T., Daniel Andrews, T., Arbury, H., Attwood, A., Auton, A., Ball, S. G., Balmforth, A. J., Barrett, J. C., Barroso, I., Barton, A., Bennett, A. J., Bhaskar, S., Blaszczyk, K., Bowes, J., Brand, O. J., Braund, P. S., Bredin, F., Breen, G., Brown, M. J., Bruce, I. N., Bull, J., Burren, O. S., Burton, J., Byrnes, J., Caesar, S., Clee, C. M., Coffey, A. J., Connell, J. M. C., Cooper, J. D., Dominiczak, A. F., Downes, K., Drummond, H. E., Dudakia, D., Dunham, A., Ebbs, B., Eccles, D., Edkins, S., Edwards, C., Elliot, A., Emery, P., Evans, D. M., Evans, G., Eyre, S., Farmer, A., Nicol Ferrier, I., Feuk, L., Fitzgerald, T., Flynn, E., Forbes, A., Forty, L., Franklyn, J. A., Freathy, R. M., Gibbs, P., Gilbert, P., Gokumen, O., Gordon-Smith, K., Gray, E., Green, E., Groves, C. J., Grozeva, D., Gwilliam, R., Hall, A., Hammond, N., Hardy, M., Harrison, P., Hassanali, N., Hebaishi, H., Hines, S., Hinks, A., Hitman, G. A., Hocking, L., Howard, E., Howard, P., Howson, J. M. M., Hughes, D., Hunt, S., Isaacs, J. D., Jain, M., Jewell, D. P., Johnson, T., Jolley, J. D., Jones, I. R., Jones, L. A., Kirov, G., Langford, C. F., Lango-Allen, H., Mark Lathrop, G., Lee, J., Lee, K. L., Lees, C., Lewis, K., Lindgren, C. M., Maisuria-Armer, M., Maller, J., Mansfield, J., Martin, P., Massey, D. C. O., McArdle, W. L., McGuffin, P., McLay, K. E., Mentzer, A., Mimmack, M. L., Morgan, A. E., Morris, A. P., Mowat, C., Myers, S., Newman, W., Nimmo, E. R., O’Donovan, M. C., Onipinla, A., Onyiah, I., Ovington, N. R., Owen, M. J., Palin, K., Parnell, K., Pernet, D., Perry, J. R. B., Phillips, A., Pinto, D., Prescott, N. J., Prokopenko, I., Quail, M. A., Rafelt, S., Rayner, N. W., Redon, R., Reid, D. M., Renwick, A., Ring, S. M., Robertson, N., Russell, E., St Clair, D., Sambrook, J. G., Sanderson, J. D., Schuilenburg, H., Scott, C. E., Scott, R., Seal, S., Shaw-Hawkins, S., Shields, B. M., Simmonds, M. J., Smyth, D. J., Somaskantharajah, E., Spanova, K., Steer, S., Stephens, J., Stevens, H. E., Stone, M. A., Su, Z., Symmons, D. P. M., Thompson, J. R., Thomson, W., Travers, M. E., Turnbull, C., Valsesia, A., Walker, M., Walker, N. M., Wallace, C., Warren-Perry, M., Watkins, N. A., Webster, J., Weedon, M. N., Wilson, A. G., Woodburn, M., Wordsworth, B. P., Young, A. H., Zeggini, E., Carter, N. P., Frayling, T. M., Lee, C., McVean, G., Munroe, P. B., Palotie, A., Sawcer, S. J., Scherer, S. W., Strachan, D. P., Tyler-Smith, C., Brown, M. A., Burton, P. R., Caulfield, M. J., Compston, A., Farrall, M., Gough, S. C. L., Hall, A. S., Hattersley, A. T., Hill, A. V. S., Mathew, C. G., Pembrey, M., Satsangi, J., Stratton, M. R., Worthington, J., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., Ouwehand, W. H., Parkes, M., Rahman, N., Todd, J. A., Samani, N. J. and Donnelly, P., 2010. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature, 464 (7289), pp. 713-722.

Crane, G. J., Dora, K. A., Ings, N. T. and Garland, C. J., 2001. Potassium induced relaxation and repolarization in denuded rat isolated mesenteric arteries. Journal of Vascular Research, 38, (S1)-14.

Crane, G. J., Gallagher, N. T., Dora, K. A. and Garland, C. J., 2003. Small and intermediate calcium-dependent K + channels provide different facets of endothelium-dependent hyperpolarization in rat mesenteric artery. The Journal of Physiology, 553, pp. 183-189.

Crane, G. J., Walker, S. D., Dora, K. A. and Garland, C. J., 2003. Evidence for a differential cellular distribution of inward rectifier K channels in the rat isolated mesenteric artery. Journal of Vascular Research, 40 (2), pp. 159-168.

Crane, G. J. and Garland, C. J., 2004. Thromboxane receptor stimulation associated with loss of SKCa activity and reduced EDHF responses in the rat isolated mesenteric artery. British Journal of Pharmacology, 142 (1), pp. 43-50.

Creighton-Gutteridge, M. and Tyrrell, R. M., 2002. A novel iron chelator that does not induce HIF-1 activity. Free Radical Biology and Medicine, 33 (3), pp. 356-363.

Cresswell, L., Yee, C. S., Farewell, V., Rahman, A., Teh, L. S., Griffiths, B., Bruce, I. N., Ahmad, Y., Prabu, A., Akil, M., McHugh, N. J., Toescu, V., D'Cruz, D., Khamashta, M. A., Maddison, P., Isenberg, D. A. and Gordon, C., 2009. Numerical scoring for the Classic BILAG index. Rheumatology, 48 (12), pp. 1548-1552.

Cronshaw, D. G., Kouroumalis, A., Parry, R., Webb, A., Brown, Z. and Ward, S. G., 2006. Evidence that phospholipase C-dependent, calcium-independent mechanisms are required for directional migration of T lymphocytes in response to the CCR4 ligands CCL17 and CCL22. Journal of Leukocyte Biology, 79, pp. 1369-1380.

Cuadrado, M.J., Bertolaccini, M.L., Seed, P.T., Tektonidou, M.G., Aguirre, A., Mico, L., Gordon, C., Ruiz-Irastorza, G., Egurbide, M.V., Gil, A., Espinosa, G., Houssiau, F., Rahman, A., Martin, H., Mchugh, N., Galindo, M., Akil, M., Amigo, M.C., Murru, V. and Khamashta, M.A., 2014. Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis : A prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS). Rheumatology, 53 (2), ket313.

Cueva, J. P., Gallardo-Godoy, A., Juncosa, J. I., Vidi, P. A., Lill, M. A., Watts, V. J. and Nichols, D. E., 2011. Probing the Steric Space at the Floor of the D(1) Dopamine Receptor Orthosteric Binding Domain: 7 alpha-, 7 beta-, 8 alpha-, and 8 beta-Methyl Substituted Dihydrexidine Analogues. Journal of Medicinal Chemistry, 54 (15), pp. 5508-5521.

Cullis, P. M., Jarvest, R. L., Lowe, G. and Potter, B. V. L., 1981. The stereochemistry of 2-substituted-2-oxo-4,5-diphenyl-1,3,2-dioxaphospholans and the related chiral [16O,17O,18O]phosphate monoesters. Journal of the Chemical Society, Chemical Communications, 5, pp. 245-246.

Cummins, J. H. and Potter, B. V. L., 1985. A simple method for the configurational analysis of a deoxynucleoside 5′- [16O,18O ,S] phosphorothioate. Journal of the Chemical Society, Chemical Communications, 1985 (13), pp. 851-853.

Cummins, J. H. and Potter, B. V. L., 1985. Stereochemical evidence for a phosphorylpyridinium intermediate in the iodine-mediated desulphurisation of a phosphorothioate diester. Journal of the Chemical Society, Chemical Communications, 1985 (12), pp. 800-802.

Cummins, J. H. and Potter, B. V. L., 1987. A general chemical method for the stereochemical analysis of nucleoside-5′ [ 16O, 18 O] phosphorothioates. Phosphorus Sulfur and Silicon and the Related Elements, 30 (3-4), pp. 589-592.

Cummins, J. H. and Potter, B. V. L., 1986. Stereochemical mechanism of the cleavage reaction catalysed by bovine intestinal mucosa 5′-nucleotide phosphodiesterase. In: Biochemical Society Transactions, 1986. Vol. 14. 6 ed. Biochemical Society, pp. 1289-1290.

Cunningham, M. O., Dhillon, A., Wood, S. J. and Jones, R. S. G., 2000. Reciprocal modulation of glutamate and gaba release may underlie the anticonvulsant effect of phenytoin. Neuroscience, 95 (2), pp. 343-351.

Cunningham, M. O., Pervouchine, D. D., Racca, C., Kopell, N. J., Davies, C. H., Jones, R. S. G., Traub, R. D. and Whittington, M. A., 2006. Neuronal metabolism governs cortical network response state. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 103 (14), pp. 5597-5601.

Cunningham, M. O., Woodhall, G. L. and Jones, R. S. G., 2003. Valproate modifies spontaneous excitation and inhibition at cortical synapses in vitro. Neuropharmacology, 45, pp. 907-917.

Cunningham, M. O., Woodhall, G. L., Thompson, S. E., Dooley, D. J. and Jones, R. S. G., 2004. Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro. European Journal of Neuroscience, 20, pp. 1566-1576.

Cunningham, S. A., Else, A. J., Potter, B. V. L. and Eperon, I. C., 1991. Influences of separation and adjacent sequences on the use of alternative 5′ splice sites. Journal of Molecular Biology, 217 (2), pp. 265-281.

Cunninghame Graham, D. S., Wong, A. K., McHugh, N. J., Whittaker, J. C. and Vyse, T. J., 2006. Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study. Human Molecular Genetics, 15 (21), pp. 3195-3205.

Curdy, C., Kalia, Y. N. and Guy, R. H., 2001. Non-invasive assessment of the effects of iontophoresis on human skin in-vivo. Journal of Pharmacy and Pharmacology, 53, pp. 769-777.

Curdy, C., Kalia, Y. N. and Guy, R. H., 2002. Post-iontophoresis recovery of human skin impedance in vivo. European Journal of Pharmaceutics and Biopharmaceutics, 53, pp. 15-21.

Curdy, C., Kalia, Y. N., Naik, A. and Guy, R. H., 2001. Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion. Journal of Controlled Release, 76, pp. 73-79.

Curdy, C., Naik, A., Kalia, Y. N., Alberti, I. and Guy, R. H., 2004. Non-invasive assessment of the effect of formulation excipients on stratum corneum barrier function in vivo. International Journal of Pharmaceutics, 271, pp. 251-256.

Curia, G., Longo, D., Biagini, G., Jones, R. S. G. and Avoli, M., 2008. The pilocarpine model of temporal lobe epilepsy. Journal of Neuroscience Methods, 172 (2), pp. 143-157.

Curnock, A. P., Logan, M. K. and Ward, S. G., 2002. Chemokine signalling: pivoting around multiple phosphinositide 3-kinases. Arthritis & Rheumatism, 105, pp. 125-136.

Cuzzocrea, S., Mazzon, E., Di Paola, R., Genovese, T., Patel, N. S. A., Muià, C., Threadgill, M. D., De Sarro, A. and Thiemermann, C., 2004. 5-Aminoisoquinolinone reduces colon injury by experimental colitis. Naunyn-Schmiedeberg's Archives of Pharmacology, 370, pp. 464-473.

Cuzzocrea, S., McDonald, M. C., Mazzon, E., Dugo, L., Serraino, I., Threadgill, M. D., Caputi, A. P. and Thiemermann, C., 2002. Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury. Biochemical Pharmacology, 63, pp. 293-304.

D

Da Silva, C. P., Potter, B. V. L., Mayr, G. W. and Guse, A. H., 1998. Quantification of intracellular levels of cyclic ADP-ribose by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications, 707 (1-2), pp. 43-50.

Dallosso, A. R., Hancock, A. L., Malik, S., Salpekar, A., King-Underwood, L., Pritchard-Jones, K., Peters, J., Moorwood, K., Ward, A., Malik, K. T. A. and Brown, K. W., 2007. Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer. RNA, 13 (12), pp. 2287-2299.

Dallosso, A. R., Hancock, A. L., Szemes, M., Moorwood, K., Chilukamarri, L., Tsai, H. H., Sarkar, A., Barasch, J., Vuononvirta, R., Jones, C., Pritchard-Jones, K., Royer-Pokora, B., Lee, S. B., Owen, C., Malik, S., Feng, Y., Frank, M., Ward, A., Brown, K. W. and Malik, K., 2009. Frequent long-range epigenetic silencing of Protocadherin gene clusters on chromosome 5q31 in Wilms' Tumor. Plos Genetics, 5 (11), e1000745.

Damager, I., Buchini, S., Amaya, M. F., Buschiazzo, A., Alzari, P., Frasch, A. C., Watts, A. G. and Withers, S. G., 2008. Kinetic and mechanistic analysis of Trypanosoma cruzi trans-sialidase reveals a classical ping-pong mechanism with acid/base catalysis. Biochemistry, 47 (11), pp. 3507-3512.

Dammermann, W., Zhang, B., Nebel, M., Cordiglieric, C., Odoardi, F., Kirchberger, T., Kawakami, N., Dowden, J., Schmid, F., Dornmair, K., Hohenegger, M., Flugel, A., Guse, A. H. and Potter, B. V. L., 2009. NAADP-mediated Ca2+ signaling via type 1 ryanodine receptor in T cells revealed by a synthetic NAADP antagonist. Proceedings of the National Academy of Sciences of the United States of America, 106 (26), pp. 10678-10683.

Danoy, P., Pryce, K., Hadler, J., Bradbury, L. A., Farrar, C., Pointon, J., Ward, M., Weisman, M., Reveille, J. D., Wordsworth, B. P., Stone, M. A., Maksymowych, W. P., Rahman, P., Gladman, D., Inman, R. D. and Brown, M. A., 2010. Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease. Plos Genetics, 6 (12), e1001195.

Darley, D. J., Butler, D. S., Threadgill, M. D. and Lloyd, M. D., 2008. Characterisation of recombinant alpha-methylacyl-CoA racemase, a novel prostate cancer target. In: RSC Bioorganic Group Annual Post-Graduate Symposium P7, 2008, 2008-03-01.

Darley, D. J., Butler, D. S., Threadgill, M. D. and Lloyd, M. D., 2007. Characterisation of recombinant alpha-methylacyl-CoA racemase, a novel prostate cancer target. In: Life Sciences Conference,2007, 2007-07-01, Glasgow.

Darley, D. J., Butler, D. S., Threadgill, M. D. and Lloyd, M. D., 2007. Characterisation of recombinant alpha-methylacyl-CoA racemase, a novel prostate cancer target. In: Northern England (and Bristol) Collaborative (PROMPT) and South of England Prostate Collaborative Joint Meeting, 2007, 2007-11-01, Cambridge.

Darley, D. J., Butler, D. S., Threadgill, M. D. and Lloyd, M. D., 2007. Characterisation of recombinant alpha-methylacyl-CoA racemase, a novel prostate cancer target. In: 3rd National Cancer Research Institute (NCRI) Cancer Conference, 2007, 2007-10-01, Birmingham.

Darley, D. J., Prideaux, S. J., Thornton, T. W., Wilson, A. D., Threadgill, M. D., Woodman, T. J. and Lloyd, M. D., 2008. Synthesis of 2-[2H]-2-[13C]-S-2-methyldecanoyl-CoA and 13C NMR study of its reaction with ∝-methylacyl-CoA racemase (AMACR. In: RSC Bioorganic Group Annual Post-Graduate Symposium P8, 2008, 2008-03-01.

Darley, D. J., Butler, D. S., Prideaux, S. J., Thornton, T. W., Wilson, A. D., Woodman, T. J., Threadgill, M. D. and Lloyd, M. D., 2009. Synthesis and use of isotope-labelled substrates for a mechanistic study on human α-methylacyl-CoA racemase 1A (AMACR; P504S). Organic and Biomolecular Chemistry, 7 (3), pp. 543-552.

Daugherty, A. L., McKee, M. L., FitzGerald, D. J. and Mrsny, R. J., 2000. Epithelial application of Pseudomonas aeruginosa exotoxin A results in a selective targeting to cells in the liver, spleen and lymph node. Journal of Controlled Release, 65 (1-2), pp. 297-302.

Daugherty, A. L. and Mrsny, R. J., 2003. Emerging technologies that overcome biological barriers for therapeutic protein delivery. Expert Opinion on Biological Therapy, 3 (7), pp. 1071-1081.

Daugherty, A. L. and Mrsny, R. J., 2006. Formulation and delivery issues for monoclonal antibody therapeutics. Advanced Drug Delivery Reviews, 58 (5-6), pp. 686-706.

Daugherty, A. L., Rangell, L. K., Eckert, R., Zavala-Solorio, J., Peale, F. and Mrsny, R. J., 2011. Sustained release formulations of rhVEGF165 produce a durable response in a murine model of peripheral angiogenesis. European Journal of Pharmaceutics and Biopharmaceutics, 78 (2), pp. 289-297.

Davie, C. A., Feinstein, A., Kartsounis, L. D., Barker, G. J., McHugh, N. J., Walport, M. J., Ron, M. A., Moseley, I. F., McDonald, W. I. and Miller, D. H., 1995. Proton magnetic resonance spectroscopy of systemic lupus erythematosus involving the central nervous system. The Journal of Comparative Neurology, 242 (8), pp. 522-528.

Davies, J. G., Brian John, M., Rees, J. and Staniforth, J., 1987. Solid Composition for Disinfecting Contact Lenses. A61L2/18-FI874192 (A), 24 September 1987.

Davies, J. G., Brian John, M. and Staniforth, J., 1988. Compositions for Treating Contact Lenses. A61L12/14-WO8808309 (A1), 03 November 1988.

Davies, J. G., Brian John, M., Rees, J. and Staniforth, J., 1990. Reinigung Und/Oder Desinfektion Von Kontaktlinsen. A61L2/18-AT57473 (T), 15 November 1990.

Dawson, H. E., Sutton, J. and Taylor, D. A., 2010. Recruitment of individuals with enduring mental health conditions for health services research. International Journal of Pharmacy Practice, 18 (Suppl 1), pp. 2-3.

Day, C. J., Price, R., Sandy, J. R. and Ireland, A. J., 2008. Inhalation of aerosols produced during the removal of fixed orthodontic appliances: A comparison of 4 enamel cleanup methods. American Journal of Orthodontics and Dentofacial Orthopedics, 133 (1).

Day, J. M., Foster, P. A., Tutill, H. J., Newman, S. P., Ho, Y. T., Leese, M. P., Potter, B. V. L., Reed, M. J. and Purohit, A., 2009. BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure. British Journal of Cancer, 100 (3), pp. 476-486.

Day, J.M., Foster, P.A., Tutill, H.J., Schmidlin, F., Sharland, C.M., Hargrave, J.D., Vicker, N., Potter, B.V.L., Reed, M.J. and Purohit, A., 2013. STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer model. Endocrine-Related Cancer, 20 (1), pp. 53-64.

Day, J. M., Foster, P. A., Tutill, H. J., Parsons, M. F. C., Newman, S. P., Chander, S. K., Allan, G. M., Lawrence, H. R., Vicker, N., Potter, B. V. L., Reed, M. J. and Purohit, A., 2008. 17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer. International Journal of Cancer, 122 (9), pp. 1931-1940.

Day, J. M., Newman, S. P., Comninos, A., Solomon, C., Purohit, A., Leese, M. P., Potter, B. V. L. and Reed, M. J., 2003. The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells. Steroid Biochemistry & Molecular Biology, 84 (2-3), pp. 317-325.

Day, J. M., Purohit, A., Tutill, H. J., Foster, P. A., Woo, L. W. L., Potter, B. V. L. and Reed, M. J., 2009. The development of steroid sulfatase iInhibitors for hormone-dependent cancer therapy. In: Bradlow, H. L. and Carruba, G., eds. Steroid Enzymes and Cancer. Vol. 1155. Blackwell Publishing, pp. 80-87. (Annals of the New York Academy of Sciences)

Day, J. M., Tutill, H. J., Foster, P. A., Bailey, H. V., Heaton, W. B., Sharland, C. M., Vicker, N., Potter, B. V. L., Purohit, A. and Reed, M. J., 2009. Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17β-hydroxysteroid dehydrogenase Type 3. Molecular and Cellular Endocrinology, 301 (1-2), pp. 251-258.

Day, J. M., Tutill, H. J., Newman, S. P., Purohit, A., Lawrence, H. R., Vicker, N., Potter, B. V. L. and Reed, M. J., 2006. 17β-hydroxysteroid dehydrogenase type 1 and type 2 : association between mRNA expression and activity in cell lines. Molecular and Cellular Endocrinology, 248 (1), pp. 246-249.

De Bank, P., 2014. Novel Treatment to Help Fight Drug-resistant Bacteria. International Pharmaceutical Industry, 6 (2), pp. 64-66.

De Bank, P. A., Kellam, B., Kendall, D. A. and Shakesheff, K. M., 2005. Altered cellular response to adsorbed matrix protein by chemoselective ligation of small molecules. Journal of Materials Chemistry, 15, pp. 2047-2055.

De Bank, P. A., Kellam, B., Kendall, D. A. and Shakesheff, K. M., 2003. Surface engineering of living myoblasts via selective periodate oxidation. Biotechnology and Bioengineering, 81 (7), pp. 800-808.

De Bank, P. A., Kendall, D. A. and Alexander, S. P. H., 2005. A spectrophotometric assay for fatty acid amide hydrolase suitable for high-throughput screening. Biochemical Pharmacology, 69, pp. 1187-1193.

De Bank, P., Jones, M. and Ellis, M., 2009. Polymeric scaffolds for regenerative medicine. In: Mattiasson, B., Kumar, A. and Galaev, I. Y., eds. Macroporous Polymers: Production Properties and Biotechnological/Biomedical Applications. CRC Press, pp. 467-495.

De Bank, P. A., Hou, Q., Warner, R. M., Wood, I. V., Ali, B. E., MacNeil, S., Kendall, D. A., Kellam, B., Makesheff, K. M. and Buttery, L. D. K., 2007. Accelerated formation of multicellular 3-D structures by cell-to-cell cross-linking. Biotechnology and Bioengineering, 97 (6), pp. 1617-1625.

De Kort, M., Correa, V., Valentijn, A. R. P. M., Van Der Marel, G. A., Potter, B. V. L., Taylor, C. W. and Van Boom, J. H., 2000. Synthesis of potent agonists of the D-myo -inositol 1,4,5-trisphosphate receptor based on clustered disaccharide polyphosphate analogues of adenophostin A. Journal of Medicinal Chemistry, 43 (17), pp. 3295-3303.

DeLisle, S., Pittet, D., Potter, B. V. L., Lew, P. D. and Welsh, M. J., 1992. InsP3 and Ins(1,3,4,5)P4 act in synergy to stimulate influx of extracellular Ca2+ in Xenopus oocytes. American Journal of Physiology - Cell Physiology, 262 (6), C1456-C1463.

DeLisle, S., Krause, K.-H., Denning, G., Potter, B. V. L. and Welsh, M. J., 1990. Effect of inositol trisphosphate and calcium on oscillating elevations of intracellular calcium in Xenopus oocytes. Journal of Biological Chemistry, 265 (20), pp. 11726-11730.

DeLisle, S., Marksberry, E. W., Bonnett, C., Jenkins, D. J., Potter, B. V. L., Takahashi, M. and Tanzawa, K., 1997. Adenophostin A can stimulate Ca2+ influx without depleting the inositol 1,4,5-trisphosphate-sensitive Ca2+ stores in the Xenopus oocyte. Journal of Biological Chemistry, 272 (15), pp. 9956-9961.

Deave, T., Weiss, M. C. and Salisbury, C., 2003. Patient group directions for antibiotic supply in Walk-in Centres: how legal are they? British Journal of Community Nursing, 8 (5), pp. 209-213.

Delcros, J. G., Tomasi, S., Carrington, S., Martin, B., Renault, J., Blagbrough, I. S. and Uriac, P., 2002. Effect of spermine conjugation on the cytotoxicity and cellular transport of acridine. Journal of Medicinal Chemistry, 45 (23), pp. 5098-5111.

Delgado-Charro, M. B. and Guy, R. H., 2003. Iontophoresis: applications in drug delivery and noninvasive monitoring. In: Guy, R. H. and Hadgraft, J., eds. Transdermal Drug Delivery Systems, 2nd ed. Vol. 2nd Edition, Revised and Expanded. New York: Marcel Dekker, pp. 199-225.

Delgado-Charro, M. B. and Guy, R. H., 2001. Transdermal drug delivery. In: Hillery, A. M., Lloyd, A. W. and Swarbrick, J., eds. Drug Delivery and Targeting for Pharmacists and Pharmaceutical Scientists. London, U. K.: Harwood Academic Publishers, pp. 207-236.

Delgado-Charro, M. B., 2012. Iontophoretic drug delivery across the nail. Expert Opinion on Drug Delivery, 9 (1), pp. 91-103.

Delgado-Charro, M. B., 2011. Sampling substrates by skin permeabilization. In: Murthy, S. N., ed. Dermatokinetics of Therapeutic Agents. Boca Raton: Taylor and Francis, pp. 149-174.

Delgado-Charro, M. B., 2013. Richard Guy and his collaborators : 'crackling' the skin code. Skin Pharmacology and Physiology, 26 (4-6), pp. 302-312.

Delgado-Charro, M. B. and Guy, R. H., 2014. Effective use of transdermal drug delivery in children. Advanced Drug Delivery Reviews, 73, pp. 63-82.

Delgado-Charro, M. B., 2009. Recent advances on transdermal iontophoretic drug delivery and non-invasive sampling. Journal of Drug Delivery Science and Technology, 19 (2), pp. 75-88.

Della Rossa, A., Valentini, G., Bombardieri, S., Bencivelli, W., Silman, A. J., D'Angelo, S., Cerinic, M. M., Belch, J. F., Black, C. M., Becvar, R., Bruhlman, P., Cozzi, F., Czirják, L., Drosos, A. A., Dziankowska, B., Gabrielli, A., Giacomelli, R., Hayem, G., Inanc, M., McHugh, N. J., Nielsen, H., Scorza, R., Tirri, E., van den Hoogen, F. H., Vlachoyiannopoulos, P. G. and C, F., 2001. European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Annals of the Rheumatic Diseases, 60 (6), pp. 585-591.

Depasquale, R., Lee, S. L., Saluja, B., Shur, J. and Price, R., 2014. Forthcoming. The influence of secondary processing on the structural relaxation dynamics of fluticasone propionate. AAPS PharmSciTech Item availability may be restricted.

Dhami, A., 2009. Approaches to new DNA-repair inhibitors for applications in cancer therapy. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Dhillon, A. S., 2010. Engineering of combination particles for improved therapeutic efficacy. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Di Paola, R., Genovese, T., Caputi, A. P., Threadgill, M. D., Thiemermann, C. and Cuzzocrea, S., 2004. Beneficial effects of 5-aminoisoquinolinone, a novel, potent, water-soluble, inhibitor of poly (ADP-ribose) polymerase, in a rat model of splanchnic artery occlusion and reperfusion. European Journal of Pharmacology, 492, pp. 203-210.

Di Venosa, G., Vallecorsa, P., Giuntini, F., Mamone, L., Batlle, A., Vanzuli, S., Juarranz, A., MacRobert, A. J., Eggleston, I. M. and Casas, A., 2015. The use of dipeptide derivatives of 5-aminolaevulinic acid promotes their entry to tumor cells and improves tumor selectivity of photodynamic therapy. Molecular Cancer Therapeutics, 14 (2), pp. 440-451.

Dias, M., Naik, A., Guy, R. H., Hadgraft, J. and Lane, M. E., 2008. In vivo infrared spectroscopy studies of alkanol effects on human skin. European Journal of Pharmaceutics and Biopharmaceutics, 69 (3), pp. 1171-1175.

Diaz del Consuelo, I., Falson, F., Guy, R. H. and Jacques, Y., 2007. Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl. Journal of Controlled Release, 122 (2), pp. 135-140.

Diaz del Consuelo, I., Falson, F., Guy, R. H. and Jacques, Y., 2005. Transport of fentanyl through pig buccal and esophageal epithelia in vitro . Influence of concentration and vehicle pH. Pharmaceutical Research, 22 (9), pp. 1525-1529.

Diaz del Consuelo, I., Pizzolato, G. P., Falson, F., Guy, R. H. and Jacques, Y., 2005. Evaluation of pig esophageal mucosa as a permeability barrier model for buccal tissue. Journal of Pharmaceutical Sciences, 94 (12), pp. 2677-2688.

Diaz del Consuelo, I., Pizzolato, G. P., Jacques, Y., Guy, R. H. and Falson, F., 2005. Comparison of the lipid composition of porcine buccal and esophageal permeability barriers. Archives of Oral Biology, 50, pp. 981-987.

Dick, G. M., Rossow, C. F., Smirnov, S. V., Horowitz, B. and Sanders, K. M., 2001. Tamoxifen activates smooth muscle BK channels through the regulatory β1 subunit. Journal of Biological Chemistry, 276 (37), pp. 34594-34599.

Dieleman, J., Lecomte, C., Schuemie, M., van Rolleghem, A., Hviid, A., Svanstrom, H., Molgaard-Nielsen, D., Jokinen, J., Nohynek, H., Kilpi, T., Storsaeter, J., van der Maas, N., Heijbel, H., Arnheim-Dahlstrom, L., Sparen, P., Sammon, C., De Vries, C., Plazzi, G., Menna, A., Trotta, F., Santuccio, C., Johansen, K., Kramarz, P., Weibel, D., Bonhoeffer, J. and Sturkenboom, M., 2011. Safety of adjuvanted pandemic influenza vaccines: background rate of narcolepsy in Europe. Pharmacoepidemiology and Drug Safety, 20 (Supplement 1), S260.

Dieleman, J., Romio, S., De Vries, C., Sammon, C., Andrews, N., Hviid, A., Svanström, H., Mølgaard-Nielsen, D., Lapeyre-Mestre, M., Sommet, A., Saussier, C., Castot, A., Heijbel, H., Arnheim Dahlström, L., Hallgren, J., Sparen, P., Mosseveld, M., Schuemie, M., van der Maas, N., Jacobs, B. C., Johansen, K., Kramarz, P., Weibel, D., Bonhoeffer, J. and Sturkenboom, M. C., 2011. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ, 343, d3908.

Dieleman, J. P., Romio, S. S., De Vries, C. S., Sammon, C. J., Andrews, N., Hviid, A., Svanstrom, H., Molgaard-Nielsen, D., Lapeyre-Mestre, M., Sommet, A., Saussier, C., Castot, A., Heijbel, H., Dahlstrom, L. A., Hallgren, J., Sparen, P., Mosseveld, M., Schuemie, M., van der Maas, N., Jacobs, B. C., Johansen, K., Kramarz, P., Weibel, D., Bonhoeffer, J. and Sturkenboom, M., 2011. Guillain-Barre Syndrome and Adjuvanted Pandemic Influenza A (H1N1) 2009 Vaccines - A Multinational Case Control Study in Europe. Pharmacoepidemiology and Drug Safety, 20 (Supplement 1), S258-S259.

Dixon, M., Nathubhai, A., Andersen, O., van Aalten, D. and Eggleston, I. M., 2008. Synthesis of cyclic peptide chitinase inhibitors : Natural products,with chemotherapeutic potential. Journal of Peptide Science, 14 (8 (Suppl S)), p. 13.

Dixon, M. J., Andersen, O. A., van Aalten, D. M. F. and Eggleston, I. M., 2005. An efficient synthesis of argifin: a natural product chitinase inhibitor with chemotherapeutic potential. Bioorganic & Medicinal Chemistry Letters, 15 (21), pp. 4717-4721.

Dixon, M. J., Andersen, O. A., van Aalten, D. M. F. and Eggleston, I. M., 2006. First synthesis of argadin: A nanomolar inhibitor of family-18 chitinases. European Journal of Organic Chemistry, 22, pp. 5002-5006.

Dixon, M. J., Andersen, O. A., van Aalten, D. M. F. and Eggleston, I. M., 2009. SPPS of the natural product chitinase inhibitor argifin: library generation and biological evaluation. In: Del Valle, S., Escher, E. and Lubell, W. D., eds. Peptides for Youth. Vol. 611. New York: Springer, pp. 143-144. (Advances in Experimental Medicine and Biology)

Dixon, M. J., Andersen, O. A., van Aalten, D. M. F., Nathubhai, A. and Eggleston, I. M., 2007. Cyclic peptide chitinase inhibitors: new leads for antifungal and anti-inflammatory drugs. Biopolymers, 88, p. 576.

Dixon, M. J., Bourre, L., MacRobert, A. J. and Eggleston, I. M., 2007. Novel prodrug approach to photodynamic therapy: Fmoc solid-phase synthesis of a cell permeable peptide incorporating 5-aminolaevulinic acid. Bioorganic & Medicinal Chemistry Letters, 17 (16), pp. 4518-4522.

Dixon, M. J., Nathubhai, A., Andersen, O. A., van Aalten, D. M. F. and Eggleston, I. M., 2009. Solid-phase synthesis of cyclic peptide chitinase inhibitors: SAR of the argifin scaffold. Organic and Biomolecular Chemistry, 7 (2), pp. 259-268.

Dixon, M. J., Nathubhai, A., Andersen, O. A., van Aalten, D. M. F. and Eggleston, I. M., 2009. Synthesis and Structure-based Dissection of Cyclic Peptide Chitinase Inhibitors: New Leads for Antifungal and Anti-inflammatory Drugs. In: DelValle, S., Escher, E. and Lubell, W. D., eds. Peptides for Youth - The Proceedings of the 20th American Peptide Symposium. Springer, pp. 525-526. (Advances in Experimental Medicine and Biology)

Dixon, M., Giuntini, F., Nathubhai, A., Andersen, O., van Aalten, D. and Eggleston, I., 2008. Synthetic approaches to cyclic peptide natural products as chitinase inhibitors. Journal of Peptide Science, 14 (8), p. 55.

Djabri, A., 2009. Iontophoresis in paediatric medicine: Non-invasive delivery and monitoring applications. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Djabri, A., Guy, R. H. and Delgado-Charro, M. B., 2012. Transdermal iontophoresis of ranitidine: An opportunity in paediatric drug therapy. International Journal of Pharmaceutics, 435 (1), pp. 27-32.

Djabri, A., van’t Hoff, W., Brock, P., Wong, I. C.K., Guy, R. H. and Delgado-Charro, B., 2015. Iontophoretic transdermal sampling of iohexol as a noninvasive tool to assess glomerular filtration rate. Pharmaceutical Journal, 32 (2), pp. 590-603. Item availability may be restricted.

Dobbin, E., Corrigan, P. M., Walsh, C. P., Welham, M. J., Freeburn, R. W. and Wheadon, H., 2008. Tel/PDGFR beta inhibits self-renewal and directs myelomonocytic differentiation of ES cells. Leukemia Research, 32 (10), pp. 1554-1564.

Dodd, C.N., Romio, S.A., Black, S., Vellozzi, C., Andrews, N., Sturkenboom, M., Zuber, P., Hua, W., Bonhoeffer, J., Buttery, J., Crawford, N., Deceuninck, G., de Vries, C., De Wals, P., Gutierrez-Gimeno, M.V., Heijbel, H., Hughes, H., Hur, K., Hviid, A., Kelman, J., Kilpi, T., Chuang, S.K., Macartney, K., Rett, M., Lopez-Callada, V.R., Salmon, D., Gimenez Sanchez, F., Sanz, N., Silverman, B., Storsaeter, J., Thirugnanam, U., van der Maas, N., Yih, K., Zhang, T. and Izurieta, H., 2013. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine, 31 (40), pp. 4448-4458.

Dohle, W., Leese, M.P., Jourdan, F.L., Chapman, C.J., Hamel, E., Ferrandis, E. and Potter, B.V.L., 2014. Optimisation of tetrahydroisoquinoline-based chimeric microtubule disruptors. ChemMedChem, 9 (8), pp. 1783-1793.

Dohle, W., Leese, M. P., Jourdan, F. L., Major, M. R., Bai, R., Hamel, E., Ferrandis, E., Kasprzyk, P. G., Fiore, A., Newman, S. P., Purohit, A. and Potter, B. V. L., 2014. Synthesis, Antitubulin, and Antiproliferative SAR of C3/C1-Substituted Tetrahydroisoquinolines. ChemMedChem, 9 (2), pp. 350-370.

Dokoumetzidis, A., Kalantzi, L. and Fotaki, N., 2007. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models. Expert Opinion Drug Metabolism and Toxicology, 3 (4), pp. 491-505.

Dora, K. A., 2001. Cell-cell communication in the vessel wall. Vascular Medicine, 6, pp. 43-50.

Dora, K. A., 2005. Does arterial myogenic tone determine blood flow distribution in vivo? American Journal of Physiology-Heart and Circulatory Physiology, 289, H1323-H1325.

Dora, K. A., 2001. Intercellular calcium signalling: the artery wall. Cell & Developmental Biology, 12, pp. 27-35.

Dora, K. A., Gallagher, N. T., McNeish, A. and Garland, C. J., 2008. Modulation of endothelial cell K(Ca)3.1 channels during endothelium-derived hyperpolarizing factor signaling in mesenteric resistance arteries. Circulation Research, 102 (10), pp. 1247-1255.

Dora, K. A. and Garland, C. J., 2001. Properties of smooth muscle hyperpolarization and relaxation to K + in the rat isolated mesenteric artery. American Journal of Physiology-Heart and Circulatory Physiology, 280, H2424-H2429.

Dora, K. A. and Garland, C. J., 2001. Properties of smooth muscle hyperpolarization and relaxation to potassium in the rat isolated mesenteric artery. Journal of Vascular Research, 38 ((S1)), P20.

Dora, K. A., Garland, C. J., Kwan, H. Y. and Yao, X., 2001. Endothelial cell protein kinase G inhibits release of EDHF through a PKG-sensitive cation channel. American Journal of Physiology-Heart and Circulatory Physiology, 280, H1272-H1277.

Dora, K. A., Garland, C. J. and Vanhoutte, P. M., 2001. Evidence for relaxation to endothelium-derived hyperpolarizing factor (EDHF) in isolated small mesenteric arteries of the mouse. In: EDHF 2000. London: Taylor & Francis, pp. 270-273.

Dora, K. A., Ings, N. T. and Garland, C. J., 2002. K Ca channel blockers reveal hyperpolarization and relaxation to K + in rat isolated mesenteric artery. American Journal of Physiology-Heart and Circulatory Physiology, 283, H606-H614.

Dora, K. A., Ings, N. T. and Garland, C. J., 2002. Modulation of responses to exogenous potassium by potassium channel activity in the rat isolated mesenteric artery. British Journal of Pharmacology, 135, 26P.

Dora, K. A., McEvoy, L., King, M., Ings, N. T., Garland, C. J. and Vanhoutte, P. M., 2003. The intensity of agonist-stimulation influences the mechanism for relaxation in the rat mesenteric artery. In: EDHF. Vol. 2002. London: Taylor & Francis, pp. 256-260.

Dora, K. A., Sandow, S. L., Gallagher, N. T., Takano, H., Rummery, N. M., Hill, C. E. and Garland, C. J., 2003. Myoendothelial gap junctions may provide the pathway for EDHF in mouse mesenteric artery. Journal of Vascular Research, 40, p. 480.

Dora, K. A., Sandow, S. L., Ings, N. T., Takano, H., Hill, C. E. and Garland, C. J., 2002. Myoendothelial gap junctions provide a pathway for EDHF in the mesenteric artery of the mouse. British Journal of Pharmacology, 135, 121P.

Dora, K. A., Takano, H., Spitaler, M. M., McSherry, I. N. and Garland, C. J., 2004. Role of endothelial cell K + channels in spreading dilatation. FASEB Journal, Abstract 437, p. 1.

Dora, K. A., Walker, S. D., Garland, C. J. and Vanhoutte, P. M., 2001. A central role for endothelial cell potassium channels in EDHF-mediated responses. In: EDHF 2000. London: Taylor & Francis, pp. 118-125.

Dora, K. A., Xia, J. and Duling, B. R., 2003. Endothelial cell signaling during conducted vasomotor responses. American Journal of Physiology-Heart and Circulatory Physiology, 285, H119-H126.

Dorenbos, R., Stein, T., Kabel, J., Bruand, C., Bolhuis, A., Bron, S., Quax, W. J. and van Dijl, J. M., 2002. Thiol-disulfide oxidoreductases are essential for the production of the lantibiotic sublancin 168. Journal of Biological Chemistry, 277 (19), pp. 16682-16888.

Dove, M.T., Calleja, M., Bruin, R., Wakelin, J., Tucker, M.G., Lewis, G.J., Hasan, S.M., Alexandrov, V.N., Keegan, M., Ballard, S., Tyer, R.P., Todorov, I., Wilson, P.B., Alfredsson, M., Price, G.D., Chapman, C., Emmerich, W., Wells, S.A., Marmier, A., Parker, S.C. and Du, Z., 2005. The eMinerals collaboratory : Tools and experience. Molecular Simulation, 31 (5), pp. 329-337.

Dowden, J. and Ward, S. G., 2001. Inhibitors of p56 lck : assessing their potential as tools for manipulating T-lymphocyte activation. Expert Opinion on Therapeutic Patents, 11 (2), pp. 295-306.

Dowden, J. and Savovic, J., 2001. Olefin metathesis in non-degassed solvent using a recyclable, polymer supported alkylideneruthenium. Chemical Communications, 1, pp. 37-38.

Dowden, J., Berridge, G., Moreau, C., Yamasaki, M., Churchill, G. C., Potter, B. V. L. and Galione, A., 2006. Cell-permeant small-molecule modulators of NAADP-mediated Ca2+ release. Chemistry & Biology, 13 (6), pp. 659-665.

Dowden, J., Brown, R. S., Moreau, C., Galione, A. and Potter, B. V. L., 2005. Chemical synthesis of the novel Ca 2+ messenger NAADP. Nucleosides, Nucleotides and Nucleic Acids, 24 ((5-7)), pp. 513-518.

Dowden, J., Hong, W., Parry, R. V., Pike, R. A. and Ward, S. G., 2010. Toward the development of potent and selective bisubstrate inhibitors of protein arginine methyltransferases. Bioorganic & Medicinal Chemistry Letters, 20 (7), pp. 2103-2105.

Dowden, J., Moreau, C., Brown, R. S., Berridge, G., Galione, A. and Potter, B. V. L., 2004. Chemical synthesis of the second messenger nicotinic acid adenine dinucleotide phosphate by total synthesis of nicotinamide adenine dinucleotide phosphate. Angewandte Chemie-International Edition, 43 (35), 4637 -4640.

Dowden, J., Pike, R. A., Parry, R. V., Hong, W., Muhsen, U. A. and Ward, S. G., 2011. Small molecule inhibitors that discriminate between protein arginine N-methyltransferases PRMT1 and CARM1. Organic and Biomolecular Chemistry, 9 (22), pp. 7814-7821.

Dowden, J. and Welham, M., 2007. Reagents and Methods for Cross-Linking Biological Molecules. C07D207/46-WO2007113575 (A2), 11 October 2007.

Drago, C., Caggiano, L. and Jackson, R. F. W., 2005. Vanadium-catalyzed sulfur oxidation/kinetic resolution in the synthesis of enantiomerically pure alkyl aryl sulfoxides. Angewandte Chemie-International Edition, 44, pp. 7221-7223.

Drago, C., Walker, E. J., Caggiano, L. and Jackson, R. F. W., 2009. Enantioselective oxidation of an alkyl aryl sulfide : Synthesis of (S)-(-)-methyl p-Bromophenyl sulfoxide. Organic Syntheses, 86, pp. 121-129.

Dubus, A., Lloyd, M. D., Lee, H.-J., Schofield, C. J., Baldwin, J. E. and Frere, J.-M., 2001. Probing the penicillin sidechain selectivity of recombinant deacetoxycephalosporin C synthase. Cellular and Molecular Life Sciences (CMLS), 58 (5-6), pp. 835-843.

Dujardin, N., Staes, E., Kalia, Y. N., Clarys, P., Guy, R. H. and Préat, V., 2002. In vivo assessment of skin electroporation using square wave pulses. Journal of Controlled Release, 79, pp. 219-227.

Duken, P., Lammers, A. A., Ozaki, S., Potter, B. V. L., Erneux, C. and Van Haastert, P. J. M., 1994. Phosphorylation of inositol 1,4,5-trisphosphate analogues by 3-kinase and dephosphorylation of inositol 1,3,4,5-tetrakisphosphate analogues by 5-phosphatase. European Journal of Biochemistry, 226 (2), pp. 561-566.

Duncan, L., Purohit, A., Howarth, N. M., Potter, B. V. L. and Reed, M. J., 1993. Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate : a potential therapeutic agent in breast cancer. Cancer Research, 53, pp. 298-303.

Dunphy, J., Oliver, M., Rands, A. L., Lovell, C. R. and McHugh, N. J., 2000. Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome. British Journal of Dermatology, 142 (3), pp. 461-467.

Dutet, J., 2009. Iontophoretic drug delivery to the nail. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Dutet, J. and Delgado-Charro, M. B., 2010. Electroosmotic transport of mannitol across human nail during constant current iontophoresis. Journal of Pharmacy and Pharmacology, 62 (6), pp. 721-729.

de Jong-van den Berg, L. T. W., Egberts, A. C. G. and de Vries, C. S., 2001. Langs de valkuilen (5) Onderzoeksopzetten en risicomaten [Study design and risk estimates]. Pharmaceutisch Weekblad, 136 (34), pp. 1280-1283.

de Jong-van den Berg, L. T. W. and de Vries, C. S., 2001. Farmaco-epidemiologie Langs de valkuilen (2) Methoden en meetsystemen. Pharmaceutisch Weekblad, 136 (28), pp. 1023-1025.

de Jong-van den Berg, L. T. W. and de Vries, C. S., 2001. Farmaco-epidemiologie Langs de valkuilen (7) Statistisch verband en causaliteit. Pharmaceutisch Weekblad, 136 (39), pp. 1468-1470.

de Jong-van den Berg, L. T. W. and de Vries, C. S., 2001. Langs de valkuilen (1) De associatie van blootstelling en uitkomst. Pharmaceutisch Weekblad, 136 (26), pp. 944-947.

de Jong-van den Berg, L. T. W. and de Vries, C. S., 2001. Pregnancy and breatfeeding mothers. In: Taylor, K. and Harding, G., eds. Pharmacy Practice. London: Taylor & Francis, pp. 301-312.

de Jong-van den Berg, L. T. W., de Vries, C. S., Brouwers, J. J. M. and Veehof, L. J. G., 2001. Zwangerschap en geneesmiddelen [Pregnancy and medicines]. Huisarts en Wetenschap, 44 (5), pp. 198-203.

de Vries, C., Bromley, S. and Farmer, R., 2006. Myocardial infarction risk and hormone replacement: Differences between products. Maturitas, 53 (3), pp. 343-350.

de Vries, C., Nightingale, A. and Farmer, R., 2008. Epidemiology of systemic lupus erythematosus in the United Kingdom: Comment on the article by Somers et al. Arthritis & Rheumatism, 59 (2), p. 297.

de Vries, C. S., 2002. Cox II inhibitors versus non-steroidal anti-inflammatory drugs in rheumatoid and osteoarthritis patients: gastrointestinal effects. In: Foxcroft, D. R. and Muthu, V., eds. STEER: Succinct and Timely Evaluated Evidence Reviews. Vol. 2(8). Wesses Institute for Health Research and Development, University of Southampton.

de Vries, C. S., 2000. Dokterende folklore [Doctoring folklore]. Pharmaceutisch Weekblad, 135 (20), p. 705.

de Vries, C. S., 2001. Effects of TNF-alpha antagonists in people with rheumatoid arthritis. In: Foxcroft, D. R. and Muthu, V., eds. STEER: Succinct and Timely Evaluated Evidence Reviews. Vol. 1(19). Wesses Institute for Health Research and Development, University of Southampton.

de Vries, C. S., 2004. MMR scare. The Independent, 27 Feb 2004.

de Vries, C. S. and , B. L., 2003. Cochlear implants in adults. In: STEER: Succinct and Timely Evaluated Evidence Reviews. Vol. 3(10). Wesses Institute for Health Research and Development, University of Southampton.

de Vries, C. S., Bromley, S. E., Thomas, H. and Farmer, R. D. T., 2005. Tibolone and endometrial cancer: a cohort and nested case-control study in the UK. Drug Safety, 28 (3), pp. 241-249.

de Vries, C. S., Herrings, R. M. C. and de Jong-van den Berg, L. T. W., 2001. Langs de valkuilen (4) Informatiebronnen voor farmacoepidemiologisch onderzoek. [Information sources for pharmacoepidemiology research]. Pharmaceutisch Weekblad, 136 (32), pp. 1190-1193.

de Vries, C. S. and Russell-Jones, D. L., 2009. Rosiglitazone or pioglitazone in type 2 diabetes? British Medical Journal, 339, b3076.

de Vries, C. S., Snowball, J., Russell-Jones, D. and Hutchison, A., 2008. Stillbirth and early neonatal death risk is reduced in those using analogue compared with those using human insulin. Pharmacoepidemiology and Drug Safety, 17 (Supplement 1), 034.

de Vries, C. S. and de Jong-van den Berg, L. T. W., 2001. Farmaco-epidemiologie Langs de valkuilen (6) Fouten en vertekening in farmacoepidemiologisch onderzoek [Bias and confounding in pharmacoepidemiology research]. Pharmaceutisch Weekblad, 136 (37), pp. 1391-1393.

de Vries, C. S. and de Jong-van den Berg, L. T. W., 2003. Langs de valkuilen (13) De begrippen 'inceptie cohort', stratification, en causaliteit [Principles of inception cohorts, stratification, and causality]. Pharmaceutisch Weekblad, 138 (13), pp. 461-464.

de Vries, C. S. and de Jong-van den Berg, L. T. W., 2003. Langs de valkuilen (14): Experiment versus observatie [experiment versus observation]. Pharmaceutisch Weekblad, 138 (21), p. 753.

de Vries, C. S. and de Jong-van den Berg, L. T. W., 2001. Langs de valkuilen (9) Handleiding kritisch lezen [A guide to critical appraisal]. Pharmaceutisch Weekblad, 136 (43), pp. 1614-1616.

de Vries, C. S. and de Jong-van den Berg, L. T. W., 2001. Pharmacovigilance and pharmacoepidemiology. In: Taylor, K. and Harding, G., eds. Pharmacy Practice. London: Taylor & Francis, pp. 367-392.

de Vries, C. S. and de Jong-van den Berg, L. T. W., 2004. Spontane rapportage en farmacoepidemiologie [spontaneous reporting and pharmacoepidemiology]. In: Buurma, H., de Jong-van den Berg, L. T. W. and Leufkens, H. G. M., eds. Het Geneesmiddel, 4th ed. Maarssen: Elsevier.

de Vries, C. S. and de Jong-van den Berg, L. T. W., 2008. Spontane rapportage en farmacoepidemiologie [spontaneous reporting and pharmacoepidemiology]. In: Buurma, H., de Jong-van den Berg, L. T. W. and Leufkens, H. G. M., eds. Het Geneesmiddel, 5th ed. Maarssen: Elsevier.

de Vries, C. S., van Groontheest, A. C. and de Jong-van den Berg, L. T. W., 2001. Farmaco-epidimiologie Langs de valkuilen (3) Spontane meldingen. Pharmaceutisch Weekblad, 136 (30), pp. 1104-1106.

de Vries, F., de Vries, C. S., Cooper, C., Leufkens, B. and van Staa, T. -P., 2006. Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database. International Journal of Epidemiology, 35 (5), pp. 1301-1308.

de Wit, M., Campbell, W., FitzGerald, O., Gladman, D. D., Helliwell, P. S., James, J., Lindsay, C., MacDonald, R., McHugh, N. J., Mease, P. J., Orbai, A.-M., Palominos, P., Parkinson, A., Tillett, W. and Goel, N., 2014. Patient Participation in Psoriasis and Psoriatic Arthritis Outcome Research : A Report from the GRAPPA 2013 Annual Meeting. The Journal of Rheumatology, 41 (6), pp. 1206-11.

E

Edge, S., Belu, A. M., Potter, U. J., Steele, D. F., Young, P. M., Price, R. and Staniforth, J. N., 2002. Chemical characterisation of sodium starch glycolate particles. International Journal of Pharmaceutics, 240, pp. 67-78.

Edge, S., Steele, D. F., Tobyn, M. J., Staniforth, J. N. and Chen, A., 2001. Directional bonding in compacted microcrystalline cellulose. Drug Development and Industrial Pharmacy, 27 (7), pp. 613-621.

Edginton, A. M. and Fotaki, N., 2010. Oral drug absorption in pediatric populations. In: Dressman, J. B. and Reppas, C., eds. Oral Drug Absorption: Prediction and Assessment, 2nd Edition. Vol. 193. New York: Informa Healthcare, pp. 108-126. (Drugs and the Pharmaceutical Sciences)

Edmead, C. E., Fox, B. C., Stace, C., Ktistakis, N. and Welham, M. J., 2006. The pleckstrin homology domain of Gab-2 is required for optimal interleukin-3 signalsome-mediated responses. Cellular Signalling, 18 (8), pp. 1147-1155.

Edwards, H. J., Hargrave, J. D., Penrose, S. D. and Frost, C. G., 2010. Synthetic applications of rhodium catalysed conjugate addition. Chemical Society Reviews, 39 (6), pp. 2093-2105.

Edwards, T., Thomas, R. D. and McHugh, N. J., 1993. Anticardiolipin antibodies in ischaemic heart disease. Lancet, 342 (8877), p. 989.

Eilers, H., Cattaruzza, F., Nassini, R., Materazzi, S., Andre, E., Chu, C., Cottrell, G. S., Schumacher, M., Geppetti, P. and Bunnett, N. W., 2010. Pungent General Anesthetics Activate Transient Receptor Potential-A1 to Produce Hyperalgesia and Neurogenic Bronchoconstriction. Anesthesiology, 112 (6), pp. 1452-1463.

El-Awady, E. S. E., Moss, S., Mottram, D. and O'Donnell, J., 2006. Student perspectives on pharmacy curriculum and instruction in Egyptian schools. American Journal of Pharmaceutical Education, 70 (1).

El-Awady, M., 2008. Molecular pharmacology of altered cardiopulmonary function in inflammation. Thesis (Doctor of Philosophy (PhD)). University of Bath.

El-Awady, M. S. H., Smirnov, S. V. and Watson, M. L., 2009. Voltage-independent calcium channels mediate lipopolysaccharide-induced hyporeactivity to endothelin-1 in the rat aorta. American Journal of Physiology-Heart and Circulatory Physiology, 296 (5), H1408-H1415.

El-Bassossy, H., El-Maraghi, N., El-Fayomi, H. and Watson, M. L., 2006. Heme oxygenase-1 protects against tumour necrosis factor-? and interleukin-1? induced hyporesponsiveness to ach in the rat pulmonary artery. In: British Pharmacological Society 75th Anniversery Meeting, 2006-12-01, Oxford.

El-Bassossy, H. M., El-Fawal, R., Fahmy, A. and Watson, M. L., 2013. Arginase inhibition alleviates hypertension in the metabolic syndrome. British Journal of Pharmacology, 169 (3), pp. 693-703.

El-Bassossy, H. M., El-Maraghy, N. N., El-Fayoumi, H. M. and Watson, M. L., 2009. Haem oxygenase-1 induction protects against tumour necrosis factor α impairment of endothelial-dependent relaxation in rat isolated pulmonary artery. British Journal of Pharmacology, 158 (6), pp. 1527-1535.

El-Sabawi, D., Edge, S., Price, R. and Young, P. M., 2006. Continued investigation into the influence of loaded dose on the performance of dry powder inhalers: Surface smoothing effects. Drug Development and Industrial Pharmacy, 32 Nov-Dec (10), pp. 1135-1138.

El-Sabawi, D., Price, R., Edge, S. and Young, P. M., 2006. Novel temperature controlled surface dissolution of excipient particles for carrier based dry powder inhaler formulations. Drug Development and Industrial Pharmacy, 32 (2), pp. 243-251.

Elhissi, A. M. A., O'Neill, M. A. A., Roberts, S. A. and Taylor, K. M. G., 2006. A calorimetric study of dimyristoylphosphatidylcholine phase transitions and steroid-liposome interactions for liposomes prepared by thin film and proliposome methods. International Journal of Pharmaceutics, 320, pp. 124-130.

Elmasry, M. S., Saleh, H. M., Kheir, A. A., Blagbrough, I. and Rogers, P. J., 2009. Quantitative HPLC analysis of mebeverine HCI and other GIT medicines stored in a monitored dosage system for polypharmacy. International Journal of Pharmacy Practice, 17 (Supplement 1), A111-A112.

Engstrom, W., Ward, A. and Moorwood, K., 2010. The role of scaffold proteins in JNK signalling. Cell Proliferation, 43 (1), pp. 56-66.

Essapen, S., Thomas, H., Green, M., de Vries, C. S., Cook, M., Marks, C., Topham, C. and Modjtahedi, H., 2004. The expression and prognostic significance of HER-2 in colorectal cancer and its relationship with clinicopathological parameters. International Journal of Oncology, 24 (2), pp. 241-248.

Evans, D. I., Jones, R. S. G. and Woodhall, G., 2000. Activation of presynaptic group III metabotropic receptors enhances glutamate release in rat entorhinal cortex. Journal of Neurophysiology, 83 (5), pp. 2519-2525.

Evans, D. M., Spencer, C. C. A., Pointon, J. J., Su, Z., Harvey, D., Kochan, G., Opperman, U., Dilthey, A., Pirinen, M., Stone, M. A., Appleton, L., Moutsianis, L., Leslie, S., Wordsworth, T., Kenna, T. J., Karaderi, T., Thomas, G. P., Ward, M. M., Weisman, M. H., Farrar, C., Bradbury, L. A., Danoy, P., Inman, R. D., Maksymowych, W., Gladman, D., Rahman, P., Morgan, A., Marzo-Ortega, H., Bowness, P., Gaffney, K., Gaston, J. S. H., Smith, M., Bruges-Armas, J., Couto, A. R., Sorrentino, R., Paladini, F., Ferreira, M. A., Xu, H. J., Liu, Y., Jiang, L., Lopez-Larrea, C., Diaz-Pena, R., Lopez-Vazquez, A., Zayats, T., Band, G., Bellenguez, C., Blackburn, H., Blackwell, J. M., Bramon, E., Bumpstead, S. J., Casas, J. P., Corvin, A., Craddock, N., Deloukas, P., Dronov, S., Duncanson, A., Edkins, S., Freeman, C., Gillman, M., Gray, E., Gwilliam, R., Hammond, N., Hunt, S. E., Jankowski, J., Jayakumar, A., Langford, C., Liddle, J., Markus, H. S., Mathew, C. G., McCann, O. T., McCarthy, M. I., Palmer, C. N. A., Peltonen, L., Plomin, R., Potter, S. C., Rautanen, A., Ravindrarajah, R., Ricketts, M., Samani, N., Sawcer, S. J., Strange, A., Trembath, R. C., Viswanathan, A. C., Waller, M., Weston, P., Whittaker, P., Widaa, S., Wood, N. W., McVean, G., Reveille, J. D., Wordsworth, B. P., Brown, M. A. and Donnelly, P., 2011. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nature Genetics, 43 (8), pp. 761-767.

Evans, L. A., Adams, H., Barber, C. G., Caggiano, L. and Jackson, R. F. W., 2007. Stereoselective synthesis of 2,3-difunctionalised thioesters using nucleophilic epoxidation of 1-arylthio-1-nitroalkenes. Organic and Biomolecular Chemistry, 5, pp. 31356-3163.

F

Fagiolino, P., Vázquez, M., Ibarra, M., Magallanes, L., Guevara, N. and Fotaki, N., 2014. Sex- and smoke-related differences in gastrointestinal transit of cyclosporin A microemulsion capsules. European Journal of Pharmaceutical Sciences, 63, pp. 140-146.

Fairholm, I. and Lench, A., 2014. Looking back : Freud, the libido and oxytocin. Psychologist, 27 (8), pp. 628-631.

Falasca, M., Chiozzotto, D., Godage, H. Y., Mazzoletti, M., Riley, A. M., Previdi, S., Potter, B. V. L., Broggini, M. and Maffucci, T., 2010. A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate. British Journal of Cancer, 102 (1), pp. 104-114.

Falasca, M., Riley, A., Godage, H. and Potter, B., 2011. Novel Inositol Phosphate Derivatives. A61K31/661-WO2011064559 (A2), 03 June 2011.

Fallows, A. J., Singh, I., Dondi, R., Cullis, P. M. and Burley, G. A., 2014. Highly efficient synthesis of DNA-binding polyamides using a convergent fragment-based approach. Organic Letters, 16 (17), pp. 4654-4657.

Family, H., 2013. The effects of mental workload on medicines safety in a community pharmacy setting. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Family, H., Bell, E., Choo, V., Hassan, S., Pugh, D. and Murphy, A., 2014. University student and staff views on the benefits and feasibility of an on-campus pharmacy. In: International Journal of Pharmacy Pratice. Vol. 22. Supplement 2 ed. , p. 48.

Family, H., Weiss, M. and Sutton, J., 2015. A diary study of community pharmacists' mental workload. In: International Journal of Pharmacy Practice. Vol. 23. Supplement 1 ed. , p. 20.

Family, H., Weiss, M. and Sutton, J., 2014. A qualitative study of the frustrations experienced by community pharmacists. In: International Journal of Pharmacy Practice. Vol. 22. Supplement 1 ed. , p. 8.

Farghaly, H., Causton, B., Blagbrough, I. and Watson, M. L., 2008. The effect of PI3K inhibition on IL-13-induced arginase I expression in mice tracheal segments. Fundamental & Clinical Pharmacology, 22, p. 14.

Farghaly, H., 2009. Pharmacological targets for gene therapy in lung inflammation. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Fasehee, H., Westers, H., Bolhuis, A., Antelmann, H., Hecker, M., Quax, W. J., Mirlohi, A. F., van Dijl, J. M. and Ahmadian, G., 2011. Functional analysis of the sortase YhcS in Bacillus subtilis. Proteomics, 11 (19), pp. 3905-3913.

Feighery, L. M., Cochrane, S. W., Quinn, T., Baird, A. W., O’Toole, D., Owens, S.-E., O’Donoghue, D., Mrsny, R. J. and Brayden, D. J., 2008. Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro. Pharmaceutical Research, 25 (6), pp. 1377-1386.

Felemez, M., Marwood, R. D., Potter, B. V. L. and Spiess, B., 1999. Inframolecular studies of the protonation of adenophostin A : comparison with 1-D-myo-inositol 1,4,5-trisphosphate. Biochemical and Biophysical Research Communications, 266 (2), pp. 334-340.

Felemez, M., Schlewer, G., Jenkins, D. J., Correa, V., Taylor, C. W., Potter, B. V. L. and Spiess, B., 1999. Inframolecular studies of the protonation of 1d-1,2,4/3,5-cyclopentanepentaol 1,3,4-trisphosphate, a ring-contracted analogue of 1d-myo-inositol 1,4,5-trisphosphate. Carbohydrate Research, 322 (1-2), pp. 95-101.

Ferbas, J., Belouski, S.S., Horner, M., Kaliyaperumal, A., Chen, L., Boyce, M., Colaço, C.B., Mchugh, N., Quick, V., Nicholl, R.J., Siu, G. and Chung, J., 2013. A novel assay to measure B cell responses to keyhole limpet haemocyanin vaccination in healthy volunteers and subjects with systemic lupus erythematosus. British Journal Of Clinical Pharmacology, 76 (2), pp. 188-202.

Ferguson, J. E., Potter, B. V. L. and Nuccitelli, R., 1990. The effect of myo-inositol 1, 4, 5-trisphosphorothioate on Cl-current pattern and intracellular Ca2+ in the Xenopus laevis oocyte. Biochemical and Biophysical Research Communications, 172 (1), pp. 229-236.

Ferrari, F., Cocconi, D., Bettini, R., Giordano, F., Santi, P., Tobyn, M., Price, R., Young, P., Caramella, C. and Colombo, P., 2004. The surface roughness of lactose particles can be modulated by wet-smoothing using a high-shear mixer. AAPS PharmSciTech, 5 (4), pp. 69-74.

Ferrer, S., Naughton, D. P., Parveen, I. and Threadgill, M. D., 2002. N- and O-Alkylation of isoquinolin-1-ones in the Mitsunobu reaction: development of potential drug delivery systems. Journal of the Chemical Society - Perkin Transcriptions 1

Ferrer, S., Naughton, D. P. and Threadgill, M. D., 2002. Labelled compounds of interest as antitumour agents - VIII. Synthesis of 2H-isotopomers of pentamethylmelamine and of a potential prodrug thereof. Journal of Labelled Compounds and Radiopharmaceuticals, 45, pp. 479-484.

Fijn, R., de Vries, C. S., Brouwers, J. R. B. J. and de Jong-van den Berg, L. T. W., 2000. Die Bedeutung von Arzneimittellisten im Krankenhaus [The impact of hospital drug formularies]. Krankenhauspharmazie, 21 (4), pp. 133-138.

Filipsson, S., Laaksonen, R., Duggan, C., Antoniou, S. and Coleman, V., 2007. Bridging therapy after heart valve replacement. Pharmacy World & Science, 29 (3), pp. 311-313.

Finnin, B. A., O'Neill, M. A. A., Gaisford, S., Beezer, A. E., Hadgraft, J. and Sears, P., 2006. Performance validation of step-isothermal calorimeters. Journal of Thermal Analysis and Calorimetry, 83 (2), pp. 331-334.

Finokaliotou, S., 2009. Synthetic and biological studies of antiparasitic natural product derivatives. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Firth, A. L., Gordienko, D. V., Yuill, K. H. and Smirnov, S. V., 2009. Cellular localization of mitochondria contributes to Kv channel-mediated regulation of cellular excitability in pulmonary but not mesenteric circulation. American Journal of Physiology-Lung Cellular and Molecular Physiology, 296 (3), L347-L360.

Firth, A. L., Gordienko, D. V., Yuill, K. H. and Smirnov, S. V., 2008. Cellular localization of mitochondria contributes to the regulation of Kv channel currents in the rat pulmonary, but not mesenteric arterial myocytes. In: Physiological Society Meeting, 2008-12-15 - 2008-12-17, Kings College London, London.

Firth, A. L., Yuill, K. H. and Smirnov, S. V., 2008. Mitochondria-dependent regulation of Kv currents in rat pulmonary artery smooth muscle cells. American Journal of Physiology-Lung Cellular and Molecular Physiology, 295 (1), L61-L70.

Fischer, D. S., Chander, S. K., Woo, L. W. L., Fenton, J. C., Purohit, A., Reed, M. J. and Potter, B. V. L., 2003. Novel D-ring modified steroid derivatives as potent, non-estrogenic steroid sulfatase inhibitors with in vivo activity. Steroid Biochemistry & Molecular Biology, 84 (2-3), pp. 343-349.

Fischer, D. S., Woo, L. W. L., Mahon, M. F., Purohit, A., Reed, M. J. and Potter, B. V. L., 2003. D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfatase. Bioorganic and Medicinal Chemistry, 11 (8), pp. 1685-1700.

Fisher, D. I., Safrany, S. T., Strike, P., McLennan, A. G. and Cartwright, J. L., 2002. Nudix hydrolases that degrade dinucleoside and diphosphoinositol polyphosphates also have 5-phosphoribosyl 1-pyrophosphate (PRPP) pyrophosphatase activity that generates the glycolytic activator ribose 1,5-biphosphate. Journal of Biological Chemistry, 277 (49), pp. 47313-47317.

Fithian, D. C., Paxton, E. W., Stone, M. L., Silva, P., Davis, D. K., Elias, D. A. and White, L. M., 2004. Epidemiology and natural history of acute patellar dislocation. The American Journal of Sports Medicine, 32 Jul-Aug (5), pp. 1114-1121.

FitzGerald, D. and Mrsny, R. J., 2000. New approaches to antigen delivery. Critical Review of Therapeutic Drug Carrier Systems, 17 (3), pp. 165-248.

Flower, V., Pauling, J. D., Shipley, J. A. and McHugh, N. J., 2010. Raynaud's phenomenon and macrocytic anaemia. BMJ, 341, c6011.

Folkes, L., Graham, A. and Weiss, M. C., 2001. A qualitative study of the views of women aged 18-29 on over-the-counter availability of hormonal emergency contraception. Journal of Family Planning and Reproductive Health Care, 27 (4), pp. 189-192.

Fonseca, C., Lindahl, G. E., Ponticos, M., Sestini, P., Renzoni, E. A., Holmes, A. M., Spagnolo, P., Pantelidis, P., Leoni, P., McHugh, N. J., Stock, C. J., Shi-Wen, X., Denton, C. P., Black, C. M., Welsh, K. I., du Bois, R. M. and Abraham, D. J., 2007. A polymorphism in the CTGF promoter region associated with systemic sclerosis. The New England Journal of Medicine, 357 (12), pp. 1210-1220.

Fonseca, C., Renzoni, E., Sestini, P., Pantelidis, P., Lagan, A., Bunn, C., McHugh, N., Welsh, K. I., Du Bois, R. M., Denton, C. P., Black, C. and Abraham, D., 2006. Endothelin axis polymorphisms in patients with scleroderma. Arthritis & Rheumatism, 54 (9), pp. 3034-3042.

Forsey, R. W., Fisher, J., Thompson, J., Stone, M. H., Bell, C. and Ingham, E., 2006. The effect of hyaluronic acid and phospholipid based lubricants on friction within a human cartilage damage model. Biomaterials, 27 (26), pp. 4581-4590.

Fossey, J.S., D'Hooge, F., van den Elsen, J.M.H., Pereira Morais, M.P., Pascu, S.I., Bull, S.D., Marken, F., Jenkins, A.T.A., Jiang, Y.-B. and James, T.D., 2012. The development of boronic acids as sensors and separation tools. Chemical Record, 12 (5), pp. 464-478.

Foster, J. G., 2012. The Role of Phosphatidylinositol 3-Kinase in P2X7R Gated Signalling in T Lymphocytes. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Foster, P. A., Chander, S. K., Newman, S. P., Woo, L. W. L., Sutcliffe, O. B., Bubert, C., Zhou, D. J., Chen, S. A., Potter, B. V. L., Reed, M. J. and Purohit, A., 2008. A new therapeutic strategy against hormone-dependent breast cancer : the preclinical development of a dual aromatase and sulfatase inhibitor. Clinical Cancer Research, 14 (20), pp. 6469-6477.

Foster, P. A., Chander, S. K., Parsons, M. F. C., Newman, S. P., Woo, L. W. L., Potter, B. V. L., Reed, M. J. and Purohit, A., 2008. Efficacy of three potent steroid sulfatase inhibitors : pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer. Breast Cancer Research and Treatment, 111 (1), pp. 129-138.

Foster, P. A., Ho, Y. T., Newman, S. P., Kasprzyk, P. G., Leese, M. P., Potter, B. V. L., Reed, M. J. and Purohit, A., 2008. 2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique. Breast Cancer Research and Treatment, 111 (2), pp. 251-260.

Foster, P. A., Ho, Y. T., Newman, S. P., Leese, M. P., Potter, B. V. L., Reed, M. J. and Purohit, A., 2009. STX140 and STX641 cause apoptosis via the intrinsic mitochondrial pathway and down-regulate survivin and XIAP expression in ovarian and prostate cancer cells. Anticancer Research, 29 (10), pp. 3751-3757.

Foster, P. A., Newman, S. P., Chander, S. K., Stengel, C., Jhalli, R., Woo, L. L. W., Potter, B. V. L., Reed, M. J. and Purohit, A., 2006. In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy. Clinical Cancer Research, 12 (18), pp. 5543-5549.

Foster, P. A., Newman, S. P., Leese, M. P., Bernetiere, S., Diolez, C., Camara, J., Hacher, B., Baronnet, M.-M., Ali, T., Potter, B. V. L., Reed, M. J. and Purohit, A., 2008. A new micronized formulation of 2-methoxyestradiol- bis -sulfamate (STX140) is therapeutically potent against breast cancer. Anticancer Research, 28 (2A), pp. 577-581.

Foster, P. A., Stengel, C., Ali, T., Leese, M. P., Potter, B. V. L., Reed, M. J., Purohit, A. and Newman, S. P., 2008. A comparison of two orally bioavailable anti-cancer agents, IRC-110160 and STX140. Anticancer Research, 28 (3A), pp. 1483-1491.

Foster, P. A., Woo, L. W. L., Potter, B. V. L., Reed, M. J. and Purohit, A., 2008. The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer. Endocrinology, 149 (8), pp. 4035-4042.

Foster, P. S., Hogan, S. P., Hansbro, P. M., O'Brien, R., Potter, B. V. L., Ozaki, S. and Denborough, M. A., 1994. The metabolism of d-myo-inositol 1,4,5-trisphosphate and d-myo-inositol 1,3,4,5-tetrakisphosphate by porcine skeletal muscle. European Journal of Biochemistry, 222 (3), pp. 955-964.

Foster, S. R., Pearce, A., Blake, A. J., Welham, M. J. and Dowden, J., 2007. Novel octavalent cross-linker displays efficient trapping of protein protein interactions. Chemical Communications

Fotaki, N., Symillides, M. and Reppas, C., 2005. Canine vs. in vitro data for predicting input profiles of L-sulpiride after oral administration. European Journal of Pharmaceutical Sciences, 26 (3-4), pp. 324-333.

Fotaki, N., Aivaliotis, A. and Reppas, C., 2005. The USP IV apparatus for the assessment of intraluminal drug release profile from extended relase products in the fasted state. In: 2nd International Symposium on Scientific and Regulatory Aspects of Dissolution and Bioequivalence, 2005, 2005-01-01, Athens.

Fotaki, N., Box, K., Comer, J., Mole, J., Taylor, R., Karki, S. and Price, R., 2013. Dissolution and precipitation studies of carbamazepine cocrystals with small scale assays. In: 2013 AAPS Annual Meeting and Exposition, 2013-11-10 - 2013-11-14, San Antonio.

Fotaki, N. and Brassine, C., 2013. Age related biorelevant dissolution testing for pediatric pellet formulations. In: 2013 AAPS Annual Meeting and Exposition, 2013-11-10 - 2013-11-14, San Antonio.

Fotaki, N., Gikas, E., Halabalaki, M. and Reppas, C., 2004. An improved GC-MS method for the quantification of isosorbide-5-mononitrate in plasma. European Journal of Pharmaceutical Sciences, 23 (Supplement), S39.

Fotaki, N., Karki, S., Price, R., Chapman, A. and Lenke, J., 2013. Forthcoming. Surface dissolution UV imaging for studying properties of pharmaceutical cocrystals for oral administration. AAPS Journal

Fotaki, N., Long, C., Tang, K. and Chokshi, H., 2013. Surface dissolution UV imaging for studying properties of a poorly soluble weak basic compound. In: 2013 AAPS Annual Meeting and Exposition, 2013-11-10 - 2013-11-14, San Antonio.

Fotaki, N., Long, C. M., Cuppok-Rosiaux, Y., Marchaud, D., Garbacz, G., Lange, S. and Klein, S., 2014. Estimating in vivo drug release from a new theophylline Compritol® 888 ATO matrix formulation using appropriate biorelevant test methods. In: 41st Annual Meeting & Exposition of the Controlled Release Society (CRS), 2014, 2014-07-13 - 2014-07-16, Chicago.

Fotaki, N., Long, C. M., Tang, K. and Chokshi, H., 2014. Dissolution of amorphous solid dispersions : theory and practice. In: Shah, N. H., Sandhu, H. K., Choi, D. S., Chokshi, H. K. and Malick, W., eds. Amorphous Solid Dispersions. New York, U. S. A.: Springer.

Fotaki, N., Martin, G.P. and Krämer, J., 2013. Dissolution highlights from the 2012 AAPS annual meeting in Chicago. Dissolution Technologies, 20 (2), pp. 57-59.

Fotaki, N., Martin, G.P. and Salt, A., 2014. Dissolution highlights from the 2013 AAPS annual meeting in San Antonio. Dissolution Technologies, 21 (3), pp. 44-46.

Fotaki, N., Obwoge, E., Tang, K. and Chokshi, H., 2007. Development of an in vitro-in vivo correlation (IVIVC) for a BCS Class II compound with pH-dependent solubility. In: American Association of Pharmaceutical Scientists (ΑΑPS) Annual Meeting and Exposition, 2007-11-09 - 2007-11-15, San Diego.

Fotaki, N. and Reppas, C., 2002. Biorelevant release data vs canine data for the prediction of isosorbide-5-mononitrate absorption profile from extended release products in the fasted state. In: SOCRATES Intensive Programme of Innovative Therapeutics : from Molecules to Drugs, 2002, 2002-06-02 - 2002-06-11, Crotone.

Fotaki, N., Vertzoni, M., Dressman, J. B. and Reppas, C., 2000. Optimising the in vitro conditions to simulate the release process in stomach after meals. European Journal of Pharmaceutical Scientists, 11 (S1), S44.

Fotaki, N., 2009. Pros and cons of methods used for the prediction of oral drug absorption. Expert Review of Clinical Pharmacology, 2 (2), pp. 195-208.

Fotaki, N., Aivaliotis, A., Butler, J., Dressman, J., Fischbach, M., Hempenstall, J., Klein, S. and Reppas, C., 2009. A comparative study of different release apparatus in generating in vitro–in vivo correlations for extended release formulations. European Journal of Pharmaceutics and Biopharmaceutics, 73 (1), pp. 115-120.

Fotaki, N., Brown, W., Kochling, J., Chokshi, H., Miao, H., Tang, K. and Gray, V., 2013. Rationale for selection of dissolution media: three case studies. Dissolution Technologies, 20 (3), pp. 6-13.

Fotaki, N., Gray, V., Kesisoglou, F., Mayock, S., Mirza, T. and Salt, A., 2013. Survey results for in vitro-in vivo correlations (IVIVC) : Critical variables for success. Dissolution Technologies, 20 (2), pp. 48-50.

Fotaki, N., Warren, K., Irish, N. and Haden Tebb, A., 2009. Development of in vitro-in vivo correlations (IVIVCs) for controlled release formulations of BSC Class I compounds. In: 2nd PharmSciFair, 2009-06-08 - 2009-06-12, Nice.

Fox, F. E., Rodham, K. J., Harris, M. F., Taylor, G. J., Sutton, J., Scott, J. and Robinson, B., 2009. Experiencing "the other side": a study of empathy and empowerment in general practitioners who have been patients. Qualitative Health Research, 19 (11), pp. 1580-1588.

Fox, F., Harris, M., Taylor, G. J., Rodham, K., Sutton, J., Robinson, B. and Scott, J., 2009. What happens when doctors are patients? qualitative study of GPs. British Journal of General Practice, 59 (568), pp. 811-818.

Fraley, C. D., Rashid, M. H., Lee, S. S. K., Gottschalk, R., Harrison, J., Wood, P. J., Brown, M. R. W. and Kornberg, A., 2007. A polyphosphate kinase 1 (ppk1) mutant of Pseudomonas aeruginosa exhibits multiple ultrastructural and functional defects. Proceedings of the National Academy of Sciences of the United States of America, 104 (9), pp. 3526-3531.

Fraser, S. J., Oughton, J., Batten, W. A., Clark, A. S. S., Schmierer, D. M., Gordon, K. C. and Strachan, C. J., 2013. Simultaneous qualitative and quantitative analysis of counterfeit and unregistered medicines using Raman spectroscopy. Journal of Raman Spectroscopy, 44 (8), pp. 1172-1180.

Freeburn, R. W., Wright, K. L., Burgess, S. J., Astoul, E., Cantrell, D. A. and Ward, S. G., 2002. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors. The Journal of Immunology, 169 (10), pp. 5441-5450.

Furkert, D. P. and Husbands, S. M., 2007. First asymmetric synthesis of trans -3,4-dimethyl-4-arylpiperidines. Organic Letters, 9 (19), pp. 3769-3771.

Fusi, L., Purohit, A., Brosens, J., Woo, L. W. L., Potter, B. V. L. and Reed, M. J., 2008. Inhibition of steroid sulfatase activity in endometriotic Implants by STX64 (667Coumate) : a potential new therapy. The Scientific World Journal, 8, pp. 1325-1327.

G

Gabra, B. H., Bailey, C. P., Kelly, E., Sanders, A. V., Henderson, G., Smith, F. L. and Dewey, W. L., 2007. Evidence for an important role of protein phosphatases in the mechanism of morphine tolerance. Brain Research, 1159, pp. 86-93.

Gabra, B. H., Bailey, C. P., Kelly, E., Smith, F. L., Henderson, G. and Dewey, W. L., 2008. Pre-treatment with a PKC or PKA inhibitor prevents the development of morphine tolerance but not physical dependence in mice. Brain Research, 1217, pp. 70-77.

Gage, H., Family, H., Murphy, F., Williams, P., Sutton, J. and Taylor, D., 2015. Comparison of sole nurse and team-delivered community clozapine services for people with treatment-resistant schizophrenia. Journal of Advanced Nursing, 71 (3), pp. 547-558.

Gaisford, S., O'Neill, M., Thompson, L. and Cahn, K. L., 2006. Shelf-life prediction of intravenous busulfan by isothermal calorimetry. Hospital Pharmacist, 13, pp. 295-298.

Gaisford, S. and O'Neill, M. A. A., 2006. Pharmaceutical Isothermal Calorimetry. USA: Informa Healthcare.

Galione, A., Parrington, J. and Dowden, J., 2004. The NAADP receptor : commentary on Billington et al. British Journal of Pharmacology, 142, pp. 1203-1207.

Galione, A. and Potter, B., 1998. Cyclic Adenosine Diphosphate Ribose Analogues. C07H19/20-WO9843992 (A1), 08 October 1998.

Galione, A., White, A., Willmott, N., Turner, M., Potter, B. V. L. and Watson, S. P., 1993. cGMP mobilizes intracellular Ca2+ in sea urchin eggs by stimulating cyclicADP-ribose synthesis. Nature, 365 (6445), pp. 456-459.

Gallagher, N. T., Garland, C. J. and Dora, K. A., 2006. Differential roles for IK Ca and SK Ca channels in EDHF-type responses in mouse mesenteric arteries. FASEB Journal, 20.

Gao, C.-H., Chen, Y.-N., Pan, L.-X., Lei, F., Long, B., Hu, L.-Q., Zhang, R.-C., Ke, K. and Huang, R.-M., 2014. Two new cyclic tetrapeptides from deep-sea bacterium bacillus amyloliquefaciens GAS 00152. Journal of Antibiotics, 67, pp. 541-543.

Gao, F. J., Cui, S. X., Chen, M. H., Cheng, Y. N., Sun, L. R., Ward, S. G., Kokudo, N., Tang, W. and Qu, X. J., 2008. Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells. Life Sciences, 83 (23-24), pp. 815-820.

Garden, D. L. F., Massey, P. V., Caruana, D. A., Johnson, B., Warburton, E. C., Aggleton, J. P. and Bashir, Z. I., 2009. Anterior thalamic lesions stop synaptic plasticity in retrosplenial cortex slices: expanding the pathology of diencephalic amnesia. Brain, 132 (7), pp. 1847-1857.

Garfield, A. S., Cowley, M., Smith, F. M., Moorwood, K., Stewart-Cox, J. E., Gilroy, K., Baker, S., Xia, J., Dalley, J. W., Hurst, L. D., Wilkinson, L. S., Isles, A. R. and Ward, A., 2011. Distinct physiological and behavioural functions for parental alleles of imprinted Grb10. Nature, 469 (7331), pp. 534-538.

Garg, P., Martin, C. F., Elms, S. C., Gordon, F. J., Wall, S. M., Garland, C. J., Sutliff, R. L. and O'Neill, W. C., 2007. Effect of the Na-K-2Cl cotransporter NKCC1 on systemic blood pressure and smooth muscle tone. American Journal of Physiology-Heart and Circulatory Physiology, 292 (5), H2100-H2105.

Garland, C. J., Smirnov, S., Bagher, P., Lim, C., Mitchell, R., Stanley, C., Pinkney, A. and Dora, K.A., 2015. TRPM4 inhibitor 9-phenanthrol activates endothelial cell intermediate conductance calcium-activated potassium channels in rat isolated mesenteric artery. British Journal of Pharmacology, 172 (4), pp. 1114-1123.

Garland, C. J., Yarova, P. L., Jiménez-Altayó, F. and Dora, K. A., 2011. Vascular hyperpolarization to β-adrenoceptor agonists evokes spreading dilatation in rat isolated mesenteric arteries. British Journal of Pharmacology, 164 (3), pp. 913-921.

Garland, C. J., 2004. Endothelium-dependent hyperpolarizing factor : a significant influence on vascular dilatation in health and disease. Journal of Medical Sciences - Taipei, 24 (2), pp. 59-70.

Garland, C. J., 2003. Role of endothelial cell ion channels in the resistance artery function. Neurophysiology, 35 (3/4), pp. 189-196.

Garnelis, T., Athanassopoulos, C. M., Papaioannou, D., Eggleston, I. M. and Fairlamb, A. H., 2004. Very short and efficient syntheses of the spermine alkaloid kukoamine A and analogs using isolable succinimidyl cinnamates. Chemistry Letters, 34 (2), pp. 264-265.

Garrett, S. W., Liu, C., Riley, A. M. and Potter, B. V. L., 1998. Rapid and practical synthesis of D-myo-inositol 1,4,5-trisphosphate. Journal of the Chemical Society, Perkin Transactions 1, 1998 (8), pp. 1367-1368.

Gawler, D. J., Potter, B. V. L., Gigg, R. and Nahorski, S. R., 1991. Interactions between inositol tris- and tetrakis-phosphates : effects on intracellular Ca2+ mobilization in SH-SY5Y cells. Biochemical Journal, 276 (1), pp. 163-167.

Gawler, D. J., Potter, B. V. L. and Nahorski, S. R., 1990. Inositol 1,3,4,5-tetrakisphosphate-induced release of intracellular Ca2+ in SH-SY5Y neuroblastoma cells. Biochemical Journal, 272 (2), pp. 519-524.

Geall, A. J., Al-Hadithi, D. and Blagbrough, I. S., 2002. Efficient calf thymus DNA condensation upon binding with novel bile acid polyamine amides. Bioconjugate Chemistry, 13, pp. 481-490.

Geall, A. J., Taylor, R. J., Earll, M. E., Eaton, M. A. W. and Blagbrough, I. S., 2000. Synthesis of cholesteryl polyamine carbamates: pK(a) studies and condensation of calf thymus DNA. Bioconjugate Chemistry, 11 (3), pp. 314-326.

Geinoz, S., Guy, R. H., Testa, B. and Carrupt, P. A., 2004. Quantitative structure-permeation relationships (QSPeRs) to predict skin permeation: a critical evaluation. Pharmaceutical Research, 21 (1), pp. 83-92.

Geinoz, S., Rey, S., Boss, G., Bunge, A. L., Guy, R. H., Carrupt, P. A., Reist, M. and Testa, B., 2002. Quantitative structure-permeation relationships for solute transport across silicone membranes. Pharmaceutical Research, 19 (11), pp. 1622-1629.

Gelfuso, G. M., Gratieri, T., Delgado-Charro, M. B., Guy, R. H. and Vianna Lopez, R. F., 2013. Iontophoresis-targeted, follicular delivery of minoxidil sulfate for the treatment of alopecia. Journal of Pharmaceutical Sciences, 102 (5), pp. 1488-1494.

Genovese, T., Mazzon, E., Di Paola, R., Muià, C., Patel, N. S. A., Threadgill, M. D., Caputi, A. P., Thiemermann, C. and Cuzzocrea, S., 2005. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and the development of bleomycin-induced lung injury. Journal of Pharmacology and Experimental Therapeutics, 313 (2), pp. 529-538.

Genovese, T., Mazzon, E., Muià, C., Patel, N. S. A., Threadgill, M. D., Bramanti, P., De Sarro, A., Thiemermann, C. and Cuzzocrea, S., 2005. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma. Journal of Pharmacology and Experimental Therapeutics, 312 (2), pp. 449-457.

Ghazaleh, H. A., Lalies, M. D., Husbands, S. M., Nutt, D. J. and Hudson, A. L., 2007. The effect of 1-(4,5-dihydro-1 H -imidazol-2-yl) on monoamine release ajnd turnover in the rat frontal cortex. Neuroscience Letters, 422, pp. 109-113.

Ghonaim, H. M., Li, S., Pourzand, C. and Blagbrough, I. S., 2007. Efficient novel unsymmetrical lipopolyamine formulations for gene delivery. Journal of Pharmacy and Pharmacology, 59, A37-A37.

Ghonaim, H. M., Li, S., Pourzand, C. and Blagbrough, I. S., 2007. Formulation and delivery of fluorescent siRNA by lipospermine nanoparticle complex formation. Journal of Pharmacy and Pharmacology, 59, A36-A37.

Ghonaim, H. M., Li, S., Soltan, M. K., Pourzand, C. and Blagbrough, I. S., 2007. Chain length modulation in symmetrical lipopolyamines and the effect on nanoparticle formulations for gene delivery. Journal of Pharmacy and Pharmacology, 59, A36-A36.

Ghonaim, H. M. and Blagbrough, I. S., 2014. Synthesis and formulations of lipid aminoglycoside conjugates : nanoparticles for efficient gene and sirna delivery. International Journal of Pharmacy and Pharmaceutical Sciences, 6 (2), pp. 153-157.

Ghonaim, H. M., 2008. Design and development of pharmaceutical dosage forms for gene and siRNA delivery. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Ghonaim, H. M., Cheng, Y. X., Pourzand, C. and Blagbrough, I., 2010. Self-assembled complex formulations of lipid-aminoglycoside conjugates : Nanoparticles for efficient gene and siRNA delivery. Journal of Pharmacy and Pharmacology, 62 (10), pp. 1295-1296.

Ghonaim, H. M., Soltan, M. K. and Blagbrough, I. S., 2010. Heterocyclic N-4, N-9-diacyl spermines : Nanoparticle lipopolyamine vectors for efficient pDNA and siRNA delivery. Journal of Pharmacy and Pharmacology, 62 (10), pp. 1276-1277.

Giardina, E., Hüffmeier, U., Ravindran, J., Behrens, F., Lepre, T., McHugh, N. J., Korendowych, E., Burkhardt, H., Novelli, G. and Reis, A., 2011. Tumor necrosis factor promoter polymorphism TNF*-857 is a risk allele for psoriatic arthritis independent of the PSORS1 locus. Arthritis & Rheumatism, 63 (12), pp. 3801-3806.

Giller, T., 2009. Iontophoretic delivery of selected antiparkinsonian agents in vitro. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Giuntini, F., Bourre, L., MacRobert, A. J., Wilson, M. and Eggleston, I. M., 2008. Quantitative determination of 5-aminolaevulinic acid and its esters in cell lysates by HPLC-fluorescence. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 875 (2), pp. 562-566.

Giuntini, F., Bourre, L., Wilson, M., MacRobert, A. J. and Eggleston, I. M., 2008. A novel approach to improve cellular delivery of 5-aminolaevulinic acid : New ALA-containing peptide prodrugs for photodynamic therapy. Journal of Peptide Science, 14 (8 (Suppl S)), p. 156.

Gladman, D. D., Cook, R. J., Schentag, C., Feletar, M., Inman, R., Hitchon, C., Karsh, J., Klinkhoff, A., Maksymowych, W., Mosher, D., Nair, B. and Stone, M. A., 2003. The clinical assessment of patients with psoriatic arthritis (PsA): Results of a validation study of the Spondyloarthritis Research Consortium of Canada. Arthritis & Rheumatism, 48 (9), S168-S168.

Gladman, D. D., Cook, R. J., Schentag, C., Feletar, M., Inman, R. I., Hitchon, C., Karsh, J., Klinkhoff, A. V., Maksymowych, W. P., Mosher, D. P., Nair, B. and Stone, M. A., 2004. The clinical assessment of patients with psoriatic arthritis: Results of a reliability study of the spondyloarthritis research consortium of Canada. Journal of Rheumatology, 31 (6), pp. 1126-1131.

Gladman, D. D., Inman, R. D., Cook, R. J., Maksymowych, W. P., Braun, J., Davis, J. C., Landewe, R. B. M., Mease, P., Brandt, J., Vargas, R. B., Chandran, V., Helliwell, P., Kavanaugh, A., O'Shea, F. D., Khan, M. A., Pipitone, N., Rahman, P., Reveille, J. D., Stone, M. A., Taylor, W., Veale, D. J. and van der Heijde, D., 2007. International spondyloarthritis interobserver reliability exercise - The INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis. Journal of Rheumatology, 34 (8), pp. 1740-1745.

Gladman, D. D., Inman, R. D., Cook, R. J., van der Heijde, D., Landewe, R. B. M., Braun, J., Davis, J. C., Mease, P., Brandt, J., Vargas, R. B., Chandran, V., Helliwell, P., Kavanaugh, A., O'Shea, F. D., Khan, M. A., Pipitone, N., Rahman, P., Reveille, J. D., Stone, M. A., Taylor, W., Veale, D. J. and Maksymowych, W. P., 2007. International spondyloarthritis interobserver reliability exercise - The INSPIRE study: I. Assessment of spinal measures. Journal of Rheumatology, 34 (8), pp. 1733-1739.

Gladman, D. D., Inman, R. D., Cook, R. R., Maksymowych, W., Van der Heijde, D., Landewe, R., Braun, J., Davis, J., Mease, P., Brandt, J., Vargas, R. B., Chandran, V., Helliwell, R., Kavanaugh, A., O'Shea, F. D., Khan, M. A., Pipitone, N., Rahman, P., Reveille, J. D., Stone, M., Taylor, W. and Veale, D. J., 2006. International spondyloarthritis inter-observer reliability exercise - The inspire study. Annals of the Rheumatic Diseases, 65, p. 217.

Gladman, D. D., Landewé, R., McHugh, N. J., Fitzgerald, O., Thaci, D., Coates, L., Mease, P. J., Qureshi, A. A., Krueger, G. G., Ritchlin, C. T., Kavanaugh, A. F. and Garg, A., 2010. Composite measures in psoriatic arthritis: GRAPPA 2008. Journal of Rheumatology, 37 (2), pp. 453-461.

Gliddon, A. E., Dore, C. J., Dunphy, J., Betteridge, Z., McHugh, N. J. and Maddison, P. J., 2011. Antinuclear antibodies and clinical associations in a British cohort with limited cutaneous systemic sclerosis. Journal of Rheumatology, 38 (4), pp. 702-705.

Gliddon, A. E., Doré, C. J., Black, C. M., McHugh, N. J., Moots, R., Denton, C. P., Herrick, A., Barnes, T., Camilleri, J., Chakravarty, K., Emery, P., Griffiths, B., Hopkinson, N. D., Hickling, P., Lanyon, P., Laversuch, C., Lawson, T., Mallya, R., Nisar, M., Rhys-Dillon, C., Sheeran, T. and Maddison, P. J., 2007. Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril. Arthritis & Rheumatism, 56 (11), pp. 3837-46.

Glouchankova, L., Krishna, U. M., Potter, B. V. L., Falck, J. R. and Bezprozvanny, I., 2000. Association of the inositol (1,4,5)-trisphosphate receptor ligand binding site with phosphatidylinositol (4,5)-bisphosphate and adenophostin A. Molecular Cell Biology Research Communications, 3 (3), pp. 153-158.

Goodyer, C. L. M., Chinje, E. C., Jaffar, M., Stratford, I. J. and Threadgill, M. D., 2003. Synthesis of N -Benzyl- and N -Phenyl-2-amino-4,5- dihydrothiazoles and thioureas and evaluation as modulators of the isoforms of nitric oxide synthase. Bioorganic and Medicinal Chemistry, 11 (19), pp. 4189-4206.

Goodyer, C. L. M., Chinje, E. C., Jaffar, M., Stratford, I. J. and Threadgill, M. D., 2003. Time-dependence and preliminary SAR studies in inhibition of nitric oxide synthase isoforms by homologues of thiocitrulline. Bioorganic & Medicinal Chemistry Letters, 13, pp. 3679-3680.

Gossec, L., Dougados, M., Phillips, C., Hammoudeh, M., de Vlam, K., Pavelka, K., Pham, T., Braun, J., Sieper, J., Olivieri, I., van der Heijde, D., Collantes, E., Stone, M., Kvien, T. K. and Asas, [N. V.], 2008. Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists. Annals of the Rheumatic Diseases, 67 (6), pp. 782-788.

Gossec, L., Kvien, T. K., Phillips, C., Hammoudeh, M., de Vlam, K., Pavelka, K., Pharm, T., Braun, J., Sieper, J., Oliveiri, I., Van der Heijde, D., Collantes, E., Stone, M. A. and Dougados, M., 2007. Dissemination and evaluation of the ASAS/EULAR recommendation for the management of ankylosing spondylitis: Results of a study among 1507 rheumatologists. Annals of the Rheumatic Diseases, 66, p. 65.

Gossec, L., Kvien, T., Phillips, C., Hammoudeh, M., de Vlam, K., Pavelka, K., Pham, T., Braun, J., Sieper, J., Oliveiri, I., van der Heijde, D., Collantes, E., Stone, M. and Dougados, M., 2007. Dissémination et évaluation des recommandations ASAS/EULAR pour la prise en charge de la Spondylarthrite Ankylosante (SA): résultats d’une étude chez 1,507 rhumatologues. Revue du Rhumatisme, 74 (11-12), pp. 1155-1156.

Gossec, L., Smolen, J. S., Gaujoux-Viala, C., Ash, Z., Marzo-Ortega, H., van der Heijde, D., Fitzgerald, O., Aletaha, D., Balint, P., Boumpas, D., Braun, J., Breedveld, F. C., Burmester, G., Cañete, J. D., de Wit, M., Dagfinrud, H., de Vlam, K., Dougados, M., Helliwell, P., Kavanaugh, A., Kvien, T. K., Landewé, R., Luger, T., Maccarone, M., McGonagle, D., McHugh, N. J., McInnes, I. B., Ritchlin, C., Sieper, J., Tak, P. P., Valesini, G., Vencovsky, J., Winthrop, K. L., Zink, A. and Emery, P., 2012. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Annals of the Rheumatic Diseases, 71 (1), pp. 4-12.

Grammatopoulos, G., Pandit, H. G., da Assunção, R., Taylor, A., McLardy-Smith, P., De Smet, K. A., Murray, D. W. and Gill, H. S., 2014. Pelvic position and movement during hip replacement. The Bone & Joint Journal, 96-B (7), pp. 876-883.

Grangier, G., Trigg, W. J., Lewis, T., Rowan, M. G., Potter, B. V. L. and Blagbrough, I. S., 1998. Synthesis of C5-substituted AE-bicyclic analogues of lycoctonine, inuline and methyllycaconitine. Tetrahedron Letters, 39 (8), pp. 889-892.

Gray, V., Fotaki, N. and Martin, G. P., 2012. Dissolution highlights from the 2011 AAPS annual meeting in Washington, D. C. Dissolution Technologies, 19 (1), pp. 69-70.

Greedy, B. M., Bradbury, F., Thomas, M. P., Grivas, K., Cami-Kobeci, G., Archambeau, A., Bosse, K., Clark, M. J., Aceto, M., Lewis, J. W., Traynor, J. R. and Husbands, S. M., 2013. Orvinols with mixed kappa/mu opioid receptor agonist activity. Journal of Medicinal Chemistry, 56 (8), pp. 3207-3216.

Greenhill, S. D., Morgan, N. H., Massey, P. V., Woodhall, G. L. and Jones, R. S. G., 2012. Ethosuximide modifies network excitability in the rat entorhinal cortex via an increase in GABA release. Neuropharmacology, 62 (2), pp. 807-814.

Greenhill, S. D., 2008. The role of synaptic noise in cortical excitability. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Grey, E.B., Harcourt, D., O'Sullivan, D., Buchanan, H. and Kilpatrick, N.M., 2013. A qualitative study of patients' motivations and expectations for dental implants. British Dental Journal, 214 (1), E1.

Grey, E., Family, H., Sutton, J. and Weiss, M., 2014. Are community pharmacists part of the primary care team? A survey of community pharmacist, GP and practice nurse perceptions of team work. In: International Journal of Pharmacy Practice. Vol. 22. Supplement 2 ed. , p. 39.

Gribbon, C. and De Bank, P., 2008. Cell/microparticle aggregates-a novel method to engineer large ex vivo neo-tissue. European Cells and Materials, 16 (Supplement 3), p. 56.

Griffiths, A. D., Potter, B. V. L. and Eperon, I. C., 1988. Substitution of pre-mRNA with phosphorothioate linkages reveals a new splicing-related reaction. Journal of Biological Chemistry, 263 (25), pp. 12295-12304.

Grint, T., Riley, A. M., Mills, S. J., Potter, B. V. L. and Safrany, S. T., 2012. Fibrinogen—a possible extracellular target for inositol phosphates. Messenger, 1 (2), pp. 160-166.

Groocock, J., Kitson, G., McGlen, S., Salek, M. and Rogers, P., 2011. The impact of the introduction of the GPhC Code of conduct for pharmacy students, and fitness to practise procedures on MPharm students in Great Britain. International Journal of Pharmacy Practice, 19 (Suppl 2), p. 10.

Grundt, P., Jales, A. R., Traynor, J. R., Lewis, J. W. and Husbands, S. M., 2003. 14-amino, 14-alkylamino, and 14-acylamino analogs of oxymorphindole. Differential effects on opioid receptor binding and functional profiles. Journal of Medicinal Chemistry, 46, pp. 1563-1566.

Grundt, P., Martinez-Bermejo, F., Lewis, J. W. and Husbands, S. M., 2003. The 14-alkyl- and 14-alkenyl-5β-methylindolomorphinan series provide δ-selective partial opioid agonists. Helvetica Chimica Acta, 86, pp. 793-798.

Grundt, P., Williams, I. A., Lewis, J. W. and Husbands, S. M., 2004. Identification of a new scaffold for opioid receptor antagonism based on the 2-amino-1,1-dimethyl-7-hydroxytetralin pharmacophore. Journal of Medicinal Chemistry, 47 (21), pp. 5069-5075.

Grégoire, S., Ribaud, C., Benech, F., Meunier, J. R., Garrigues-Mazert, A. and Guy, R. H., 2009. Prediction of chemical absorption into and through the skin from cosmetic and dermatological formulations. British Journal of Dermatology, 160 (1), pp. 80-91.

Gulmez, E., Lignot, S., Larrey, D., De Vries, C., Gutthann, S. P., Montastruc, J., Sturkenboom, M., Benichou, J., Velo, G., Caputi, A., Salvo, F., Hamoud, F., Micon, S., Lassalle, R., Jove, J., Pageaux, G., Horsmans, Y., Bernuau, J., Bissoli, F., Stricker, B., Thorburn, D., Gatta, A., Monteiro, E., Vafiadis, I., McCormick, A., Metselaar, H., Sen, E., Nightingale, A., Blin, P. and Moore, N., 2011. NSAID Exposure and Risk of Acute Liver Failure Leading to Transplantation: Principal Results of the 7-Country Case-Population Study (SALT). Drug Safety, 34 (10), p. 895.

Gulmez, E. S., Lignot, S., Larrey, D., De Vries, C., Perez-Gutthann, S., Montastruc, J. L., Sturkenboom, M., Benichou, J., Velo, G., Caputi, A., Salvo, F., Hamoud, F., Micon, S., Lassalle, R., Jove, J., Pageaux, G. P., Horsmans, Y., Bernuau, J., Bissoli, F., Stricker, B., Thorburn, D., Gatta, A., Monteiro, E., Vafiadis, I., McCormick, A., Metselaar, H., Sen, E., Nightingale, A., Blin, P. and Moore, N., 2011. NSAID Exposure and Risk of Acute Liver Failure Leading to Transplantation: Preliminary Results of the Study of Acute Liver Transplant (SALT) in 7 European Countries. Pharmacoepidemiology and Drug Safety, 20 (Supplement 1), S305-S305.

Gulmez, S.E., Larrey, D., Pageaux, G.-P., Lignot, S., Lassalle, R., Jové, J., Gatta, A., McCormick, P.A., Metselaar, H.J., Monteiro, E., Thorburn, D., Bernal, W., Zouboulis-Vafiadis, I., De Vries, C., Perez-Gutthann, S., Sturkenboom, M., Bénichou, J., Montastruc, J.-L., Horsmans, Y., Salvo, F., Hamoud, F., Micon, S., Droz-Perroteau, C., Blin, P. and Moore, N., 2013. Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen) : The multinational case-population SALT study. Drug Safety, 36 (2), pp. 135-144.

Gulmez, S.E., Larrey, D., Pageaux, G.-P., Lignot-Maleyran, S., De Vries, C., Sturkenboom, M., Perez-Gutthann, S., Bénichou, J., Bissoli, F., Horsmans, Y., Bernuau, J., Stricker, B., Thorburn, D., Blin, P. and Moore, N., 2013. Methodology for a multinational case-population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT). European Journal of Clinical Pharmacology, 69 (3), pp. 605-616.

Gunawardena, H., Wedderburn, L. R., North, J., Betteridge, Z., Dunphy, J., Chinoy, H., Davidson, J. E., Cooper, R. G., McHugh, N. J. and Juvenile Dermatomy Res Grp, U. K., 2008. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology, 47 (3), pp. 324-328.

Gunawardena, H., Harris, N. D., Carmichael, C. and McHugh, N. J., 2007. Maximum blood flow and microvascular regulatory responses in systemic sclerosis. Rheumatology, 46 (7), pp. 1079-1082.

Gunawardena, H. and McHugh, N. J., 2008. Features and recommended treatment of systemic sclerosis. Prescriber, 19 (18), pp. 59-65.

Gunawardena, H., Wedderburn, L. R., Chinoy, H., Betteridge, Z. E., North, J., Ollier, W. E. R., Cooper, R. G., Oddis, C. V., Ramanan, A. V., Davidson, J. E. and McHugh, N. J., 2009. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis & Rheumatism, 60 (6), pp. 1807-1814.

Guse, A. H., da Silva, C. P., Potter, B. V. L. and Mayr, G. W., 1997. Ca2+-signalling in human T-lymphocytes : potential roles for cyclic ADP-ribose and 2'- phospho-cyclic ADP-ribose. In: Koch-Nolte, F. and Haag, F., eds. ADP Ribosylation in Animal Tissues. London, U. K.: Plenum, pp. 431-436. (Advances in Experimental Medicine and Biology; 419)

Guse, A. H., Berg, I., da Silva, C. P., Potter, B. V. L. and Mayr, G. W., 1997. Ca2+ entry induced by cyclic ADP-ribose in intact T-lymphocytes. Journal of Biological Chemistry, 272 (13), pp. 8546-8550.

Guse, A. H., Cakir-Kiefer, C., Fukuoka, M., Shuto, S., Weber, K., Bailey, V. C., Matsuda, A., Mayr, G. W., Oppenheimer, N., Schuber, F. and Potter, B. V. L., 2002. Novel hydrolysis-resistant analogues of cyclic ADP-ribose : modification of the "northern" ribose and calcium release activity. Biochemistry, 41 (21), pp. 6744-6751.

Guse, A. H., Da Silva, C. P., Berg, I., Skapenko, A. L., Weber, K., Heyer, P., Hohenegger, M., Ashamu, G. A., Schulze-koops, H., Potter, B. V. L. and Mayr, G. W., 1999. Regulation of calcium in T lymphocytes by the second messenger cyclic ADP-ribose. Nature, 398 (6722), pp. 70-73.

Guse, A. H., Silva, C. P., Weber, K., Armah, C. N., Ashamu, G. A., Schulze, C., Potter, B. V. L., Mayr, G. W. and Hilz, H., 1997. 1-(5-Phospho-beta-D-ribosyl)2'-phosphoadenosine 5'-phosphate cyclic anhydride induced Ca2+ release in human T-cell lines. European Journal of Biochemistry, 245 (2), pp. 411-417.

Guse, A. H., da Silva, C. P., Emmrich, F., Ashamu, G. A., Potter, B. V. L. and Mayr, G. W., 1995. Characterization of cyclic adenosine diphosphate-induced Ca2-release in T-lymphocyte cell lines. The Journal of Immunology, 155 (7), pp. 3353-3359.

Guse, A. H., da Silva, C. P., Weber, K., Ashamu, G. A., Potter, B. V. L. and Mayr, G. W., 1996. Regulation of cADP-ribose-induced Ca2+ Release by Mg2+ and inorganic phosphate. Journal of Biological Chemistry, 271 (39), pp. 23946-23953.

Guy, R. H., 2003. 'Minimally invasive' technologies for transdermal delivery and clinical chemistry. In: Challenge in Drug Delivery for the New Millenium. Bulletin Technique Gattefossé 96. Vol. 96. , pp. 47-61. (Bulletin Technique Gattefossé)

Guy, R. H., 2007. Transdermal science and technology - an update. Drug Delivery System, 22 (4), pp. 442-449.

Guy, R. H., Delgado-Charro, M. B. and Kalia, Y. N., 2001. Iontophoretic transport across the skin. Skin Pharmacology and Applied Skin Physiology, 14 (Suppl 1), pp. 35-40.

Guy, R. H. and Hadgraft, J., 2003. Transdermal Drug Delivery (2nd ed). New York. U. S. A.: CRC Press.

Guy, R.H., Kuma, H. and Nakanishi, M., 2014. Serious photocontact dermatitis induced by topical ketoprofen depends on the formulation. European Journal of Dermatology, 24 (3), pp. 365-371.

Guy, R. H., 2010. Transdermal drug delivery. In: Schafer-Korting, M., ed. Drug Delivery. Springer, pp. 399-410. (Handbook of Experimental Pharmacology; 197)

Gülmez, S. E., Lignot-Maleyran, S., De Vries, C. S., Sturkenboom, M., Micon, S., Hamoud, F., Blin, P. and Moore, N., 2012. Administrative complexities for a European observational study despite directives harmonising requirements. Pharmacoepidemiology and Drug Safety, 21 (8), pp. 851-856.

Güngör, S., Delgado-Charro, M. B., Ruiz-Perez, B., Schubert, W., Isom, P., Moslem, P., Patane, M. A. and Guy, R. H., 2010. Trans-scleral iontophoretic delivery of low molecular weight therapeutics. Journal of Controlled Release, 147 (2), pp. 225-231.

Güngör, S., Delgado-Charro, M. B., Masini-Etévé, V., Potts, R. O. and Guy, R. H., 2013. Transdermal flux predictions for selected selective oestrogen receptor modulators (SERMs) : Comparison with experimental results. Journal of Controlled Release, 172 (3), pp. 601-606.

H

Hadgraft, J. and Guy, R. H., 2004. Biotechnological aspects of transport across human skin. Biotechnology & Genetic Engineering Reviews, 21, pp. 183-193.

Hadgraft, J. and Guy, R. H., 2003. Feasibility assessment in topical and transdermal delivery: mathematical models and in vitro studies. In: Guy, R. H. and Hadgraft, J., eds. Transdermal Drug Delivery, 2nd ed. Vol. 2nd Edition, Revised and Expanded. New York: Marcel Dekker, pp. 1-23.

Haigh, R. C. and Blake, D. R., 2001. Understanding pain. Clinical Medicine, 1 (1), pp. 44-48.

Hall, J., Rosenthal, M., Family, H., Sutton, J., Hall, K. and Tsuyuki, R. T., 2013. Personality traits of hospital pharmacists : Toward a better understanding of factors influencing pharmacy practice change. The Canadian Journal of Hospital Pharmacy, 66 (5), pp. 289-295.

Hamann, P.D.H., Cooper, R.G., McHugh, N.J. and Chinoy, H., 2013. Statin-induced necrotizing myositis - A discrete autoimmune entity within the "statin-induced myopathy spectrum". Autoimmunity Reviews, 12 (12), pp. 1177-1181.

Hamblin, M. R., Cummins, J. H. and Potter, B. V. L., 1986. Mung bean nuclease catalyses DNA cleavage with inversion of configuration at phosphorus. In: Biochemical Society Transactions, 1986. Vol. 14. 5 ed. Biochemical Society, pp. 899-900.

Hamblin, M. R., Cummins, J. H. and Potter, B. V. L., 1987. Mung bean (Phaseolus aureus) nuclease. Biochemical Journal, 241 (3), pp. 827-833.

Hamblin, M. R., Gigg, R. and Potter, B. V. L., 1987. Bisphosphorylation of a vic-diol using a phosphite approach : synthesis of myo-inositol 4,5-bisphosphate. Journal of the Chemical Society, Chemical Communications, 1987 (8), pp. 626-627.

Hamblin, M. R., Potter, B. V. L. and Gigg, R., 1987. Synthesis of myo-inositol phosphates and analogues using a phosphite chemistry approach. In: Biochemical Society Transactions, 1987. Vol. 15. 3 ed. Biochemical Society, pp. 1289-1290.

Hamilton, C. J., Fairlamb, A. H. and Eggleston, I. M., 2002. Regiocontrolled synthesis of the macrocyclic polyamine alkaloid ( + )-lunarine, a time-dependent inhibitor of trypanothione reductase. Journal of the Chemical Society - Perkin Transcriptions 1, 8, pp. 1115-1123.

Hamilton, C. J., Saravanamuthu, A., Fairlamb, A. H. and Eggleston, I. M., 2003. Benzofuranyl 3,5-bis-polyamine derivatives as time-dependent inhibitors of trypanothione reductase. Bioorganic and Medicinal Chemistry, 11, pp. 3683-3693.

Hamilton, C. J., Saravanamuthu, A., Poupat, C., Fairlamb, A. H. and Eggleston, I. M., 2006. Time-dependent inhibitors of trypanothione reductase. Analogues of the spermidine alkaloid lunarine and related natural products. Bioorganic and Medicinal Chemistry, 14, pp. 2266-2278.

Hamilton, C. S., Yasuhara, A., Baldwin, J. E., Lloyd, M. D. and Rutledge, P. J., 2001. Contrasting fates for 6-α-methylpenicillin N upon oxidation by deacetoxycephalosporin C synthase (DAOCS) and deacetoxy/deacetylcephalosporin C synthase (DAOC/DACS). Bioorganic & Medicinal Chemistry Letters, 11, pp. 2511-2514.

Hanning, L. M., Parmar, N. R. and Morris, E. J., 2013. Experiences using the Confluence wiki as an e-portfolio in a Pharmacist Prescribing Programme. In: Monash Pharmacy Education Symposium 2013, 2013-07-08 - 2013-07-10, Prato.

Hansbro, P.M., Foster, P. S., Liu, C. S., Potter, B. V. L. and Denborough, M. A., 1994. Kinetic analysis of novel inhibitors of inositol polyphosphate metabolism. Biochemical and Biophysical Research Communications, 200 (1), pp. 8-15.

Haque, S., Gordon, C., Isenberg, D., Rahman, A., Lanyon, P., Bell, A., Emery, P., McHugh, N. J., Teh, L. S., Scott, D. G. I., Akil, M., Naz, S., Andrews, J., Griffiths, B., Harris, H., Youssef, H., McLaren, J., Toescu, V., Devakumar, V., Teir, J. and Bruce, I. N., 2010. Risk factors for clinical coronary heart disease in systemic lupus erythematosus : The Lupus and Atherosclerosis Evaluation of Risk (LASER) study. Journal of Rheumatology, 37 (2), pp. 322-329.

Hargrave, J. D., Allen, J. C., Kociok-Kohn, G., Bish, G. and Frost, C. G., 2010. Catalytic enantioselective Dieckmann-type annulation: Synthesis of pyrrolidines with quaternary stereogenic centers. Angewandte Chemie-International Edition, 49 (10), pp. 1825-1829.

Hargrave, J.D., Allen, J.C. and Frost, C.G., 2010. Alternatives to organoboron reagents in rhodium-catalyzed conjugate additions. Chemistry - An Asian Journal, 5 (3), pp. 386-396.

Hargrave, J.D., Herbert, J., Bish, G. and Frost, C.G., 2006. Rhodium-catalysed addition of organotrialkoxysilanes to α-substituted acrylic esters. Organic and Biomolecular Chemistry, 4 (17), pp. 3235-3241.

Hargrave, J. D., Bish, G., Kociok-Kohn, G. and Frost, C. G., 2010. Rhodium-catalysed conjugate addition of arylboronic acids to enantiopure dehydroamino acid derivatives. Organic and Biomolecular Chemistry, 8 (22), pp. 5120-5125.

Harootunian, A. T., Kao, J. P. Y., Paranjape, S., Adams, S.R., Potter, B. V. L. and Tsien, R. Y., 1991. Cytosolic Ca2+ oscillations in REF52 fibroblasts : Ca2+-stimulated IP3 production or voltage-dependent Ca2+ channels as key positive feedback elements. Cell Calcium, 12 (2-3), pp. 153-164.

Harrington, L. S., Carrier, M. J., Gallagher, N., Gilroy, D., Garland, C. J. and Mitchell, J. A., 2007. Elucidation of the temporal relationship between endothelial-derived NO and EDHF in mesenteric vessels. American Journal of Physiology-Heart and Circulatory Physiology, 293 (3), H1682-H1688.

Harris, H., 2008. Rapid preformulation screening of drug candidates for dry powder inhaler preparation. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Harris, S. J., Foster, J. G. and Ward, S. G., 2009. PI3K isoforms as drug targets in inflammatory diseases : Lessons from pharmacological and genetic strategies. Current Opinion in Investigational Drugs, 10 (11), pp. 1151-1162.

Harris, S. J., Parry, R. V., Westwick, J. and Ward, S. G., 2008. Phosphoinositide lipid phosphatases: Natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes. Journal of Biological Chemistry, 283 (5), pp. 2465-2469.

Harris, S. J., 2010. Characterisation of SHIP-1 as a Regulator of T Lymphocyte Function. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Harris, S. J., Parry, R. V., Foster, J. G., Blunt, M. D., Wang, A., Marelli-Berg, F., Westwick, J. and Ward, S. G., 2011. Evidence that the lipid phosphatase SHIP-1 regulates T lymphocyte morphology and motility. The Journal of Immunology, 186 (8), pp. 4936-4945.

Harris, S. J., Ciuclan, L., Finan, P. M., Wymann, M. P., Walker, C., Westwick, J., Ward, S. G. and Thomas, M. J., 2012. Genetic ablation of PI3Kγ results in defective IL-17RA signalling in T lymphocytes and increased IL-17 levels. European Journal of Immunology, 42 (12), pp. 3394-3404.

Harvey, G., Black, C., Maddison, P. and McHugh, N., 1997. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives. Journal of Rheumatology, 24 (3), pp. 477-484.

Harvey, G. R., Butts, S., Rands, A. L., Patel, Y. and McHugh, N. J., 1999. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis. Clinical And Experimental Immunology, 117 (2), pp. 395-402.

Harvey, G. R. and McHugh, N. J., 1999. Serologic abnormalities in systemic sclerosis. Current Opinion in Rheumatology, 11 (6), pp. 495-502.

Hasdemir, B., Murphy, J. E., Cottrell, G. S. and Bunnett, N. W., 2009. Endosomal Deubiquitinating Enzymes Control Ubiquitination and Down-regulation of Protease-activated Receptor 2. Journal of Biological Chemistry, 284 (41), pp. 28453-28466.

Hassell, K., Atella, V., Schafheutle, E., Weiss, M. C. and Noyce, P., 2003. Cost to the patient or cost to the healthcare system? Which one matters most for GP prescribing decisions? A UK-Italy comparison. European Journal of Public Health, 13 (1), pp. 18-23.

Hathout, R. M. and Woodman, T. J., 2012. Applications of NMR in the characterization of pharmaceutical microemulsions. Journal of Controlled Release, 161 (1), pp. 62-72.

Hathout, R. M., Woodman, T. J., Mansour, S., Mortada, N. D., Geneidi, A. S. and Guy, R. H., 2010. Microemulsion formulations for the transdermal delivery of testosterone. European Journal of Pharmaceutical Sciences, 40 (3), pp. 188-196.

Hathout, R. M., Mansour, S., Mortada, N. D., Geneidi, A. S. and Guy, R. H., 2010. Uptake of microemulsion components into the stratum corneum and their molecular effects on skin barrier function. Molecular Pharmaceutics, 7 (4), pp. 1266-1273.

Hathout, R. M., Mansour, S., Geneidi, A. S. and Mortada, N. D., 2011. Visualization, dermatopharmacokinetic analysis and monitoring the conformational effects of a microemulsion formulation in the skin stratum corneum. Journal of Colloid and Interface Science, 354 (1), pp. 124-130.

Hathout, R. M. and Woodman, T. J., 2014. NMR diffusion-ordered spectroscopy can explain differences in skin penetration enhancement between microemulsion formulations. Nanomedicine: Nanotechnology, Biology, and Medicine, 10 (7), pp. 1389-1390.

Hay, F. R., O'Neill, M. A. A., Beezer, A. E. and Gaisford, S., 2006. Isothermal micro-calorimetry: a tool to predict seed longevity? Seed Science Research, 16, pp. 89-96.

Hayes, J. D., Kelleher, M. O. and Eggleston, I. M., 2008. The cancer chemopreventive actions of phytochemicals derived from glucosinolates. European Journal of Nutrition, 47, pp. 73-88.

Hayes, J. D., Kelleher, M. O., Eggleston, I. M., Akesson, B. and Merke, P., 2007. Anticarcinogenic effects of glucosinalate breakdown products. In: Dietary vitamins, polyphenols, selenium and probiotics: biomarkers of exposure and mechanisms of anticarcinogenic action. Nofer Institute of Occupational Medicine, pp. 140-160.

Heid, I. M., Jackson, A. U., Randall, J. C., Winkler, T. W., Qi, L., Steinthorsdottir, V., Thorleifsson, G., Zillikens, M. C., Speliotes, E. K., Mägi, R., Workalemahu, T., White, C. C., Bouatia-Naji, N., Harris, T. B., Berndt, S. I., Ingelsson, E., Willer, C. J., Weedon, M. N., Luan, J.'a., Vedantam, S., Esko, T., Kilpeläinen, T. O., Kutalik, Z., Li, S., Monda, K. L., Dixon, A. L., Holmes, C. C., Kaplan, L. M., Liang, L., Min, J. L., Moffatt, M. F., Molony, C., Nicholson, G., Schadt, E. E., Zondervan, K. T., Feitosa, M. F., Ferreira, T., Allen, H. L., Weyant, R. J., Wheeler, E., Wood, A. R., Estrada, K., Goddard, M. E., Lettre, G., Mangino, M., Nyholt, D. R., Purcell, S., Smith, A. V., Visscher, P. M., Yang, J., McCarroll, S. A., Nemesh, J., Voight, B. F., Absher, D., Amin, N., Aspelund, T., Coin, L., Glazer, N. L., Hayward, C., Heard-Costa, N. L., Hottenga, J.-J., Johansson, Å., Johnson, T., Kaakinen, M., Kapur, K., Ketkar, S., Knowles, J. W., Kraft, P., Kraja, A. T., Lamina, C., Leitzmann, M. F., McKnight, B., Morris, A. P., Ong, K. K., Perry, J. R. B., Peters, M. J., Polasek, O., Prokopenko, I., Rayner, N. W., Ripatti, S., Rivadeneira, F., Robertson, N. R., Sanna, S., Sovio, U., Surakka, I., Teumer, A., van Wingerden, S., Vitart, V., Zhao, J. H., Cavalcanti-Proença, C., Chines, P. S., Fisher, E., Kulzer, J. R., Lecoeur, C., Narisu, N., Sandholt, C., Scott, L. J., Silander, K., Stark, K., Tammesoo, M.-L., Teslovich, T. M., Timpson, N. J., Watanabe, R. M., Welch, R., Chasman, D. I., Cooper, M. N., Jansson, J.-O., Kettunen, J., Lawrence, R. W., Pellikka, N., Perola, M., Vandenput, L., Alavere, H., Almgren, P., Atwood, L. D., Bennett, A. J., Biffar, R., Bonnycastle, L. L., Bornstein, S. R., Buchanan, T. A., Campbell, H., Day, I. N. M., Dei, M., Dörr, M., Elliott, P., Erdos, M. R., Eriksson, J. G., Freimer, N. B., Fu, M., Gaget, S., Geus, E. J. C., Gjesing, A. P., Grallert, H., Gräßler, J., Groves, C. J., Guiducci, C., Hartikainen, A.-L., Hassanali, N., Havulinna, A. S., Herzig, K.-H., Hicks, A. A., Hui, J., Igl, W., Jousilahti, P., Jula, A., Kajantie, E., Kinnunen, L., Kolcic, I., Koskinen, S., Kovacs, P., Kroemer, H. K., Krzelj, V., Kuusisto, J., Kvaloy, K., Laitinen, J., Lantieri, O., Lathrop, G. M., Lokki, M.-L., Luben, R. N., Ludwig, B., McArdle, W. L., McCarthy, A., Morken, M. A., Nelis, M., Neville, M. J., Paré, G., Parker, A. N., Peden, J. F., Pichler, I., Pietiläinen, K. H., Platou, C. G. P., Pouta, A., Ridderstråle, M., Samani, N. J., Saramies, J., Sinisalo, J., Smit, J. H., Strawbridge, R. J., Stringham, H. M., Swift, A. J., Teder-Laving, M., Thomson, B., Usala, G., van Meurs, J. B. J., van Ommen, G.-J., Vatin, V., Volpato, C. B., Wallaschofski, H., Walters, G. B., Widen, E., Wild, S. H., Willemsen, G., Witte, D. R., Zgaga, L., Zitting, P., Beilby, J. P., James, A. L., Kähönen, M., Lehtimäki, T., Nieminen, M. S., Ohlsson, C., Palmer, L. J., Raitakari, O., Ridker, P. M., Stumvoll, M., Tönjes, A., Viikari, J., Balkau, B., Ben-Shlomo, Y., Bergman, R. N., Boeing, H., Smith, G. D., Ebrahim, S., Froguel, P., Hansen, T., Hengstenberg, C., Hveem, K., Isomaa, B., Jørgensen, T., Karpe, F., Khaw, K.-T., Laakso, M., Lawlor, D. A., Marre, M., Meitinger, T., Metspalu, A., Midthjell, K., Pedersen, O., Salomaa, V., Schwarz, P. E. H., Tuomi, T., Tuomilehto, J., Valle, T. T., Wareham, N. J., Arnold, A. M., Beckmann, J. S., Bergmann, S., Boerwinkle, E., Boomsma, D. I., Caulfield, M. J., Collins, F. S., Eiriksdottir, G., Gudnason, V., Gyllensten, U., Hamsten, A., Hattersley, A. T., Hofman, A., Hu, F. B., Illig, T., Iribarren, C., Jarvelin, M.-R., Kao, W. H. L., Kaprio, J., Launer, L. J., Munroe, P. B., Oostra, B., Penninx, B. W., Pramstaller, P. P., Psaty, B. M., Quertermous, T., Rissanen, A., Rudan, I., Shuldiner, A. R., Soranzo, N., Spector, T. D., Syvanen, A.-C., Uda, M., Uitterlinden, A., Völzke, H., Vollenweider, P., Wilson, J. F., Witteman, J. C., Wright, A. F., Abecasis, G. R., Boehnke, M., Borecki, I. B., Deloukas, P., Frayling, T. M., Groop, L. C., Haritunians, T., Hunter, D. J., Kaplan, R. C., North, K. E., O'Connell, J. R., Peltonen, L., Schlessinger, D., Strachan, D. P., Hirschhorn, J. N., Assimes, T. L., Wichmann, H.-E., Thorsteinsdottir, U., van Duijn, C. M., Stefansson, K., Cupples, L. A., Loos, R. J. F., Barroso, I., McCarthy, M. I., Fox, C. S., Mohlke, K. L. and Lindgren, C. M., 2010. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nature Genetics, 42 (11), pp. 949-960.

Hejaz, H. A. M., Woo, L. W. L., Purohit, A., Reed, M. J. and Potter, B. V. L., 2004. Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulfatase. Bioorganic and Medicinal Chemistry, 12 (10), pp. 2759-2772.

Hendryk, S., Czuba, Z. P., Jędrzejowska-Szypułka, H., Szliszka, E., Phillips, V. A., Threadgill, M. D. and Król, W., 2008. Influence of 5-aminoisoquinolin-1-one (5-AIQ) on neutrophil chemiluminescence in rats with transient and prolonged focal cerebral ischaemia and after reperfusion. Journal of Physiology and Pharmacology, 59 (4), pp. 811-822.

Herkenne, C., Alberti, I., Naik, A., Kalia, Y. N., Mathy, F. X., Préat, V. and Guy, R. H., 2008. In vivo methods for the assessment of topical drug bioavailability. Pharmaceutical Research, 25 (1), pp. 87-103.

Herkenne, C., Naik, A., Kalia, Y. N., Hadgraft, J. and Guy, R. H., 2007. Dermatopharmacokinetic prediction of topical drug bioavailability in vivo. Journal Of Investigative Dermatology, 127 (4), pp. 887-894.

Herkenne, C., Naik, A., Kalia, Y. N., Hadgraft, J. and Guy, R. H., 2008. Effect of propylene glycol on ibuprofen absorption into human skin in vivo. Journal of Pharmaceutical Sciences, 97 (1), pp. 185-197.

Herkenne, C., Naik, A., Kalia, Y. N., Hadgraft, J. and Guy, R. H., 2007. Ibuprofen transport into and through skin from topical formulations: in vitro - in vivo comparison. Journal Of Investigative Dermatology, 127 (1), pp. 135-142.

Herkenne, C., Naik, A., Kalia, Y. N., Hadgraft, J. and Guy, R. H., 2006. Pig ear skin ex vivo as a model for in vivo dermatopharmacokinetic studies in man. Pharmaceutical Research, 23 (8), pp. 1850-1856.

Herrick, A. L., Lunt, M., Whidby, N., Ennis, H., Silman, A., McHugh, N. J. and Denton, C. P., 2010. Observational study of treatment outcome in early diffuse cutaneous systemic sclerosis. Journal of Rheumatology, 37 (1), pp. 116-124.

Herrick, A. L., Roberts, C., Tracey, A., Silman, A., Anderson, M., Goodfield, M., McHugh, N. J., Muir, L. and Denton, C. P., 2009. Lack of agreement between rheumatologists in defining digital ulceration in systemic sclerosis. Arthritis & Rheumatism, 60 (3), pp. 878-882.

Hertle, R., Mrsny, R. and Fitzgerald, D. J., 2001. Dual-function vaccine for Pseudomonas aeruginosa : characterization of chimeric exotoxin A-Pilin protein. Infection and Immunity, 69 (11), pp. 6962-6969.

Hewinson, J., Moore, S. F., Glover, C., Watts, A. and Mackenzie, A. B., 2008. A key role for redox signaling in rapid P2X7 receptor-induced IL-1 β processing in human monocytes. The Journal of Immunology, 180 (12), pp. 8410-8420.

Hickman, M., Lingford-Hughes, A., Bailey, C., Macleod, J., Nutt, D. and Henderson, G., 2008. Does alcohol increase the risk of overdose death: the need for a translational approach. Addiction, 103 (7), pp. 1060-1062.

Hidalgo Aragones, M. I., Purohit, A., Parish, D., Sahm, U. G., Pouton, C. W., Potter, B. V., L. and Reed, M. J., 1996. Pharmacokinetics of oestrone-3-O-sulphamate. Steroid Biochemistry & Molecular Biology, 58 (5-6), pp. 611-617.

Higgins, L. G., Kelleher, M. O., Eggleston, I. M., Itoh, K., Yamamoto, M. and Hayes, J. D., 2009. Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents. Toxicology and Applied Pharmacology, 237 (3), pp. 267-280.

Hill, C. E., Rummery, N. M., Hickey, H. and Sandow, S. L., 2002. Heterogeneity in the distribution of vascular gap junctions and connexins : implications for function. Clinical and Experimental Pharmacology and Physiology, 29 (7), pp. 620-625.

Hill, C. E., Phillips, J. K. and Sandow, S. L., 2001. Heterogeneous control of blood flow amongst different vascular beds. Medicinal Research Reviews, 21 (1), pp. 1-60.

Hinch, M., Jacques, O., Drago, C., Caggiano, L., Jackson, R. F. W., Dexter, C., Anson, M. S. and MacDonald, S. J. F., 2006. Effective asymmetric oxidation of enones and alkyl aryl sulfides. Journal of Molecular Catalysis A: Chemical, 251 (1-2), pp. 123-128.

Hirst, P. H., Riley, A. M., Mills, S. J., Spiers, I. D., Poyner, D. R., Freeman, S., Potter, B. V. L. and Smith, A. W., 1999. Inositol polyphosphate-mediated iron transport in Pseudomonas aeruginosa. Journal of Applied Microbiology, 86 (3), pp. 537-543.

Ho, M. W. Y., Yang, X., Carew, M. A., Zhang, T., Hua, L., Kwon, Y.-U., Chung, S.-K., Adelt, S., Vogel, G., Riley, A. M., Potter, B. V. L. and Shears, S. B., 2002. Regulation of Ins(3,4,5,6)P 4 signaling by a reversible kinase/phosphatase. Current Biology, 12 (6), pp. 477-482.

Ho, Y. T., Newman, S. P., Purohit, A., Leese, M. P., Potter, B. V. L. and Reed, M. J., 2003. The effects of 2-methyl oestrogens and their sukphamaoylated derivatives in conjunction with TNF-α on endothelial and fibroblast cell growth, morphology and apoptosis. Steroid Biochemistry & Molecular Biology, 86, pp. 189-196.

Ho, Y. T., Newman, S. P., Purohit, A., Leese, M. P., Potter, B. V. L. and Reed, M. J., 2003. The effects of 2-methoxy oestrogens and their sulphamoylated derivatives in conjunction with TNF-α on endothelial and fibroblast cell growth, morphology and apoptosis. Steroid Biochemistry & Molecular Biology, 86 (2), pp. 189-196.

Ho, Y. T., Purohit, A., Vicker, N., Newman, S. P., Robinson, J. J., Leese, M. P., Ganeshapillai, D., Woo, L. W. L., Potter, B. V. L. and Reed, M. J., 2003. Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates. Biochemical and Biophysical Research Communications, 305 (4), pp. 909-914.

Hobbs, C. M., 2010. The Functional Expression of N-Methyl-D-Aspartate Glutamate-Type Receptors by Megakaryocytes and Platelets. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Hobert, M. E., Sands, K. A., Mrsny, R. J. and Madara, J. L., 2002. Cdc42 and Rac1 regulate late events in Salmonella typhimurium -induced Interleukin-8 secretion from polarizedepithelial cells. Journal of Biological Chemistry, 277 (52), pp. 51025-51032.

Hobson, R. J., Scott, J. and Sutton, J., 2010. Pharmacists and nurses as independent prescribers: Exploring the patient's perspective. Family Practice, 27 (1), pp. 110-120.

Hobson, R. J. and Sewell, G. J., 2003. A national survey of pharmacist transcribing of discharge prescriptions. International Journal of Pharmacy Practice, 11, pp. 89-95.

Hobson, R. J. and Sewell, G. J., 2006. A survey of nurse prescribing implementation in primary and secondary care in England. In: 12th Health Services Research & Pharmacy Practice Conference, 2006-01-01, University of Bath.

Hobson, R. J. and Sewell, G. J., 2004. Responsibility, accountability and factors influencing provision of pharmacist transcription of discharge prescriptions. International Journal of Pharmacy Practice, 12, pp. 163-168.

Hobson, R. J. and Sewell, G. J., 2006. Risks and concerns about supplementary prescribing: survey of primary and secondary care pharmacists. Pharmacy World & Science, 28 (2), pp. 76-90.

Hobson, R. J. and Sewell, G. J., 2006. Supplementary prescribing by pharmacists in England. American Journal of Health-Systems Pharmacy, 63, pp. 244-253.

Hobson, R. J. and Sewell, G. J., 2002. UK survey of discharge prescriptions, transcribing and development of the hospital pharmacist-prescribing role. International Journal of Pharmacy Practice, 10, R10.

Hobson, R. J., 2008. Investigation into early implementation of non medical prescribing in the UK. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Hodgkin, M., Craxton, A., Parry, J. B., Hughes, P. J., Potter, B. V. L., Michell, R. H. and Kirk, C. J., 1994. Bovine testis and human erythrocytes contain different subtypes of membrane-associated Ins(1,4,5)P3/Ins(1,3,4,5)P4 5-phosphomonoesterases. Biochemical Journal, 297 (3), pp. 637-645.

Hohenegger, M., Berg, I., Weigl, L., Mayr, G. W., Potter, B. V. L. and Guse, A. H., 1999. Pharmacological activation of the ryanodine receptor in Jurkat T-lymphocytes. British Journal of Pharmacology, 128 (6), pp. 1235-1240.

Holbourn, K. P., Lloyd, M. D., Thompson, A. S., Threadgill, M. D. and Acharya, K. R., 2011. Cloning, purification, crystallization and preliminary crystallographic analysis of the human histone deacetylase sirtuin 1. Acta Crystallographica Section F-Structural Biology and Crystallization Communications, 67 (4), pp. 461-463.

Holmström, A.-R., Airaksinen, M., Weiss, M., Laaksonen, R., Wuliji, T. and Chan, X.H., 2012. National and local medication error reporting systems: a survey of practices in 16 countries. Journal of Patient Safety, 8 (4), pp. 165-176.

Holt, R. J., Zhang, Y. M., Binia, A., Dixon, A. L., Vandiedonck, C., Cookson, W. O., Knight, J. C. and Moffatt, M. F., 2011. Allele-specific transcription of the asthma-associated PHD finger protein 11 gene (PHF11) modulated by octamer-binding transcription factor 1 (Oct-1). Journal of Allergy and Clinical Immunology, 127 (4), 1054-U322.

Hope, V., Scott, J., Cullen, K., Parry, J., NCube, F. and Hickman, M., 2015. Forthcoming. Going into the groin : injection into the femoral vein among people who inject drugs in three urban areas of England. Drug and Alcohol Dependence Item availability may be restricted.

Hopkins, A. M., Li, D. X., Mrsny, R. J., Walsh, S. V. and Nusrat, A., 2000. Modulation of tight junction function by G protein-coupled events. Advanced Drug Delivery Reviews, 41 (3), pp. 329-340.

Horne, G., Maechling, C., Fleig, A., Hirata, M., Penner, R., Spiess, B. and Potter, B. V. L., 2004. D-6-Deoxy-myo-inositol 1,3,4,5-tetrakisphosphate, a mimic of D-myo-inositol 1,3,4,5-tetrakisphosphate : biological activity and pH-dependent conformational properties. Biochemical and Biophysical Research Communications, 320 (4), pp. 1262-1270.

Hou, Q., De Bank, P. A. and Shakesheff, K. M., 2004. Injectable scaffolds for tissue regeneration. Journal of Materials Chemistry, 14, p. 1915.

Houston, D. R., Eggleston, I. M., Synstad, B., Eijsink, V. G. H. and van Aalten, D. M. F., 2002. The cyclic dipeptide CI-4 [ cyclo- (L-Arg-D-Pro)] inhibits family 18 chitinases by structural mimicry of a reaction intermediate. Biochemical Journal, 368 (27), pp. 23-27.

Houston, D. R., Synstad, B., Eijsink, V. G. H., Stark, M. J. R., Eggleston, I. M. and van Aalten, D. M. F., 2004. Structure-based exploration of cyclic dipeptide chitinase inhibitors. Journal of Medicinal Chemistry, 47, pp. 5713-5720.

Howarth, N. M., Cooper, G., Purohit, A., Duncan, L., Reed, M. J. and Potter, B. V. L., 1993. Phosphonates and thiophosphonates as sulfate surrogates : synthesis of estrone 3-methylthiophosphonate, a potent inhibitor of estrone sulfatase. Bioorganic & Medicinal Chemistry Letters, 3 (2), pp. 313-318.

Howarth, N. M., Purohit, A., Reed, M. J. and Potter, B. V. L., 1994. Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential. Journal of Medicinal Chemistry, 37 (2), pp. 219-221.

Howarth, N. M., Purohit, A., Reed, M. J. and Potter, B. V. L., 1997. Estrone sulfonates as inhibitors of estrone sulfatase. Steroids, 62 (4), pp. 346-350.

Howarth, N. M., Purohit, A., Robinson, J. J., Vicker, N., Reed, M. J. and Potter, B. V. L., 2002. Estrone 3-sulfate mimics, inhibitors of estrone sulfatase activity : homology model construction and docking studies. Biochemistry, 41 (50), pp. 14801-14814.

Howson, S. E., Bolhuis, A., Brabec, V., Clarkson, G. J., Malina, J., Rodger, A. and Scott, P., 2012. Optically pure, water-stable metallo-helical ‘flexicate’ assemblies with antibiotic activity. Nature Chemistry, 4 (1), pp. 31-36.

Hoyles, R. K., Ellis, R. W., Wellsbury, J., Lees, B., Newlands, P., Goh, N. S. L., Roberts, C., Desai, S., Herrick, A. L., McHugh, N. J., Foley, N. M., Pearson, S. B., Emery, P., Veale, D. J., Denton, C. P., Wells, A. U., Black, C. M. and du Bois, R. M., 2006. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis & Rheumatism, 54 (12), pp. 3962-3970.

Hsieh, J. C., Tham, D. M., Feng, W., Huang, F., Embaie, S., Liu, K., Dean, D., Hertle, R., Fitzgerald, D. J. and Mrsny, R. J., 2005. Intranasal immunization strategy to impede pilin-mediated binding of Pseudomonas aeruginosa to airway epithelial cells. Infection and Immunity, 73 (11), pp. 7705-7717.

Hu, Z., Pantoș, G. D., Kuganathan, N., Arrowsmith, R., Jacobs, R. M. J., Kociok-Köhn, G., O'Byrne, J., Jurkschat, K., Burgos, P., Tyrrell, R. M., Botchway, S. W., Sanders, J. K. M. and Pascu, S. I., 2012. Interactions between amino acid-tagged naphthalenediimide and single walled carbon nanotubes for the design and construction of new bioimaging probes. Advanced Functional Materials, 22 (3), pp. 503-518.

Huang, R. M., Yi, X. X., Zhou, Y., Su, X., Peng, Y. and Gao, C. H., 2014. An update on 2,5-Diketopiperazines from marine organisms. Marine Drugs, 12 (12), pp. 6213-6235.

Hudson, A. L., Nutt, D. J. and Husbands, S. M., 2001. Imidazoline receptors and their role in depression. Pharmaceutical News, 8 (3), pp. 18-24.

Hudson, A. L., Tyacke, R. J., Lalies, M. D., Davies, N., Finn, D. P., Martí, O., Robinson, E., Husbands, S. M., Minchin, M. C. W., Kimura, A. and Nutt, D. J., 2003. Novel ligands for the investigation of imidazoline receptors and their binding proteins. Annals of the New York Academy of Sciences, 1009, pp. 302-308.

Huffmeier, U., Uebe, S., Ekici, A. B., Bowes, J., Giardina, E., Korendowych, E., Juneblad, K., Apel, M., McManus, R., Ho, P., Bruce, I. N., Ryan, A. W., Behrens, F., Lascorz, J., Bohm, B., Traupe, H., Lohmann, J., Gieger, C., Wichmann, H. E., Herold, C., Steffens, M., Klareskog, L., Wienker, T. F., FitzGerald, O., Alenius, G. M., McHugh, N. J., Novelli, G., Burkhardt, H., Barton, A. and Reis, A., 2010. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nature Genetics, 42 (11), pp. 996-999.

Hull, L. C., Llorente, J., Gabra, B. H., Smith, F. L., Kelly, E., Bailey, C., Henderson, G. and Dewey, W. L., 2010. The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy. Journal of Pharmacology and Experimental Therapeutics, 332 (3), pp. 1127-1135.

Hull, L.C., Gabra, B.H., Bailey, C.P., Henderson, G. and Dewey, W.L., 2013. Reversal of morphine analgesic tolerance by ethanol in the mouse. Journal of Pharmacology and Experimental Therapeutics, 345 (3), pp. 512-519.

Hurley, B. P., Siccardi, D., Mrsny, R. J. and McCormick, B. A., 2004. Polymorphonuclear cell transmigration induced by Pseudomonas aeruginosa requires the eicosanoid hepoxilin A 3 1. The Journal of Immunology, 173 (9), pp. 5712-5720.

Husbands, S. M., 2004. Kappa-opioid receptor ligands. Expert Opinion on Therapeutic Patents, 14 (12), pp. 1725-1741.

Husbands, S. M., Glennon, R. A., Gorgerat, S., Gough, R., Tyacke, R., Crosby, J., Nutt, D. J., Lewis, J. W. and Hudson, A. L., 2001. β-carboline binding to imidazoline receptors. Drug and Alcohol Dependence, 64, pp. 203-208.

Husbands, S. M., Neilan, C. L., Broadbear, J., Grundt, P., Breeden, S., Aceto, M. D., Woods, J. H., Lewis, J. W. and Traynor, J. R., 2005. BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism. European Journal of Pharmacology, 509, pp. 117-125.

Husbands, S. M., 2013. Buprenorphine and related orvinols. In: Ko, M.-C. and Husbands, S. M., eds. Research and Development of Opioid-Related Ligands. Washington, DC: American Chemical Society, pp. 127-144. (ACS Symposium Series; 1131)

Hutcheon, G. W. and Bolhuis, A., 2003. The archael twin-arginine translocation pathway. Biochemical Society Transactions, 31 (3), pp. 686-689.

Hutcheon, G. W., Vasisht, N. and Bolhuis, A., 2005. Characterisation of a highly stable α-amylase from the halophilic archaeon Haloarcula hispanica. Extremophiles, 9, pp. 487-495.

Hutchison, A., Russell-Jones, D., Hordern, V. and de Vries, C. S., 2008. Reduced risk of hypoglycaemia in analogue compared with human insulin : An observational study in the UK. Pharmacoepidemiology and Drug Safety, 17 (Supplement 1), p. 271.

Hutchison, A., Russell-Jones, D. and de Vries, C. S., 2009. Predictors of drug choice in newly diagnosed type 2 diabetes. Diabetologia, 52 (Supplement 1), p. 314.

Huws, S. A., Morley, R. J., Jones, M. V., Brown, M. R. W. and Smith, A. W., 2008. Interactions of some common pathogenic bacteria with Acanthamoeba polyphaga. FEMS Microbiology Letters, 282 (2), pp. 258-265.

Huws, S. A., Smith, A. W., Enright, M. C., Wood, P. J. and Brown, M. R. W., 2006. Amoebae promote persistence of epidemic strains of MRSA. Environmental Microbiology, 8 (6), pp. 1130-1133.

Hyyryläinen, H. L., Bolhuis, A., Darmon, E., Muukkonen, L., Koski, P., Vitikainen, M., Sarvas, M., Prágai, Z., Bron, S., van Dijl, J. M. and Kontinen, V. P., 2001. A novel two-component regulatory system in Bacillus subtilis for the survival of severe secretion stress. Molecular Microbiology, 41 (5), pp. 1159-1172.

Hébert, H. L., Bowes, J., Smith, R. L., McHugh, N. J., Barker, J. N. W. N., Griffiths, C. E. M., Barton, A. and Warren, R. B., 2013. Polymorphisms in IL-1B distinguish between psoriasis of early and late onset. Journal Of Investigative Dermatology, 134 (5), pp. 1459-1462.

I

Iarova, P. L., Garland, C. J. and Dora, K. A., 2010. Activation of β-adrenoceptors evokes local and spreading dilatation in rat isolated mesenteric arteries. In: 60th Annual British Microcirculation Meeting, 2010-01-01, Peninsula Medical School, Exeter.

Iarova, P. L., Smirnov, S. V., Dora, K. A. and Garland, C. J., 2013. β1-adrenoceptor stimulation suppresses endothelial IKCa-channel hyperpolarization and associated dilatation in resistance arteries. British Journal of Pharmacology, 169 (4), pp. 875-886.

Iarova, P. L., 2011. Mechanisms underlying the endothelium-dependent modulation of vascular tone. Thesis (Doctor of Philosophy (PhD)). University of Bath. Item availability may be restricted.

Iiott, N. E., Heward, J. A., Roux, B., Tsitsiou, E., Fenwick, P. S., Lenzi, L., Goodhead, I., Hertz-Fowler, C., Heger, A., Hall, N., Donnelly, L. E., Sims, D. and Lindsay, M. A., 2014. Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide- induced inflammatory response in human monocytes. Nature Communications, 5, 3979.

Inman, R. and Stone, M., 2007. Reactive Arthritis: Etiology and Pathogenesis. In: Hochberg, M., Silman, A., Smolen, J., Weinblatt, M. and Weisman, M., eds. Rheumatology, 4th Edition. .

Irarrazabal, C. E., Burg, M. B., Ward, S. G. and Ferraris, J. D., 2006. Phosphatidylinositol 3-kinase mediates activation of ATM by high NaCl and by ionizing radiation: role in osmoprotective transcriptional regulation. Proceedings of the National Academy of Sciences of the United States of America, 103 (23), pp. 8882-8887.

Ireland, A. J., Moreno, T. and Price, R., 2003. Airborne particles produced during enamel cleanup after removal of orthodontic appliances. American Journal of Orthodontics and Dentofacial Orthopedics, 124, pp. 683-686.

Ireland, A. J., Wilson, A. A., Blythe, L., Johnston, N. J., Price, R. and Sandy, J. R., 2011. Particulate production during orthodontic production laboratory procedures. Journal of Exposure Science and Environmental Epidemiology, 21 (5), pp. 536-540.

Ireson, C. R., Chander, S. K., Purohit, A., Parish, D. C., Woo, L. W. L., Potter, B. V. L. and Reed, M. J., 2004. Pharmacokinetics of the nonsteroidal sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in rats. British Journal of Cancer, 91 (7), pp. 1399-1404.

Ireson, C. R., Chander, S. K., Purohit, A., Perera, S., Newman, S. P., Parish, D., Leese, M. P., Smith, A. C., Potter, B. V. L. and Reed, R. J., 2004. Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents. British Journal of Cancer, 90 (4), pp. 932-937.

Ireson, C. R., Parish, D., Purohit, A., Woo, L. W. L., Potter, B. V. L., Chander, S. K. and Reed, M. J., 2003. Development of a sensitive high-performance liquid chromatography method for the detection of 667 COUMATE in vivo. Journal of Steroid Biochemistry and Molecular Biology, 84 (2), pp. 337-342.

Isenberg, D. A., Rahman, A., Allen, E., Farewell, V., Akil, M., Bruce, I. N., D'Cruz, D., Griffiths, B., Khamashta, M., Maddison, P., McHugh, N., Snaith, M., Teh, L. S., Yee, C. S., Zoma, A. and Gordon, C., 2005. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology, 44 (7), pp. 902-906.

J

Jackson, T., Woo, L. W. L., Trusselle, M. N., Purohit, A., Reed, M. J. and Potter, B. V. L., 2008. Non-steroidal aromatase inhibitors based ona biphenyl scaffold: synthesis, in vitro SAR, and molecular modelling. ChemMedChem, 3, pp. 603-618.

Jackson, T. R., Springall, J. S., Rogalle, D., Masurnoto, N., Li, H. C., D'Hooge, F., Perera, S. P., Jenkins, A. T. A., James, T. D., Fossey, J. S. and van den Elsen, J. M. H., 2008. Boronate affinity saccharide electrophoresis : A novel carbohydrate analysis tool. Electrophoresis, 29 (20), pp. 4185-4191.

Jackson, T., Woo, L. W. L., Trusselle, M. N., Chander, S. K., Purohit, A., Reed, M. J. and Potter, B. V. L., 2007. Dual aromatase-sulfatase inhibitors based on the anastrozole template : synthesis, in vitro SAR, molecular modelling and in vivo activity. Organic and Biomolecular Chemistry, 5, pp. 2940-2952.

Jackson, T., Woo, L. W. L., Trusselle, M. N., Purohit, A., Reed, M. J. and Potter, B. V. L., 2008. Non-steroidal aromatase inhibitors based on a biphenyl scaffold : synthesis, in vitro SAR, and molecular modelling. ChemMedChem, 3 (4), pp. 603-618.

Jadon, D., Tillett, W., Wallis, D., Cavill, C., Bowes, J., Waldron, N., Dixon, A., Sengupta, R., Barton, A., Korendowych, E. and McHugh, N. J., 2013. Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis. Rheumatology, 52 (2), pp. 261-6.

Jakubovics, N. S., Smith, A. W. and Jenkinson, H. F., 2002. Oxidative stress tolerance is managanese (Mn 2+ ) regulated in Streptococcus gordonii. Microbiology, 148 (10), pp. 3255-3263.

James, K. L., Barlow, D., Bithell, A., Burfield, R., Hiom, S., Lord, S., Pollard, M., Roberts, D., Way, C., Sutton, C. and Whittlesea, C., 2011. Measuring dispensary workload: a comparison of the event recording and direct time techniques. International Journal of Pharmacy Practice, 19 (4), pp. 264-275.

James, K. L., Barlow, D., Burfield, R., Hiom, S., Roberts, D. and Whittlesea, C., 2008. A study of unprevented dispensing incidents in Welsh NHS hospitals. International Journal of Pharmacy Practice, 16 (3), pp. 175-188.

James, K. L., Barlow, D., Burfield, R., Hiom, S., Roberts, D. and Whittlesea, C., 2011. Unprevented or prevented dispensing incidents: which outcome to use in dispensing error research? International Journal of Pharmacy Practice, 19 (1), pp. 36-50.

James, K. L., Barlow, D., McArtney, R., Hiom, S., Roberts, D. and Whittlesea, C., 2009. Incidence, type and causes of dispensing errors : A review of the literature. International Journal of Pharmacy Practice, 17 (1), pp. 9-30.

James, K. L., Davies, J. G., Kinchin, I., Patel, J. P. and Whittlesea, C., 2010. Understanding vs. competency: the case of accuracy checking dispensed medicines in pharmacy. Advances in Health Sciences Education, 15 (5), pp. 735-747.

James, K. L., Barlow, D., Bithell, A., Hiom, S., Lord, S., Oakley, P., Pollard, M., Roberts, D., Way, C. and Whittlesea, C., 2013. The impact of automation on pharmacy staff experience of workplace stressors. International Journal of Pharmacy Practice, 21 (2), pp. 105-116.

James, K. L., Barlow, D., Bithell, A., Hiom, S., Lord, S., Pollard, M., Roberts, D., Way, C. and Whittlesea, C., 2013. The impact of automation on workload and dispensing errors in a hospital pharmacy. International Journal of Pharmacy Practice, 21 (2), pp. 92-104.

James, K. L., Barlow, D., Hiom, S., Roberts, D. and Whittlesea, C., 2008. Development and use of the critical incident technique in evaluating causes of dispensing incidents. International Journal of Pharmacy Practice, 16 (4), pp. 239-249.

Janciene, R., Stumbreviciute, Z., Podeniene, D., Puodziunaite, B. D., Black, S. and Husbands, S. M., 2006. Synthesis of novel 1-substituted [1,3]thiazolo[3,2- a ]-[1,5]benzodiazepine derivatives from 1,5-benzodiazepine-2-thiones and α-halogen carbonyl compounds. Journal of Heterocyclic Chemistry, 43, pp. 979-984.

Jarvest, R. L., Lowe, G. and Potter, B. V. L., 1981. Analysis of the chirality of [16O,17O,18O] phosphate esters by 31P nuclear magnetic resonance spectroscopy. Journal of the Chemical Society, Perkin Transactions 1

Jarvest, R. L., Lowe, G. and Potter, B. V. L., 1980. A stereochemical investigation of the cyclisation of D-glucose-6[(R)-16O,17O,18O]phosphate and adenosine-5′[(R)-16O,17O,18O]phosphate. Journal of the Chemical Society, Chemical Communications, 1980 (23), pp. 1142-1145.

Jenkins, D. J., Riley, A. M. and Potter, B. V. L., 1998. Carbohydrates as sources of chiral inositol polyphosphates and their mimics. In: Chapleur, Y., ed. Carbohydrate Mimics, Concepts and Methods. Chichester, U. K.: Wiley-VCH, pp. 171-208.

Jenkins, D. J., Dubreuil, D. and Potter, B. V. L., 1996. Synthesis of D-2-deoxy-myo-inositol 1,3,4,5-tetrakisphosphate from D-glucose. Journal of the Chemical Society - Perkin Transcriptions 1, 1996 (12), pp. 1365-1372.

Jenkins, D. J., Marwood, R. D. and Potter, B. V. L., 1997. A disaccharide polyphosphate mimic of 1D-myo-inositol 1,4,5-trisphosphate. Chemical Communications, 1997 (5), pp. 449-450.

Jenkins, D. J. and Potter, B. V. L., 1995. (2-Hydroxyethyl)-∝-D-glucopyranoside-2',3,4-trisphosphate : synthesis of a second messenger mimic related to adenophostin A. Journal of the Chemical Society, Chemical Communications, 1995 (11), pp. 1169-1170.

Jenkins, D. J., Riley, A. M. and Potter, B. V. L., 1996. Chiral cyclopentane-based mimics of D-myo -inositol 1,4,5-trisphosphate from D- glucose. Journal of Organic Chemistry, 61 (22), pp. 7719-7726.

Jenkinson, T., Armas, J., Evison, G., Cohen, M., Lovell, C. and McHugh, N. J., 1994. The cervical spine in psoriatic arthritis : a clinical and radiological study. British Journal of Rheumatology, 33 (3), pp. 255-259.

Jiang, L. H., Rassendren, F., Mackenzie, A. B., Zhang, Y. H., Surprenant, A. and North, R. A., 2005. N -methyl-D-glucamine and propidium dyes utilize different permeation pathways at rat P2X 7 receptors. American Journal of Physiology - Cell Physiology, 289, C1295-C1302.

Jiang, X., Tsitsiou, E., Herrick, S. E. and Lindsay, M. A., 2010. MicroRNAs and the regulation of fibrosis. FEBS Journal, 277 (9), pp. 2015-2021.

Jin, L., Weisman, M., Zhang, G., Ward, M., Luo, J., Bruckel, J., Inman, R., Khan, M. A., Schumacher, H. R., Maksymowych, W. P., Mahowald, M., Martin, T., Rosenbaum, J. T., Yu, D. T. Y., Stone, M., Watson, J., Dickman, E., Davis, J. and Reveille, J. D., 2005. Lack of association of matrix metalloproteinase 3 (MMP3) genotypes with ankylosing spondylitis susceptibility and severity. Rheumatology, 44 (1), pp. 55-60.

Jin, L., Zhang, G., Akey, J. M., Luo, J. C., Lee, J., Weisman, M. H., Bruckel, J., Inman, R. D., Stone, M. A., Khan, M. A., Schumacher, H. R., Maksymowych, W. P., Mahowald, M. L., Sawitzke, A. D., Vasey, F. B., Yu, D. T. Y. and Reveille, J. D., 2004. Lack of linkage of IL1RN genotypes with ankylosing spondylitis susceptibility. Arthritis & Rheumatism, 50 (9), pp. 3047-3048.

Jo, J., Ball, S. M., Seok, H., Oh, S. B., Massey, P. V., Molnar, E., Bashir, Z. I. and Cho, K., 2006. Experience-dependent modification of mechanisms of long-term depression. Nature Neuroscience, 9, pp. 170-172.

Johnson, E. A., Oldfield, S., Braksator, E., Gonzalez-Cuello, A., Couch, D., Hall, K. J., Mundell, S. J., Bailey, C. P., Kelly, E. and Henderson, G., 2006. Agonist-selective mechanisms of μ-opioid receptor desensitization in human embryonic kidney 293 cells. Molecular Pharmacology, 70 (2), pp. 676-685.

Jolly, P., Formisano, N., Djahanbakhsh Rafiee, S., Bhalla, N., Miodek, A., Dondi, R., Yang, D. K., Chen, L.C., Kasak, P., Tkac, J., Lloyd, M. D., Eggleston, I. M. and Estrela, P., 2014. DNA aptamer-based approaches for detection of multiple prostate cancer biomarkers. In: 22nd Meeting of the EAU Section of Urological Research (ESUR), 2014, 2014-10-09 - 2014-10-11, Glasgow.

Jones, C., Junk, P. C., Black, S. J. and Lewis, J., 2001. The molecular structure of [InBr(Salen)(OSMe2)]. Main Group Metal Chemistry, 24 (2), pp. 123-124.

Jones, M. D., Harris, H., Hooton, J. C., Shur, J., King, G. S., Mathoulin, C. A., Nichol, K., Smith, T. L., Dawson, M. L., Ferrie, A. R. and Price, R., 2008. An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances. European Journal of Pharmaceutics and Biopharmaceutics, 69 (2), pp. 496-507.

Jones, M. D., Hooton, J. C., Dawson, M. L., Ferrie, A. R. and Price, R., 2006. Dehydration of trehalose dihydrate at low relative humidity and ambient temperature. International Journal of Pharmaceutics, 313 (1-2), pp. 87-98.

Jones, M. D., Hooton, J. C., Dawson, M. L., Ferrie, A. R. and Price, R., 2006. The use of AFM to investigate how fines improve DPI performance. Journal of Pharmacy and Pharmacology, 58, A42-A43.

Jones, M. D., Hooton, J. C., Dawson, M. L., Ferrie, A. R. and Price, R., 2008. An investigation into the dispersion mechanisms of ternary dry powder inhaler formulations by the quantification of interparticulate forces. Pharmaceutical Research, 25 (2), pp. 337-348.

Jones, M. D., Young, P. M., Traini, D., Shur, J., Edge, S. and Price, R., 2008. The use of atomic force microscopy to study the conditioning of micronised budesonide. International Journal of Pharmaceutics, 357 (1-2), pp. 314-317.

Jones, S. M., Armas, J. B., Cohen, M. G., Lovell, C. R., Evison, G. and McHugh, N. J., 1994. Psoriatic arthritis : outcome of disease subsets and relationship of joint disease to nail and skin disease. British Journal of Rheumatology, 33 (9), pp. 834-839.

Jones, S. M., Harris, C. P., Lloyd, J., Stirling, C. A., Reckless, J. P. and McHugh, N. J., 2000. Lipoproteins and their subfractions in psoriatic arthritis : identification of an atherogenic profile with active joint disease. Annals of the Rheumatic Diseases, 59 (11), pp. 904-909.

Jones, S. M., Mathew, C. M., Dixey, J., Lovell, C. R. and McHugh, N. J., 1996. VCAM-1 expression on endothelium in lesions from cutaneous lupus erythematosus is increased compared with systemic and localized scleroderma. British Journal of Dermatology, 135 (5), pp. 678-686.

Jones, S. M. and McHugh, N. J., 1994. Subgroups in psoriatic arthritis. British Journal of Rheumatology, 33 (8), p. 789.

Jones, S. M., McKay, K. M. and McHugh, N. J., 1997. Bilateral hip replacements in a man with cystic fibrosis and episodic arthritis. British Journal of Rheumatology, 36 (2), pp. 298-299.

Jones, V. T., Lowe, G. and Potter, B. V. L., 1980. Evidence against a step-wise mechanism for the fumarase-catalysed dehydration of (2S)-malate. European Journal of Biochemistry, 108 (2), pp. 433-437.

Jongbloed, J. D. H., Bolhuis, A., Braun, P. G., Darmon, E., Dorenbos, R., Tjalsma, H., Westers, H., Zanen, G. E., Quax, W. J., Bron, S. and van Dijl, J. M., 2000. Functional analysis of the secretome of Bacillus subtilis. In: Biotechnology: Practice in Non-Food, 2000-10-22 - 2000-10-25, Muenster.

Jourdan, F., Bubert, C., Leese, M. P., Smith, A., Ferrandis, E., Regis-Lydi, S., Newman, S. P., Purohit, A., Reed, M. J. and Potter, B. V. L., 2008. Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates : synthesis, in vitro evaluation and computational modelling. Organic and Biomolecular Chemistry, 6 (22), pp. 4108-4119.

Jourdan, F., Leese, M. P., Dohle, W., Ferrandis, E., Newman, S. P., Chander, S., Purohit, A. and Potter, B. V. L., 2011. Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agents. Journal of Medicinal Chemistry, 54 (13), pp. 4863-4879.

Jourdan, F., Leese, M. P., Dohle, W., Hamel, E., Ferrandis, E., Newman, S. P., Purohit, A., Reed, M. J. and Potter, B. V. L., 2010. Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-Methoxyestradiol-3,17-O,O-bis-sulfamate. Journal of Medicinal Chemistry, 53 (7), pp. 2942-2951.

Ju, M., Scott-ward, T. S., Liu, J., Khuituan, P., Li, H., Cai, Z., Husbands, S. M. and Sheppard, D. N., 2014. Loop diuretics are open-channel blockers of the cystic fibrosis transmembrane conductance regulator with distinct kinetics. British Journal of Pharmacology, 171 (1), pp. 265-278.

Judd, K., 2011. Synthesis and evaluation of narciclasine analogues. Thesis (Doctor of Philosophy (PhD)). University of Bath.

K

Kabasakal, Y., Elvins, D. M., Ring, E. F. and McHugh, N. J., 1996. Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Annals of the Rheumatic Diseases, 55 (8), pp. 507-512.

Kaerger, J. S., Edge, S. and Price, R., 2004. Influence of particle size and shape on flowability and compactibility of binary mixtures of paracetamol and microcrystalline cellulose. European Journal of Pharmaceutical Sciences, 22 (2-3), pp. 173-179.

Kaestner, S. A. and Sewell, G. J., 2007. Chemotherapy dosing. Part I: scientific basis for current practice and use of body surface area. Clinical Oncology, 19 (1), pp. 23-37.

Kaestner, S. A. and Sewell, G. J., 2007. Chemotherapy dosing part II : alternative approaches and future prospects. Clinical Oncology, 19 (2), pp. 99-107.

Kaestner, S. and Sewell, G. J., 2007. A sequential temperature cycling study for the investigation of carboplatin infusion stability to facilitate 'dose-banding'. Journal of Oncology Pharmacy Practice, 13 (2), pp. 119-126.

Kaestner, S. and Sewell, G. J., 2007. Dose-banding of carboplatin: rationale and proposed banding scheme. Journal of Oncology Pharmacy Practice, 13 (2), pp. 109-117.

Kaestner, S., Walker, V., Roberts, S., Perren, T. and Sewell, G. J., 2004. Clinical and pharmacokinetic (PK) study on 'dose-banded' and individual-dose chemotherapy: an interim report. Journal of Oncology Pharmacy Practice, 10 (2), p. 100.

Kalia, Y. N., Alberti, I., Naik, A. and Guy, R. H., 2001. Assessment of topical bioavailability in vivo: the importance of stratum corneum thickness. Skin Pharmacology and Applied Skin Physiology, 14 (Suppl 1), pp. 82-86.

Kalia, Y. N. and Guy, R. H., 2001. Modeling transdermal drug release. Advanced Drug Delivery Reviews, 48, pp. 159-172.

Kalia, Y. N., Naik, A., Garrison, J. and Guy, R. H., 2004. Iontophoretic drug delivery. Advanced Drug Delivery Reviews, 56, pp. 619-658.

Kankaanranta, H., Ilmarinen, P., Zhang, X., Adcock, I.M., Lahti, A., Barnes, P.J., Giembycz, M.A., Lindsay, M. A. and Moilanen, E., 2014. Tumour necrosis factor-α regulates human eosinophil apoptosis via ligation of TNF-receptor 1 and balance between NF-κB and AP-1. PLoS ONE, 9 (2), e90298.

Kashmery, H. A., Clark, A. W., Dondi, R., Fallows, A. J., Cullis, P. M. and Burley, G. A., 2014. Defining the structural parameters of triazole ligands in the templated synthesis of silver nanoparticles. European Journal of Inorganic Chemistry, 2014 (28), 4886–4895.

Katz, J. L., Libby, T. A., Kopajtic, T., Husbands, S. M. and Newman, A. H., 2003. Behavioral effects of rimcazole analogues alone and in combination with cocaine. European Journal of Pharmacology, 468, pp. 109-119.

Kay, G. R., Staniforth, J. N., Newnes, L. B. and MacGregor, S. A., 1996. Powder comminution and blending characteristics of a novel jet multi-operational processor. European Journal of Pharmaceutical Scientists, 4 (Supplement 1), S184.

Kealey, S., Turner, E.M., Husbands, S.M., Salinas, C.A., Jakobsen, S., Tyacke, R.J., Nutt, D.J., Parker, C.A. and Gee, A.D., 2013. Imaging imidazoline-I binding sites in porcine brain using C-BU99008. The Journal of Nuclear Medicine, 54 (1), pp. 139-144.

Kealey, S., Gee, A. D., Husbands, S. M., Bennacef, I. and Passchier, J., 2011. (11)C Urea synthesis via palladium(II)-mediated oxidative carbonylation of amines. Journal of Labelled Compounds & Radiopharmaceuticals, 54 (Supplement 1), S108.

Kealey, S., Husbands, S., Casey, E. M., Salinas, C. A., Parker, C. A., Jakobsen, S., Tyacke, R. J., Nutt, D. J. and Gee, A. D., 2010. Synthesis and in vivo evaluation of 11C BU99008 as a ligand for the imidazoline 12 binding site. NeuroImage, 52 (Supplement 1), S127-S128.

Kealey, S., Husbands, S. M., Casey, E., Salinas, C. A., Parker, C. A., Jakobsen, S., Tyacke, R. J., Nutt, D. J. and Gee, A. D., 2011. Synthesis and in vivo evaluation of (11)C BU99008 as a ligand for the imidazoline I(2) binding site. Journal of Labelled Compounds & Radiopharmaceuticals, 54 (Supplement 1), S304.

Kealey, S., Husbands, S. M., Bennacef, I., Gee, A. D. and Passchier, J., 2014. Palladium-mediated oxidative carbonylation reactions for the synthesis of 11C-radiolabelled ureas. Journal of Labelled Compounds & Radiopharmaceuticals, 57 (4), pp. 202-208.

Kealey, S., Jennings, L. E., Miller, P. W., Gee, A. D., Plisson, C., White, A. J. P., Husbands, S. and Long, N. J., 2011. Copper(I) tris(pyrazolyl)borate complexes for use in positron emission tomograhpy. Journal of Labelled Compounds & Radiopharmaceuticals, 54 (7), p. 392.

Kealey, S., Plisson, C., Collier, T. L., Long, N. J., Husbands, S. M. and Gee, A. D., 2011. Solution (11)C carbonylation chemistry for the synthesis of a PET tracer - (11)C MK0233. Journal of Labelled Compounds & Radiopharmaceuticals, 54 (Supplement 1), S107.

Kealey, S., Plisson, C., Collier, T. L., Long, N. J., Husbands, S. M., Martarello, L. and Gee, A. D., 2011. Microfluidic reactions using C-11 carbon monoxide solutions for the synthesis of a positron emission tomography radiotracer. Organic and Biomolecular Chemistry, 9 (9), pp. 3313-3319.

Kee, C. H., Ariffin, A., Awang, K., Takeya, K., Morita, H., Hussain, S. I., Chan, K. M., Wood, P. J., Threadgill, M. D., Lim, C. G., Ng, S., Weber, J. F. F. and Thomas, N. F., 2010. Challenges associated with the synthesis of unusual o-carboxamido stilbenes by the Heck protocol: Intriguing substituent effects, their toxicological and chemopreventive implications. Organic and Biomolecular Chemistry, 8 (24), pp. 5646-5660.

Kellam, B., De Bank, P. A. and Shakesheff, K. M., 2003. Chemical modification of mammalian cell surfaces. Chemical Society Reviews, 32 (6), pp. 327-337.

Keller, G. A., Li, W. and Mrsny, R. J., 2000. Targeting macromolecular therapeutics to specific cell organelles. In: Park, K. and Mrsny, R. J., eds. Controlled Drug Delivery: Designing Technologies for the Future. Vol. 752. Washington, DC: American Chemical Society, pp. 168-183. (ACS Symposium Series)

Kelly, E., Bailey, C. P. and Henderson, G., 2008. Agonist-selective mechanisms of GPCR desensitization. British Journal of Pharmacology, 153 (S1), S379-S388.

Kershaw, N. J., Mukherji, M., MacKinnon, C. H., Claridge, T. W. D., Odell, B., Wierzbicki, A. S., Lloyd, M. D. and Schofield, C. J., 2001. Studies on phytanoyl-CoA 2-hydroxylase and synthesis of phytanoyl-coenzyme A. Bioorganic & Medicinal Chemistry Letters, 11, pp. 2545-2548.

Khan, M., Akey, J., Bruckel, J., Weisman, M., Inman, R., Stone, M., Maksymowych, W., Schumacher Jr, H., Mahowald, M., Sawitzke, A., Vasey, F., Yu, D., Newman, P., McClain, J., Jin, L. and Reveille, J., 2002. HLA-DRB1*0101 and DRB1*1501 but not HLA-B60(B*4001) Contribution to susceptability to Ankylosing Spondylitis (AS. Arthritis and Rheumatism, 46 (9), S1138.

Kim, J.-H., Resende, R., Wennekes, T., Chen, H.-M., Bance, N., Buchini, S., Watts, A. G., Pilling, P., Streltsov, V. A., Petric, M., Liggins, R., Barrett, S., Mckimm-Breschkin, J. L., Niikura, M. and Withers, S. G., 2013. Mechanism-based covalent neuraminidase inhibitors with broad spectrum influenza antiviral activity. Science, 340 (6128), pp. 71-75.

Kim, T. H., Stone, M., Payne, U., Zhang, X., King, L., Ionescu, M., Lobanok, T., Poole, A. R. and Inman, R. D., 2004. Biomarkers differentiate axial and peripheral disease in Ankylosing Spondylitis, and reflect response to infliximab. Arthritis & Rheumatism, 50 (9), S620-S620.

Kim, T. H., Stone, M., Rahman, P., Payne, U. and Inman, R. D., 2004. Analysis of IL-1 complex polymorphisms in Korean and Toronto ankylosing spondylitis patients. Arthritis & Rheumatism, 50 (9), S214-S214.

Kim, T. H., Stone, M. A., Rahman, P., Yoo, D. H., Park, Y. W., Payne, U., Hallett, D. and Inman, R. D., 2005. Interleukin 1 and nuclear factor-kappa B polymorphisms in ankylosing spondylitis in Canada and Korea. Journal of Rheumatology, 32 (10), pp. 1907-1910.

Kim, T., Stone, M., Payne, U., Zhang, X., Ionescu, M., Lobanok, T., King, L., Poole, A. and Inman, R., 2005. Cartilage Biomarkers in Ankylosing Spondylitis: Relationship to clinical variables and treatment response. Arthritis & Rheumatism, 52 (3), pp. 885-891.

Kimura, A., Tyacke, R. J., Robinson, J. J., Husbands, S. M., Minchin, M. C. W., Nutt, D. J. and Hudson, A. L., 2009. Identification of an imidazoline binding protein: Creatine kinase and an imidazoline-2 binding site. Brain Research, 1279, pp. 21-28.

Kingham, E., 2009. Investigation of phosphoinositide 3-kinase dependent signalling in the regulation of embryonic stem cell fate. Thesis (Doctor of Philosophy (PhD)). University of Bath.

Kingsley, G. H., Kowalczyk, A., Taylor, H., Ibrahim, F., Packham, J. C., McHugh, N. J., Mulherin, D. M., Kitas, G. D., Chakravarty, K., Tom, B. D. M., O'Keeffe, A. G., Maddison, P. J. and Scott, D. L., 2012. A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. Rheumatology, 51 (8), pp. 1368-1377.

Kinnunen, H., Shur, J., Hebbink, G., Muresan, A. S. and Price, R., 2010. Lactose fluidisation properties and their relationship to dry powder inhaler performance. Journal of Pharmacy and Pharmacology, 62 (10), pp. 1342-1343.

Kirchberger, T., Moreau, C., Wagner, G. K., Fliegert, R., Siebrands, C. C., Nebel, M., Schmid, F., Harneit, A., Odoardi, F., Flugel, A., Potter, B. V. L. and Guse, A. H., 2009. 8-Bromo-cyclic inosine diphosphoribose : towards a selective cyclic ADP-ribose agonist. Biochemical Journal, 422 (1), pp. 139-149.

Kissin, M. W., Snook, K. L., Layer, G. T., Jackson, P., de Vries, C. S., Shousha, S., Sinnett, H. D., Singhal, H., Nigar, E., Cunnick, G. and Chia, Y., 2009. Intraoperative molecular sentinel lymph node analysis with OSNA : Multicentre prospective UK evaluation. Cancer Research, 69 (2 Suppl), 106S.

Klein, M., Mann, H., Pleštilova, L., Betteridge, Z., McHugh, N., Remáková, M., Novota, P. and Vencovsky, J., 2014. Arthritis in Idiopathic Inflammatory Myopathy : Clinical Features and Autoantibody Associations. The Journal of Rheumatology

Kluettgens, B. U., Sewell, G. J. and Nunn, A. J., 2003. Current clinical practice in neonatal and paediatric parenteral nutrition in Europe. European Journal of Hospital Pharmacy, 9, pp. 122-126.

Kluettgens, B. U., Sewell, G. J. and Nunn, A. J., 2002. Current paediatric parenteral nutrition practice in Europe. International Journal of Pharmacy Practice, 10 (S1), R77.

Knez, L., Laaksonen, R. and Duggan, C., 2010. Evaluation of clinical interventions made by pharmacists in chemotherapy preparation. Radiology and Oncology, 44 (4), pp. 249-256.

Knez, L., Laaksonen, R., Duggan, C. and Nijjar, R., 2008. Evaluation of clinical interventions made by pharmacists in cancer services. The Pharmaceutical Journal, 280 (7492), pp. 277-280.

Ko, M. C. and Husbands, S. M., 2009. Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates. Journal of Pharmacology and Experimental Therapeutics, 328 (1), pp. 193-200.

Koffarnus, M. N., Greedy, B., Husbands, S. M., Grundt, P., Newman, A. H. and Woods, J. H., 2009. The discriminative stimulus effects of dopamine D2-and D3-preferring agonists in rats. Psychopharmacology, 203 (2), pp. 317-327.

Koh, W. H., Dunphy, J., Dixey, J., Calin, A., McHugh, N. J. and Maddison, P. J., 1995. Atypical antineutrophil cytoplasmic antibodies in patients with ankylosing spondylitis. British Journal of Rheumatology, 34 (7), pp. 695-696.

Koh, W. H., Dunphy, J., Whyte, J., Dixey, J. and McHugh, N. J., 1995. Characterisation of anticytoplasmic antibodies and their clinical associations. Annals of the Rheumatic Diseases, 54 (4), pp. 269-273.

Kolios, G., Valatas, V. and Ward, S. G., 2004. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology, 113, pp. 427-437.

Kommander, D., Fairservice, A., Deak, M., Gular, G. S., Prescott, A. R., Downes, C. P., Safrany, S. T., Alessi, D. R. and van Aalten, D. M. F., 2004. Structural insights into the regulation of PDK1 by phosphoinositides and inositol phosphates. EMBO Journal, 23, pp. 3918-3928.

Koob, Z., Perez, A., Bascompta, E., Soulard, C., Caroline, C., Hillairet de Boisferon, M., Woo, L. W. L., Potter, B. V. L., Reed, M. J., Ali, T., Bichat, F. and Prevost, G., 2011. Forthcoming. The steroid sulfatase inhibitor BN-83495 inhibits the growth of DMBA induced mammary tumors in rats alone or in combination with estradiol receptor blockers. Breast Cancer Research and Treatment

Korendowych, E., Owen, P., Ravindran, J., Carmichael, C. and McHugh, N., 2005. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. Rheumatology, 44 (8), pp. 1056-1060.

Korendowych, E., Dixey, J., Cox, B., Jones, S. and McHugh, N., 2003. The influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis. Journal of Rheumatology, 30 (1), pp. 96-101.

Korendowych, E. and McHugh, N., 2005. Genetic factors in psoriatic arthritis. Current Rheumatology Reports